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Abstract 
 There has been a significant increase in the number of people using club drugs and entering treatment 
for problematic club drug use in the United Kingdom. It has been suggested, based on socio-demographics, 
that the treatment needs of such users are different from those of users of traditional drugs, and consequently 
specialist club drug clinics were introduced.   
 However, to date no research has explored the subjective experience of problematic club drug use to 
substantiate an understanding of users’ psychological treatment needs or the subjective psychological 
motivations to use club drugs, or how such users self-identify rather than being categorised in terms of socio-
demographics. This research aims to answer these questions, with a focus on mephedrone, one of the most 
newly identified and popularly used club drugs in the United Kingdom.  
 Semi-structured interviews with six male users of mephedrone were analysed using interpretative 
phenomenological analysis. Findings suggested that the subjective experience of mephedrone use is like that 
of traditional drug use, and consequently that corresponding users’ psychological treatment needs are similar. 
The subjective motivation to use mephedrone was primarily concerned with a want to appease identity distress, 
a common precursor to substance misuse. Users of mephedrone appeared to make sense of their problematic 
use by progressing through the stages of change. Moreover, findings implied that stigmatising beliefs operated 
within the drug-using community, which facilitated the social construction of mephedrone as harmless in 
comparison to traditional drugs. This perception was found to be further propagated by terminology such as 
“club drugs” that are used within the professional arena and represent mephedrone as “fun”. Not only did the 
socially constructed image of mephedrone as harmless and fun encourage its use, it appeared to prevent users 
self-identifying with the stereotypical identity of problematic substance misuse commonly associated with 
traditional drug use. This potentially acted as a barrier against users of club drugs seeking treatment from 
generalised services based on the needs of traditional drug use, thus highlighting the necessity for specialised 
club drug clinics.   
 Implications of this research include introducing the under-represented area of problematic substance 
misuse to counselling psychology to promote the applicability of counselling psychologists to work in this field. 
This research fills the imperative training gap experienced by healthcare professionals based in the United 
Kingdom in relation to the understanding of problematic club drug use, and does so by providing subjective 
knowledge of the experience of problematic mephedrone use in order to develop the psychological treatments 
delivered. Furthermore, this research advocates the introduction of policies that would reduce the harm caused 
by mephedrone and demystify its socially constructed image.  One such policy would be to suggest interventions 
to distribute information concerning the harms associated with mephedrone.  Another would be to reframe the 
professional language used to describe club drugs. Lastly, this study highlights the need for further investigation 
into the stigmatising beliefs operating within the drug-using community that potentially act as a barrier preventing 
users of mephedrone from seeking treatment.  
  
 Keywords: mephedrone, club drugs, party drugs, subjective experience, qualitative research  
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1. Introduction 
 
1.1 Overview 
 The aim of this research is to explore the experiences, motivations and sense-making of users1 of 
mephedrone in the United Kingdom (UK). This section develops a basic understanding of the key concepts and 
provides an overview of the study, followed by a reflexive account prior to commencing the research. 
 
1.2 Key Concepts 
 1.2.1 Problematic substance misuse. As opposed to behavioural-related addictions such as 
gambling, this research focuses on the substance-related addiction of mephedrone use (for an explanation of 
mephedrone see section 1.2.2.1.1, p.16-17), which is characterised by corresponding symptoms of 
psychological and physical dependence on withdrawal (Marlatt & Donovan, 2005). Throughout this study the 
term problematic substance misuse (PSM) will replace the pejorative term addiction (for an understand ing of 
the stigma associated with the term addiction, see section 2.2.3, p.27-28). The term PSM appreciates that 
“certain individuals use certain substances in certain ways, thought at certain times to be unacceptable by 
certain other individuals for reasons both certain and uncertain” (Burglass & Shaffer, 1984, p.19). This definition 
understands that PSM is a unique lived experience that aligns itself with the subjective epistemology of this 
study (for an understanding of the research paradigm, see section 3.2.1, p.40-41), and with the principle of 
counselling psychology (CoP) that does “not assume the automatic superiority of any one way of experiencing, 
feeling, valuing and knowing” (Larsson, Brooks & Loewenthal, 2012, p.55). In line with Mirza and Mirza’s (2008; 
see Table 5, Appendix D, p.110-111) model of stages of drug use, PSM is synonymous with the “late at risk 
stage” and those beyond, whereas recreational drug use is synonymous with the “experimental” to the “early at 
risk stage” of use. Substance m isuse involves the misuse of drugs beyond their intended use, such as the 
intended use of ketamine as an anaesthetic which is also sometimes misused as a recreational drug.  
 
 1.2.2 Types of drugs. 
  1.2.2.1 Club drugs. New club drugs are rapidly produced: as of 2009 there were 24 new club 
drugs, rising to 41 by 2010, 49 by 2011, 57 by 2012 and so forth (Cole, 2011; Hawkes, 2012; European 
Monitoring Centre for Drugs and Drug Addiction, 2012). Conventionally, the term club drug categorised newly 
emerging drugs predominantly used in nightclubs, concerts and parties (Gahlinger, 2004; Smith, Larive & 
Romanelli, 2002). However, use has now expanded to other recreational contexts, e.g. homes, shopping malls 
and schools (Parks & Kennedy, 2004; Ramo, Gov, Delucchi, Kelly & Parsons, 2010). Some club drugs are sold 
on the illicit market, while others are sold as “legal highs”, “designer drugs” or “novel/new psychoactive 
                                                                 
1 The term “user” is thought to characterise and label people who misuse a chosen substance, and in doing so it linguistically  erases 
indiv idual differences in experience and therefore depersonalises the people to whom the term is applied (Broy les et al., 2014). In this  
thesis, the term “user” refers “to a person using a specific drug problematically”. Such use of “people-first language” respects an 
indiv idual’s identity  as a person ﬁrst and foremost (Broy les et al., 2014). This perspective is aligned to the philosophical underpinnings 
of counselling psychology that appreciates subjectiv ity  and humanistic values. 
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substances” (NPS; Novel Psychoactive Treatment United Kingdom Network; NEPTUNE, 2015). Such drugs are 
synthesised substances produced to mimic the desirable effects of favoured controlled substances such as 
“traditional drugs” (for an understanding of traditional drugs, see section 1.2.2.2, p.17-18), although they have 
different chemical compositions to evade the provisions of national policies (Advisory Council on the Misuse of 
Drugs, 2011; Carroll, Lewin, Mascarella, Seltsman & Reddy, 2012).  
 
   1.2.2.1.1 Mephedrone (4-methylmethcathinone). In no particular order, the five most 
commonly used club drugs in the UK consist of: (1) gamma-hydroxybutrate (GHB) and its derivative gamma-
Butyrolactone (GBL), (2) ketamine, (3) ecstasy, (4) methamphetamine and (5) mephedrone (NEPTUNE, 2015). 
Increases in the number of users presenting to treatment were observed for all five club drugs. However, the 
most significant was an 82% increase in mephedrone presentations from 900 in 2011-12 to 1,641 in 2013-2014 
(NEPTUNE, 2015).  
 Mephedrone is a stimulant manufactured from cathinone, the active ingredient of the African shrub 
Khat, which is marketed legally as plant food or bath salts (Mackay, Taylor & Bajaj, 2011). It is sold as a white 
powder that is administered orally, via nasal insufflation or injection. Desirable physiological and psychological 
effects include increased energy, euphoria, talkativeness, empathy, increased sexual desire and visual and 
auditory hallucinations (The National Treatment Agency for Substance Misuse; NTA, 2005; Winstock et al., 
2011). Such effects have been commonly found to facilitate “chemsex”, a term used to describe sexual 
intercourse between individuals under the influence of drugs which are taken immediately preceding and/or 
during intercourse (Bourne, Reid, Hickson, Torres Rueda & Weatherburn, 2014). Adverse effects include nose-
bleeds, tachycardia, headaches, tremors and skin rashes (Kapitany-Foveny et al., 2013). Deaths by 
mephedrone have tripled from 6 in 2010 to 18 in 2014 in the UK (Health & Social Care Information Centre, 
2014). 
 Since mephedrone was prohibited as an illegal Class B drug in April 2010, the Crime Survey for 
England and Wales (CSEW) suggested that mephedrone use reduced. The use of mephedrone among adults 
(16-to-59-year-olds) was reported as 1.3% (418,600) in 2010-2011; it fell to 1.0% (322,000) in 2011-2012 and 
to 0.5% (161,000) in 2012-2013, before stabilising in 2013-2014 (0.6%; 193,000; authors’ calculations based 
on 2012 population; Home Office, 2014). However, small-scale surveys of club goers suggested that 
mephedrone use may have in fact increased from 2010-2011 (Measham, Wood, Dargan & Moore, 2011; Wood, 
Measham & Dargan, 2012). Either way, the 2011-2012 CSEW reported that mephedrone remained the most 
used club drug (Home Office, 2014). Mephedrone use among adults (16-to-59-year-olds) was higher (1.0%) 
than any other club drugs measured in the survey that year (GBL/GHB, spice and Benzylpiperazine were 0.1%). 
Moreover, during 2014-2015 mephedrone remained the most commonly used drug in combination with other 
drugs by adults (16-to-59-year-olds) in the UK at 68% (22.4 million people approximately; Home Office, 2015). 
More recently the UK Psychoactive Substances Act (2016) that aimed to eradicate the market in NPS, including 
club drugs, claimed that “mephedrone [specifically] has remained popular on the London drug sc ene” 
(Hockenhulla, Murphy & Patersona, 2016, p.1720).  
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 Arguably the reliability of the survey data reviewed could be questionable. When completing surveys, 
the participants could have given exaggerated or false information. However, providing the confiden tial and 
flexible method of surveys could have encouraged participants to be more open without the fear of judgement. 
Arguably, the decrease in mephedrone use, as reported by the CSEW from 2010-2014, could be due to 
participants being unwilling to disclose their use over time since mephedrone had been made illegal. 
Nevertheless, the CSEW supported that mephedrone use had remained the most popular club drug of choice, 
and it could be assumed that such survey data is both internally and externally valid since it is not subject to a 
particular setting but is undertaken nationally. Whereas, the studies conducted by Measham et al. (2011) and 
Wood et al. (2012), that suggested that mephedrone use may have increased during 2010-2011, could be 
deemed internally valid as they provide survey data of the intake of mephedrone by club goers that attended 
“gay” dance clubs in South London (Measham et al., 2011, p.263), though such findings may not be deemed 
externally valid as they may not be generalisable to settings outside of the one investigated. However, it could 
be argued that data that is valid but not generalisable is at least useful for informing practice in the setting in 
which it is carried out, and that perhaps such studies highlight that such drug use may be problematic or popular 
in certain settings.  Nevertheless, Wood et al. (2012) suggested that although there were overall higher levels 
of drug use by this particular sample disproportionate to the general population, a salient feature of their survey 
data is that the ranking of drugs used by participants mirrors that of the CSEW general population survey that 
suggested mephedrone use was the most preferred drug despite its prohibition. 
 While research has suggested that mephedrone use is significantly popular and potentially expanding, 
it is one of the most under-researched club drugs (Van Hout & Brennan, 2011). To increase professional 
knowledge and inform the development of specialised treatments, NEPTUNE (2015) made an advisory request 
for “prioritised high-quality research” exploring newly evolving club drugs, including mephedrone (p.44). 
Therefore, this prompted the focus of this research towards the exploration of problematic mephedrone use. 
 
  1.2.2.2 Traditional drugs. The NTA (2012) define the most familiar, eldest and popularly 
used drugs in the UK as ‘traditional drugs’, which includes: heroin, crack and powder cocaine. Arguably the 
criteria of such a definition is unclear and reductionist. For example, the club drug MDMA meets the criteria to 
be considered a traditional drug. However, since MDMA is considerably used within the context of nightclubs, 
it is arguably classified accordingly. Nevertheless, cannabis, that has no common context of use and meets the 
criteria to be considered a traditional drug, is commonly known as a recreational drug. It could be argued that 
although the definition of traditional drugs appears to be ambiguous, its introduction allows for the ease of 
identifying particular drugs, a practice this thesis will adopt. 
 Heroin is an opioid drug synthesised from morphine and sold as a white or brown powder or black 
sticky substance that is injected, inhaled or smoked. Desirable psychological effects include a sense of euphoria 
and drowsiness (National Institute of Drug Abuse; NIDA, 2014). Cocaine is a stimulant drug sold as a white 
powder that is administered via nasal insufflation or injection, while its processed form, known as crack cocaine, 
forms rock crystals that are smoked. The desirable psychological effects of cocaine are like those of 
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mephedrone (NIDA, 2013; for undesirable effects of mephedrone, see section 1.2.2.1.1, p.16-17). The adverse 
effects of these traditional drugs include dysphoria, collapsed veins, abscesses, gastrointestinal, heart, liver or 
kidney disease and death (NIDA, 2014, 2013). No dominant context of use for traditional drugs has been 
identified (Flowers, Marriott & Hart, 2010). 
 
 1.2.3. Types of drug user. A “club drug user” refers to a person who uses a club drug as their primary 
drug of choice, whereas a “traditional drug user” refers to a person who uses a traditional drug as their primary 
drug of choice. In both cases drugs are used either solely or simultaneously (polydrug use) with other drugs 
(NEPTUNE, 2015). The profile of a club drug user is thought to be broadly similar to the profile of a user of NPS; 
it was suggested that both are generally young, male, and active participants in the night-time economy (Home 
Office, 2014; for further exploration of the characteristics of club drug users, see sec tion 2.4.4, p.33-34). By 
contrast, traditional drug users are thought to be predominately in their forties and male (NTA, 2010, 2012). 
 
1.3 Problematic mephedrone use in the United Kingdom 
 In the UK, a significant increase in club drug use was identified (Smith & Flatley, 2011; NTA, 2010, 
2012). Like traditional drug use, it was suggested that problematic club drug use negatively impacted the user, 
although to a lesser extent (Joint Commissioning Panel for Mental Health; JCPMH, 2013). Hence the treatment 
needs of mephedrone users were thought to be different from those of traditional drug users. This was based 
on socio-demographic characteristics, e.g. functionality, sexual orientation and age (for an exploration of the 
characteristics of club drug users, see section 2.4.4, p.33-34). As a result, specialised club drug clinics were 
developed, since treatment services were conventionally based on the treatment needs of traditional drug users.    
 However, to date no research has expanded on the understanding of the subjective experience of 
problematic club drug use, specifically mephedrone use (Maxwell, 2003, 2005). Little is known of the subjective 
psychological motivations to use mephedrone or of the subjective psychological effects of mephedrone, and 
how such users may self-identify rather than being categorised in terms of socio-demographics. Such 
understandings could contribute towards appreciating the psychological treatment needs of mephedrone users. 
This would help develop psychological interventions, enrich the knowledge of healthcare professionals and 
introduce an under-represented area of work to CoP. Therefore, this study aims to explore mephedrone users’ 
experiences and sense-making of their problematic use (for research aim and questions, see section 2.6, p.37-
38). 
  
1.4 The Organisation of the Research Study 
 The Literature Review (p.22-39) traces the line of enquiry for this research that led to the development 
of the research questions. The Methodology (p.40-54) summarises the rationale for the methodology, the 
method chosen and the procedures implemented to gather and analyse data. The Results (p.55-74) outline and 
discuss the themes revealed through interpretative phenomenological analysis (IPA). The Discussion and 
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Conclusions (p.75-90) offer detailed theoretical considerations in relation to the insights gained by the research 
in order to provide a contextualised and meaningful account of the research findings. 
  
1.5 Reflexive Statement: Part One  
 As it is impossible for the researcher to remain completely objective, reflexive research attempts to 
understand researcher involvement (Orlans, 2013). Reflexivity is an exercised self-awareness that involves an 
in-depth understanding of how one’s own experiences and cognitions, together with the wide r society and 
culture, may impact on ways of relating or being in the world (Etherington, 2004). Reflexivity is encouraged as 
an ethical responsibility of the qualitative researcher (British Psychological Society; BPS, 2010), and as a key 
component of CoP professional practice (Vespia, Sauer & Lyddon, 2006). It makes cognitions, experiences and 
assumptions explicit and challenges their potential impact on the research process and outcomes (McLeod, 
2011). To be consistent with the epistemological ontological position of a constructivist stance, this reflexive 
statement aims to make explicit my assumptions and experiences in relation to this research topic. It also seeks 
to understand my involvement in the construction of this research topic and my potential impact on the research 
process in order to enhance the rigour of this research (McLeod, 2011; Willig, 2001). 
 On reflection, I understand that my interest in the field of substance misuse originates from professional 
and personal experiences, which Kasket (2012) explained is a common starting point for identifying a need for 
research. Through reflexive practice I will attempt to describe these experiences from past to present, identifying 
what has supported my interest in researching substance misuse.  
 Beginning with my personal experiences, during my teenage years I was diagnosed with a chronic 
physical illness which was treated successfully by various medications. Intrigued by the powerful properties of 
medications on the body, I was prompted to pursue a career in pharmacy. What followed was a bout of mental 
illness caused by the side-effects of medications taken to treat my physical ailment. This mental illness was 
successfully treated with medication, although this treatment also required psychological in tervention that 
helped shift my interest towards a concern with the implications of medications on the mind, and a curiosity 
towards the mind itself as a healing agent. This led to me changing my career pathway and becoming a 
psychologist, with an interest in the psychopharmacology of drugs and a new belief that the treatment of physical 
illness could also lie in the treatment of underlying psychological trauma. 
 During this time a family member began a battle with his use of traditional drugs. Despite the 
destructive effects of his PSM, he was conflicted over a desire to continue his drug use – something I could not 
understand. Retrospectively, I appreciate that the personal experiences I have outlined so far influenced my 
decision to undertake a placement from 2011 until 2013 as a counselling psychologist in training at a charity 
that provided non-specialist treatment for PSM. On reflection, perhaps pursuing this placement was an 
unconscious attempt to understand why my family member continued using drugs despite their debilitating 
effects. Or perhaps it was an attempt to somehow feel that I was helping him through his PSM by helping others.  
 During this clinical placement, I noticed an increasing incidence of club drug users seeking treatment. 
At the same time, commissioning bodies introduced club drug clinics, as it was suggested that such specialist 
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clinics were required because the socio-demographic characteristics of club drug users were different to those 
of traditional drug users (JCPMH, 2013). Hence, the experience and treatment needs of traditional drug users 
were thought to be somehow different from those of club drug users. However, at that time no research was 
available to inform healthcare professionals about the potential subjective differences between club drug and 
traditional drug users. In line with my “scientist-practitioner” identity as a counselling psychologist to produce 
research that informs professional practice, I was motivated by this gap in knowledge to study the experience 
and sense-making of problematic club drug use in the UK, specifically the popularly used and under-researched 
club drug mephedrone (Kasket, 2012).  
 As a result of my personal and professional experiences, I am aware that I developed several 
assumptions. One was that club drug users were different from traditional drug users in terms of their treatment 
needs, since traditional drug use appeared to be more debilitating than club drug use, which is why different 
types of services were suggested. Moreover, I assumed that PSM was an addictive disease that appeared to 
be impossible to overcome. I appreciate that such assumptions or “blinding biases” left unaddressed could 
affect the research process. The researcher may source or critique literature and analyse data in a manner that 
aligns their research argument or outcomes to their biases. Also, blinding biases could prevent the researcher 
from “hearing participants clearly or may influence how [they] make sense of what [they] are hearing” while 
interviewing (Etherington, 2004, p.128).  
 To prevent such occurrences, I developed my self-awareness via personal therapy that enabled my 
potential blinding biases to become “enabling biases”, which allowed me to “clear or free up” unresolved 
thoughts and feelings that may have otherwise hindered the research process as described (Etherington, 2004, 
p.128; Bernstein, 1983). For instance, I realised that perhaps by exploring users’ experiences of problematic 
mephedrone use, my need to make sense of my family member’s motivations to  use drugs may have been 
fulfilled. If left unaddressed, the impact of such a bias could make this research a personal quest to establish 
some sense of closeness to my estranged relative instead of developing a wider understanding of problematic 
mephedrone use. 
 Although my personal experience of drug use in my family could have become a hindrance to the 
research process if left unmonitored as mentioned above, it provided a source of motivation to pursue this 
research. I hope that my research will help to develop an under-researched but significant area of CoP by giving 
voice to drug users who are often stigmatised by society.  I also hope it will enable practitioners to better 
understand such individuals, which could potentially facilitate their treatment. Nevertheless, I am also aware 
that my hopes for this research may influence the research process. This could be shown in how I construct my 
research questions, choose my methodology and review and critique literature. This “epistemological reflexivity” 
has encouraged me to be mindful of such hopes during the research process for the reasons described (Willig, 
2013).  
 To further limit the influence of my hopes, assumptions and biases as described, I will apply the 
principles of phenomenology to the research process (Smith, Flowers & Larkin, 2009). I will endeavour to 
“bracket off” my hopes and biases, to try and understand different research perspectives during the literature 
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review process, and to develop impartial research questions and outcomes (Spinelli, 2005). However, as Milton 
(2010) explained, it is difficult for a person to be completely objective. Therefore, I aim to maintain my personal 
and epistemological reflexivity throughout this research in a range of ways. I will monitor and exploring my 
internal processes through keeping a reflexive journal and I will continue to access personal therapy (Kasket, 
2012). I will also undergo supervision to explore and monitor my conscious and unconscious processes and 
consider how these may affect the research (Evans, 2007). In these ways, the “reflective-practitioner” stance of 
CoP will be further instilled (Orlans & van Scoyoc, 2008).
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2. Literature Review 
 
2.1 Overview 
 This section presents literature that focusses on problematic club drug use in the UK, specific ally 
mephedrone. The phrase PSM will be explored by critiquing diagnostic definitions, its biopsychosocial 
underpinnings, societal perceptions and research on the subjective experience. This will be followed by an 
outline and review of the treatments available for users of traditional drugs and club drugs, while exploring in 
detail the factors that informed the rationale for the opening of club drug clinics. This will include the in -depth 
examination of evidence proposing the socio-demographic characteristics of club drug users that correspond to 
their unique treatment needs. Further analysis will reveal the absence of evidence investigating the subjective 
experience of problematic club drug use, with a focus on mephedrone, that could inform users’ treatment needs.  
This will lead to the identification of gaps in the existing literature, concluding with the specific research questions 
that this study seeks to address. Throughout this literature review, attention will be given to the theoretical 
values underpinning the philosophy of CoP. 
 
2.2 Conceptualising problematic substance misuse 
This section provides a basis of understanding of PSM by exploring its diagnostic definitions, 
biopsychosocial underpinnings, societal perceptions and research on the subjective experience. 
 
 2.2.1 Diagnostic definitions of problematic substance misuse. The International Classification of 
Disease-10 (ICD; World Health Organisation; WHO, 2010) and Diagnostic and Statistical Manual -4 (DSM; 
American Psychological Association; APA, 1994) define two categories of PSM: (1) ‘substance dependence’, 
and (2) ‘substance abuse’ in DSM-4 that corresponds to ‘harmful use’ in ICD-10 (Appendix A, p.106; Appendix 
B, p.107-108). Such diagnostic criteria are predominately used in the USA. Although i t is suggested that the 
substance dependence and abuse definitions are independent diagnoses, there is overlapping conceptual 
content. For example, within the substance abuse criteria the interpersonal/social problems symptom is defined 
by continued use despite consequences, and the role impairment symptom defined by recurrent intoxication 
leading to impaired functioning, which correlates to the compulsive patterns of use typified by substance 
dependence (Babor, 2007).  
 Consequently, the DSM-5 created a unifying syndrome known as a ‘substance use disorder’ (SUD) 
with varying severities categorised by the heading ‘addiction and related disorders’ (APA, 2013; Appendix C, 
p.109). Criticisms have followed concerning this new diagnostic criterion. For example, M artin, Langenbucher, 
Chung and Sher (2014) suggested that the inclusion of social and legal implications of PSM within the diagnostic 
criteria of SUD engenders socioeconomic, cultural and contextual biases, and that psychological and 
physiological processes ought to be prioritised. Moreover, the term ‘dependence’ was replaced with the 
debatably pejorative term ‘addiction’, to avoid confusion with the diagnosis of the ‘physical dependence’ of 
medication (Erikson, 2008; O’Brien, 2011). Consequently, individua ls with a DSM-4 substance abuse diagnosis 
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may now be diagnosed with a DSM-5 mild-SUD instead and be considered to have an addictive disorder, a 
label that has stigmatising implications (for an understanding of the stigmatising implications of the term 
addiction, see section 2.2.3, p.27-28).  
 Ultimately, there is no consensual definition of PSM which, in turn, arguably discredits the diagnostic 
process (First, 2009). Mirza and Mirza (2008) attempted to explain the stages of substance misuse without 
offering diagnostic criteria (Appendix D, p.110-111). This developmental perspective appreciates the complexity 
of substance misuse, whilst understanding that not all stages must be experienced and that PSM might not 
develop. However, the categorisation of stages removes the subjective understanding of substance misuse and 
prevents deeper explanations of this complex phenomenon from being achieved. Such an approach is adopted 
by drug services in the UK, where the practitioner and client collaboratively identify the  clients diverse drug 
needs and work towards understanding the clients subjective problematic drug use. Such an approach aligns 
itself with the values of CoP that attempt to have “respect for the personal, subjective experience of the client 
over and above notions of diagnoses” (Lane & Corrie, 2006, p.17; Rizq, 2008). 
 
 2.2.2 Theoretical perspectives of problematic substance misuse. Approximately one million adults 
used club drugs during 2011-12, though only 6,846 were treated for problematic club drug use (NTA, 2012). 
Perhaps, individuals have vulnerabilities that may predispose them to developing problematic club drug use, a 
suggestion that will be explored by reviewing theories of PSM. Psychological theories will be privileged as these 
are most relevant to the topic of this research. 
 
  2.2.2.1 Biological. The disease model describes PSM as a brain disease resulting from 
inevitable neuroadaptations in serotonin (Muller & Hombery, 2015) and dopamine pathways (Di Chiara & 
Bassareo, 2007) following drug use, which causes compulsive behaviour (Allan, 2014). Although genetic 
theories share a medical perspective, they suggest a greater likelihood that an individual may develop PSM 
rather than conferring certainty. Advances in genetic studies suggest that PSM is hereditary (Volkow & Muenke, 
2012), and that predisposed personality traits (e.g., stress reactivity, impulsivity) increase the risk of PSM 
(Gorwood et al., 2012). However, Wilbank (1989) suggested that pathologising PSM removes individual 
responsibility, choice and willpower and instead induces learned helplessness and a reduced self-efficacy that 
inhibit recovery. Moreover, it is suggested that by “viewing addicts as victims of a disease” (Wilbanks, 1989, 
p.407) individuals are encouraged to produce an “excuse repertoire” that justifies associated criminality as a 
potential symptom (Snyder, Higgins & Stucky, 1983).  
 
  2.2.2.2 Sociological. Social learning theory (Bandura, 1977) identifies PSM as a learned 
behaviour acquired through classical conditioning (Pavlov, 1928) and maintained via operant conditioning 
(Skinner, 1938). Drug use is reinforced by observing others e.g., parents (Barrocas, Paixao & Vieira-Santos, 
2016), peers (Baumeister & Leary, 1995) or actors in films (Sulkunen 2007; Waylen, Leary, Ness, Tanski, & 
Sargent, 2011), gaining pleasure from it or experiencing the pleasure oneself and the punishment of withdrawal 
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(Sussman & Ames, 2001; Wikler, 1984).  Arguably, the learning model is reductionist as it explains human 
complexities in terms of contingencies and patterns of reward while not considering individual differences. 
 Theories that explore individual differences via social factors such as socioeconomic status and 
ethnicity offer a different perspective as to how PSM could develop. Strain theory (Merton, 1968) claims that 
strain occurs when society popularises aspirations such as wealth that are unattainable for some – defined as 
“marginalisation”. People from ethnic minorities may also experience marginalisation because of “acculturative 
stress” that could manifest itself if an individual has not yet fully adopted their new culture and concurrently is 
experiencing a loss of cultural contact with their traditional culture (Berry, Poortinga, Segall & Dasen, 1992; 
Nouroozifar & Zangeneh, 2006). Although such sociological findings elucidate the etiology of PSM, they also 
seem to be reductionist and deterministic and to stigmatise members of society.  
 The moral model concludes that PSM is a choice which corresponds to the rational choice model 
(Coleman & Fararo, 1992) which proposed PSM as an act of free will made by sinful people with low moral 
standards (Peele, 1987). This theory may account for religiosity acting as a protective factor for PSM (Yeung, 
Chan & Lee, 2009), although the moral model has little therapeutic value as it implies that users ought to be 
punished rather than treated.  
 
  2.2.2.3 Psychological. Studies have suggested that identity distress is propelled by those 
negative life events that inhibit attachment formation and resul t in low self-esteem, which increases one’s 
vulnerability to substance misuse (Archer, 2008; Berzonsky & Adams, 1999; Campbell, 1990; Cast & Burke, 
2002; Pittman, Keiley, Kerpelman & Vaughn, 2011). The psychology of identity, attachment and self-esteem are 
explored in relation to substance misuse. 
 There are three distinct definitions of identity: i) that which refers to the culture of a person; ii) that 
which refers to common identification with a collective or social category such as in social identity theory (Tajfel, 
1982); and iii) that which refers to parts of a ‘self’, composed of the meanings that people attach to the multiple 
roles they play in differentiated contexts. Identity is dynamic, flexible and develops over time.  
 Marcia (1966) operationalised Erikson’s (1963, 1968) identity theory and created the identity status 
paradigm. Marcia (1966) proposed that individuals progress through a process of exploration until they are 
committed to a set of options as an integral part of the self. Marcia proposed four stages of identity development: 
i) identity diffusion (low exploration, low commitment), where identity options are not explored, nor specific roles, 
goals and values committed too; ii) moratorium (high exploration, low commitment), characterised  by 
experiencing a crisis without adoption of a fixed set of values and beliefs; iii) foreclosure (low exploration, high 
commitment), characterised by forming identity commitments prematurely without first exploring many identity 
options, and iv) commitment (high exploration, high commitment), through internalising a set of values and 
beliefs. 
 It is at the stage of moratorium that individuals experience identity distress, “severe subjective distress 
regarding [the] inability to reconcile aspects of the self into a relatively coherent and acceptable sense of self” 
(American Psychiatric Association, 1980, p. 65). Wiley and Berman (2012) found that although relationships 
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between identity formation and substance abuse have been found, these associations may be largely a function 
of identity distress.  
 As a consequence of identity distress, individuals may search for a social identity by adopting the 
beliefs and practices of a drug subculture, corresponding to social identity theory (Tajfel & Turner, 1979). By 
means of social categorisation, the in-group (the group to which a person belongs e.g. club drug users) 
discriminates and stereotypes against the out-group (the group to which a person does not belong e.g. 
traditional drug users) by highlighting differences between them. Research has identified that this may increase 
individuals’ social status and create a sense of belonging, acceptance and support, together with a false sense 
of empowerment (Dodes, 2002; Anderson & Mott, 1998; Moshier et al., 2012; Neale, 2002; Suh, Mandell, Latkin, 
& Kim, 1997). What follows is social identification, the adoption of the group identity that one has categorised 
themselves as belonging to. For example, by adopting the identity of a club drug user, one would begin to act 
in ways that would represent the identity of that drug subculture. Consequently, PSM behaviours form a central 
part of the new self-concept, where one’s group membership is bound to one’s self-esteem, and abandoning 
these beliefs would exacerbate further identity distress (Koski-Jannes, 2002). Perhaps the adoption of the 
ingroup identity could be perceived as the ‘false self’ that acts as a defence against a feeling of internal 
emptiness and perhaps low self-esteem, that removes oneself from experiencing or exploring their authentic 
‘true self’ (Winnicott, 1960). 
 The concept of self-esteem in the context of this research refers to the ways in which individuals feel 
about themselves, based on their sense of worth and competence, formed by ongoing transactions with  their 
environment and is conceptualised as a part of the self-concept or identity (Cast & Burke, 2002). The minority 
stress theory (Meyer, 1995) suggests that individuals may internalise stigmatising beliefs such as negative 
beliefs concerning homosexuality which are held by society or family members (DiPlacido, 1998). The 
internalisation of such beliefs become a stable part of one’s self-concept, and can lead to feelings of guilt, self-
loathing, shame and low self-esteem, together with a delay in identity formation (Allen & Oleson, 1999; 
Grossman & Kerner, 1998; Shidlo,1994). Such negative life events that inhibit identity development are thought 
to increase the likelihood of substance misuse, as drugs are used as a maladaptive coping strategy 
(Etherington, 2006; Bruce, 1990; Larkin & Griffith, 2002). 
 Research has proposed that attachment theory provides a foundation for social and personality 
development which is key in the formation of identity (Pittman, Keiley, Kerpelman & Vaughn, 2011). Moreover, 
research has suggested that caregiver-child interaction constitutes the basis for development of one’s early 
sense of self-esteem (Arbona & Power, 2003; Laible, Carlo, & Roesch, 2004), which is a precursor to the 
development of identity (Berzonsky & Admans, 1999; Campbell, 1990; Cast & Burke, 2002). Attachment can 
be defined as a deep and enduring emotional bond across time and space, that provides a sense of security 
and stability, nurtured via the caregiver-child relationship (Ainsworth, 1973; Bowlby, 1969). Four styles of 
attachment have been identified: secure, avoidant, anxious and disorganised (Ainsworth, 1973). Research 
suggests an association between insecure attachments (avoidant, anxious and disorganised) and substance 
misuse, perhaps because insecure attachments are associated with poor emotional regulation, poor social 
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skills, fears of intimacy and low self-esteem (Borhani, 2013; Kassel, Wardle & Roberts, 2007; Thorberg & Lyvers, 
2010). Substances may be misused to manage these negative feelings. 
 Substance misuse may facilitate self-harming behaviours, including sadistic and masochistic forms of 
sexual behaviour, to appease psychological distress (Shaw, 2012). In line with the self-medication hypothesis 
(Khantzian, 2003), substance misuse may function as a coping strategy to appease the symptoms of mental 
health issues including identity distress, or negative life events such as sexual abuse. Although the self -
medication hypothesis has received widespread acceptance, arguably it does not capture the com plexity of the 
process of PSM by just focusing on an individual’s use of substances to address discomforting affective states. 
Moreover, it is difficult to establish whether psychological distress precedes the development of PSM or vice 
versa. 
 
  2.2.2.4 Biopsychosocial model. Ultimately, PSM is a multifaceted phenomenon where a 
combination of the preceding models, known as the biopsychosocial model, provides a multi -dimensional 
explanation of its onset. Figure 1 (p.26) proposes how the interplay of factors influences the development of 
substance misuse and PSM, where the balance of such influences will be unique to each person. This holistic 
perspective is consistent with the philosophy of CoP that respects individual differences and the complexity of 
humans that cannot be separated from their biological, psychological or social influences (Ashley, 2010; 
Strawbridge & Woolfe, 2010; Swanepoel, 2013). 
 
Figure 1: Factors influencing the patterns of substance misuse (DiClemente, 2003). 
 
 
 
 
 
 
 
 
 
 
 
  
  As highlighted in Figure 1 above, all the factors mentioned influenced the development of the 
research questions of this study (see section 2.6, p.37-38) apart from the factor of genetics. The factor of 
genetics is not relevant to the psychological perspective taken in this research, which the other factors inform. 
For example, the factor of physiology is related to the stress-related physiological response to attachments 
made in relationships. Where attachment theory is thought to explain the process of and vulnerability towards 
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substance misuse (Flores, 2004). This could shed light upon the subjective psychological experience and 
sense-making of drug use. 
 
 2.2.3 Perceptions of substance misuse. The normalisation theory (Measham, Newcombe & Parker, 
1994) attempted to explain why recreational drug use and types of users increased and became part of everyday 
‘normal’ life, as opposed to PSM that remained stigmatised in the UK. Parker, Aldridge and Measham (1998) 
tracked the drug attitudes and consumption patterns of a cohort of nearly 800 British adolescents over five 
years, and considered the following as indications of normalisation: (i) the availability and accessibility of some 
illicit drugs, (ii) drug “trying” rates, (iii) regular use of some illicit drugs, (iv) levels of drug knowledge, (v) future 
intentions to use drugs, and (vi) the cultural accommodation of some illicit drug use (e.g. among non-drug users, 
in popular culture and in policy). 
 It was suggested that the use of some illicit drugs (cannabis, nitrates and amphetamines, ecstasy) had 
become ‘normalised’ by young people and socially and culturally accepted by members of the non -drug using 
population, as the use of such drugs were likened to leisurely activities e.g., shopping, holidays etc., (Gourley, 
2004; Cieslik & Pollock, 2002; Measham, Newcombe, & Parker, 1994; Parker, 1997; Shiner & Newburn, 1997). 
While research suggested that stigmatising attitudes were common amongst society and non-specialist 
professionals towards people experiencing PSM, who are often labelled as “addicts” (Lloyd, 2013, p.85).  
‘Addicts’ are perceived to be more blameworthy and dangerous than individuals labelled as ‘mentally ill’ or 
recreational drug users, who are in-turn viewed more harshly that individuals labelled physically ill (Link, Phelan, 
Bresnahan, Stueve & Pescosolido, 1999; Rasinski, Woll, & Cooke, 2005; Room, 2005). It appears that rather 
than the behaviour of drug taking itself being stigmatised it is the persona associated with PSM that is 
stigmatised while that of a recreational drug user is normalised (Measham, Newcombe, & Parker, 1994). 
 Further research indicated that stigma operated within the drug-using population itself e.g., those who 
inject or use heroin are more stigmatised than cocaine users (Power, Power & Gibson, 1996), whilst regular 
marijuana users stigmatise alcohol and heroin users more than occasional or past users of marijuana 
(Plancherel et al., 2005). Despite findings of stigma regarding PSM in society and within the drug -using 
population, little research has explored how such stigma could be managed to reduce its effects as a barrier 
preventing users seeking treatment (Adlaf, Hamilton, FeiWu & Noh, 2009). 
 The most normalised and popular type of drug user is thought to be club drug users, indicative by their 
drug experience (Parker et al., 1998). Their lifetime rates of “cannabis trying” at nearly 100 percent, and rates 
for amphetamines, LSD and ecstasy in the 60–90 percent range (Measham, Aldridge & Parker, 2000). Club 
drugs are also suggested to be normalised by the routinisation of the way in which they are supplied through 
social networks despite this breaching the Misuse of Drugs Act (Parker, Aldridge & Egginton, 2001). 
Furthermore, it has been suggested that the use of licit drugs (e.g. alcohol) with the illicit drug (e.g. ecstasy) 
use, as part of weekend relaxation is commonly referred to in television dramas and serials (e.g. This Life, 
BBC2, Ali G, Channel 4), that helps to further normalise club drug use (Parker et al., 1998). 
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 However, the normalisation theory has been extensively critic ised in that drug use has only become 
normalised, if at all, for particular users of particular drugs in some countries, and that further consideration 
ought to be given to the influence of social factors: gender, social class, the legal status of a drug, ethnicity, 
age, relationships or social context (Pennay & Measham, 2016). For example, it has been suggested that there 
is an overall normalisation of club drug use and users. However, with consideration to the social factors 
highlighted it could be argued that club drug use has become particularly normalised for young adults (18-24-
year-olds) who have suggested to be predominant users within the socially acceptable context of nightclubs 
(NTA, 2010, 2012). Whereas, older adults who may be unemployed, could be stigmatised for using such drugs. 
More specifically the significant increase in mephedrone use, could indicate the normalisation of the drug due 
to its then legal status; its reduction in use and hence denormalisation indicative of its now illegal statu s. 
However, despite mephedrone’s illegal status, it could be argued that it has remained popular and hence 
normalised for the LGBT proportion of society due to its pertinent chemsex properties (Measham et al., 2011; 
Wood et al., 2012). Furthermore, mephedrone appears to be normalised for those users that snort it than those 
that inject it, due to the latter being associated with PSM (Van Hout & Brennan, 2011). 
 These examples highlight that the concept of drug normalisation evolves meaningfully with shifting 
drug trends and attitudes, and so it requires in-depth exploration to understand the consequences and 
particulars of normalisation and to form adequate responses to it. Although the normalisation theory offers a 
broad explanation of the normalisation of a drug on a social level, this study attempts to explore the potential 
subjective process of mephedrone use for the individual. 
 
 2.2.4 Subjective experience of problematic substance misuse. Quantitative research has 
dominated the understanding of PSM.  However, there is now a growing interest in the use of qualitative 
methods that describe the lived experience of drug use from the participant’s perspective (Rhodes & Moore 
2001; Neale, Allen & Coombes, 2005; Nichter, Quintero & Nichter, 2004). Due to the lack of research 
commenting on the subjective experience of problematic club drug use, three relevant studies were located that 
describe the experiences of problematic illicit drug use, including the use of stimulants, and of alcohol misuse. 
Also, it has been suggested that stimulants and alcohol use parallel the pattern of problematic club drug use 
(NEPTUNE, 2015). 
 Through narrative inquiry, Hsieh et al. (2015) explored the subjective experience of problematic illicit 
drug use. Ten participants were recruited from therapeutic communities in Taiwan. Results proposed three 
themes that described the participants’ experiences of PSM: (1) An “uncontrollable adherence” to the 
substance, where the positive experience of the substance reinforced its continuous use and subsequently the 
substance became the participants’ highest priority. (2) A “trapped life”, where participants explained that they 
felt the drug controlled their lives as they were trapped within a cycle of love while using the drug and 
experienced feelings of hate upon withdrawal. Participants reported missing critical life events such as funerals 
in preference for drugs. (3) Participants described their “tragic descent” as they experienced conflict between 
their desire to use and to quit the drug. Although it was an insightful description of the experience of PSM was 
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given, the study did not identify what specific drugs participants used. Moreover, the study took place in Taiwan, 
and arguably the results may not be generalisable to the UK, due to differences in culture (Firestone, 1993). 
 Shinebourne and Smith (2009) researched the experience of alcohol addiction of a female participant 
from the UK, using data from semi-structured interviews that were analysed using IPA. Three superordinate 
themes were identified: (1) The experience of the self.  The experience of PSM is likened to a state of flux and 
instability. Initially the use of alcohol is described as an enabler, providing a route from feeling depressed to 
enjoyment, contentment and sociability. A loss of control is experienced as well as the negative side-effects 
upon withdrawal. (2) I created such a character for myself: The participant described the initiation of an 
alternative character via drinking that allowed her to feel free.  However, this personality conflicted with her true 
self.  (3) Perception of the self: The participant perceived herself to be a mixture of conflicting selves, from one 
self that acknowledged that her PSM was destructive and wanted to stop, to the other that enjoyed engaging in 
the positive qualities associated with her drinking. 
 Shinebourne and Smith (2010) also researched how participants used metaphors to communicate 
experiences of alcohol misuse using IPA. Six participants were recruited and their experience of PSM  was 
described as an “affliction” via several classes of metaphors that explained a range of phenomena: the futile 
struggle to get rid of psychic “pain”; “the void” as an emotional emptiness which could not be ﬁlled; the 
“detachment” from emotional engagement; and PSM as a “battleﬁeld” between surrendering to the drug or 
fighting against one’s own personal demons. 
 
2.3 Treatment of Problematic Substance Misuse  
 A considerable number of individuals with PSM recover without engaging in treatment or self-help 
groups, this is known as ‘natural recovery’ (Slutske, 2006). It has been suggested there can be a “maturing out” 
phenomenon (Best, Ghurfran, Day, Ray & Loaring, 2008) or an experience of a “eureka” moment 
(Mariezcurrana, 1994), where individuals become less interested in their drug use over time. There are many 
different factors that could contribute towards individuals’ natural recovery, these include social factors: 
marriage, a change of job, legal problems, pregnancy, financial crisis; or biological fac tors: changes in physical 
health; or psychological factors: self-control, willpower, motivation or the creation of a new identity 
(Mariezcurrana, 1994). The simultaneous consideration of the factors outlined forms a biopsychosocial 
theoretical perspective, that provides a meaningful account of how subjective natural recovery can occur.  
 Nevertheless, this section highlights the stages of change a user enters that could result in them 
seeking treatment, and with relevance to this research explores the recom mended evidenced-based 
psychosocial interventions (PSIs) that form the basis of treatment for substance misuse services in the UK. This 
includes an evaluation of present guidelines available for the treatment of problematic club drug use in the UK. 
 
 2.3.1 The transtheoretical model. The transtheoretical model (Prochaska & DiClemente, 1983; 
Prochaska, DiClemente, & Norcross, 1992) highlights the process of intentional behaviour change motivating a 
user to access treatment. The transtheoretical model includes the stages of change which individuals move 
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through, often in a non-linear fashion, when modifying their PSM. An outline of each state of change is given in 
Appendix E (p.112). It is the stage of “action” in which individuals begin to engage with treatments, including 
PSIs.    
 
 2.3.2 Psychosocial interventions. In line with the psychological interest of this study, a focus is 
placed on PSIs rather than pharmacological interventions. PSIs address the psychological, social, personal, 
relational and vocational problems associated with PSM. PSIs aim to assist individuals in making and sustaining 
changes in their substance misuse behaviours, and in addressing underlying or additional mental health 
problems (NTA, 2005). Some interventions are termed psychological therapies but come under the PSI 
umbrella. PSIs are the principal treatment for PSM for most substances, as few types of PSM have recognised 
pharmacological interventions (Amato, Minozzi, Davoli & Vecchi, 2011).  
 
 2.3.3 Psychosocial interventions for problematic substance misuse. In the UK, the evidence-
based guidelines provided by National Institute for Health and Care Excellence (NICE) and NTA suggest 
specific PSIs for the treatment of PSM, based on widespread research into the effectiveness of PSIs for alcohol, 
opiates, stimulants and cannabis (NTA, 2005; Appendix F, p.113-114). However, the NTA and NICE do not 
provide specific guidance on how to treat problematic club drug use.   There is evidently a disparity between 
the availability of NICE guidelines and suggested PSIs by the NTA for the treatment of problematic club drug 
use in comparison to other types of PSM, and this may reflect that problematic club drug use is relatively new 
and an extensive literature base is yet to develop.  
 Nevertheless, Mollon (2009) proposed that NICE guidelines, aligned with the medical model, implicitly 
reduce psychological therapy to a standardised “verbal drug” to treat clients (p.15). In doing so, the complexity 
and individuality of clients are eliminated, and clinicians are devoid of “clinical judgement, innovation and 
adaptation to the individual client” (Mollon, 2009, p.15). Mollon (2009) suggested the introduction of “truth 
therapy” (Langs, 1982), i.e. the use of many theories that evolve and change when applied to treat the client’s 
unique needs. This approach aligns itself to the philosophy of CoP that “challenges the views of people who 
pathologise” and instead strives to be “attentive to life experience, modes of inquiry and areas of knowledge” to 
aid the unique, pluralistic treatment of clients’ subjective needs (BPS, 2005, p.7). 
   
 2.3.4 Psychosocial interventions for problematic club drug use. The JCPMH (2013) produced a 
commissioning report requesting more efficient substance misuse services due to a shortfall in relevant services 
in the UK. Bowden-Jones (a consultant psychiatrist in substance misuse and past Chair of the Faculty of 
Addictions at the Royal College of Psychiatrists) presented as an “expert reference” for developments in 
problematic club drug use (JCPMH, 2013, p.21). Bowden-Jones opened the first official club drug clinic in 2010 
in Central and North West London (CNWL; Wise, 2011). The opening of other club drug clinics soon followed, 
including: The Party Drug Clinic (South London & Maudsley, 2010), MMagik (Bristol, 2013), The Haringey Club 
Drug Clinic (Haringey, Enfield & Barnet, 2013) and Grip (Camden & Islington, 2014).  
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 Bowden-Jones recommended that tailored and “new models of treatments” ought to be introduced to 
these specialist services in order to meet the suggested unique treatment needs of club drug users (Hawkes, 
2012, p.1; NTA, 2012). Bowden-Jones subsequently founded NEPTUNE in 2013, which released clinical 
guidelines in relation to the treatment of club drug and NPS use (NEPTUNE, 2015). Due to a “lack of robust 
evidence” in club drugs, treatment recommendations were based on available research for the treatment of 
stimulant misuse, as “most NPS are stimulant in nature”, and for alcohol misuse, as “NPS use shows a close 
parallel” to the pattern of alcohol use (NEPTUNE, 2015, p.45; for guidelines that were also recommended for 
the treatment of problematic club drug use, see Appendix F, p.113-114). Arguably, unifying treatments for 
different types of PSM suggests that users of different types of drugs have the same treatment needs 
irrespective of the context in which the drug is used, or of the effects of specific drugs and characteristics of 
different types of drug user. Such an approach seems reductionist and departs from a CoP perspective that 
attempts to understand individual differences and the complexities of different types of drug user. It also brings 
into question the necessity for specialist club drug clinics that attend to the suggested unique treatment needs 
of problematic club drug users.  
 As “the bulk of the research available provides what is referred to as emerging research evidence” 
such as case reports and the analysis of patient records (NEPTUNE, 2015, p.21), perhaps further empirical 
research in problematic club drug use is necessary in order to inform what such users’ unique treatments are 
and how they could subsequently advise treatment suggestions. 
 
2.4 Rationale for Specialist Club Drug Clinics in the United Kingdom 
 With an understanding of the treatments available for PSM, specifically club drug use, now in mind, 
this section explores and critiques the factors that informed the rationale for the opening of club drug clinics. 
 
 2.4.1 Diversification of drug use in the United Kingdom. Bowden-Jones proposed the opening of 
club drug clinics based on the “changing pattern of drug use” in the UK (Wise, 2011, p.1). It was suggested that 
club drugs were replacing traditional drugs as the leading drugs of choice, since club drug use was increasing 
and traditional drug use was decreasing (Wise, 2011). Bowden-Jones’ assertions were gleaned from statistical 
evidence from 2005-2011 from the CSEW and National Drug Treatment Monitoring System (NDTMS). 
 The CSEW estimates the prevalence of illicit substance misuse among a nationally representative 
sample of residents (16-to-59-year-olds) in households in England and Wales. From 2005-2006 to 2010-2011 
problematic cocaine users decreased from 764,000 to 684,000; problematic crack cocaine users decreased 
from 53,000 to 47,000, and problematic heroin users decreased from 39,000 to 34,000 (Lader, 2015). From 
2005-2011 mephedrone use was not monitored due to its prohibition in 2010. However, ketamine was controlled 
as a Class C drug in 2006. From 2006-2007 to 2010-2011 problematic ketamine users increased from 93,000 
to 197,000 (Lader, 2015). 
 Although these findings validated Bowden-Jones’ observations, the CSEW findings do not include 
minority groups that potentially have relatively higher rates of drug use such as homeless people or  prisoners 
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(Smith & Flatley, 2011). Also, the CSEW does not “reach those problematic drug users whose lives are so busy 
or chaotic…that are unable to take part in an interview” and consequently the use of “cocaine” might be 
underestimated (Smith & Flatley, 2011, p.43). Moreover, the CSEW only monitors the use of controlled drugs, 
and consequently the use of legal club drugs is unknown. There may also be issues concerning the participants’ 
willingness to report illicit substance misuse during an interview. Hence, estimates of the prevalence of illicit 
substance misuse may be considered lower estimates of the true level within the general population.  
 The NDTMS is a part of Public Health England and collects data from all substance misuse treatment 
services, which is analysed by the National Drug Evidence Centre and reported on by the NTA. From 2008-
2009 to 2009-2010 the number of people in treatment for problematic cocaine use decreased from 8,522 to 
7,304; problematic crack cocaine use decreased from 5,045 to 3,686; and problematic heroin use decreased 
from 3,005 to 2,312 (NTA, 2010). However, from 2005-2006 to 2011-2012 the number of people in treatment 
for problematic club drug use increased from 4,656 to 6,486 (NTA, 2012). These statistics suggested that the 
number of problematic traditional drug users in treatment was decreasing whilst the number of problematic club 
drug users in treatment was increasing, which is thought to parallel the changing pattern of PSM in the general 
population, as suggested by Bowden-Jones. 
 However, rather than the decreasing number of users of traditional drugs in treatment reflecting a 
decrease in the use of such drugs in the general population, the results could reflect an improvement in the 
effectiveness of treatments available provided by non-specialist substance misuse services. A government 
initiative was introduced in 2001 to improve non-specialist treatment services in the UK, and consequently 64% 
of cocaine users who finished treatment in 2005-2006 did not return to treatment within four years of leaving, 
which suggests they sustained recovery (NTA, 2013; NTA, 2010). Moreover, the increasing prevalence of 
problematic club drug use could be accounted for by the legal status and ease of availability of club drugs on 
the internet (Winstock et al., 2011). Drug users may have also preferred to buy cheaper alternatives to cocaine 
such as mephedrone, as it was proposed that its purity had decreased while its cost had increased over the 
years (NTA, 2010). 
 However, Bowden-Jones (2012) suggested that there are more problematic club drug users than 
documented by the NDTMS, as many do not seek treatment because non-specialist services lack the expertise 
to meet their unique treatment needs. This is based on anecdotal evidence, as no documented subjective 
accounts by problematic club drug users exist, nor does a summary of how such users’ treatment needs might 
differentiate from problematic traditional drug users. Although Bowden-Jones’ assertions are insufficiently 
substantiated as they are not grounded in systematic research, arguably gaps in service provision may be 
identified through clinical experience at the level of service delivery that spurs further research (Kasket, 2012). 
 In summary, there may be a “changing pattern of drug use” as Bowden-Jones suggested, although it 
is unclear whether club drugs are becoming the leading drugs of choice (Wise, 2011, p.1). 
 
 2.4.2 Health and wellbeing. To further emphasise the need for club drug clinics, Bowden-Jones used 
anecdotal evidence to describe the adverse effects of club drug use in two articles for the British Medical Journal 
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(BMJ; Hawkes, 2012; Wise, 2011). These effects are the same as those described in the JCPMH (2013) and 
associated with general PSM, which include an increase in c rime, family breakdown and poverty. Physiological 
harms include death, intoxication, consequences of injecting such as vein damage, sexually transmitted 
diseases, hypertension, stroke and coronary heart disease. Psychological harms include depression, anxiety 
and the exacerbation of mental illnesses e.g., psychosis (JCPMH, 2013).  
 Since the harms caused by club drug use are like those caused by PSM in general, it is difficult to 
substantiate how the treatment needs of club drug users are unique, and, in tu rn, if they warranted the 
commissioning of specialist clinics. The subjective experience of users could be explored in order to better 
develop an understanding of the psychological harms of problematic club drug use. Such an approach would 
depart from the medical genre of the BMJ and adopt a CoP perspective with a phenomenological epistemology 
(Woolfe, Strawbridge, Douglas & Dryden, 2010). Such an understanding could inform the understanding of the 
psychological treatment needs of club drug users and elucidate how such treatment needs may differ from those 
of traditional drug users. 
 
 2.4.3 Training gap. Using anecdotal evidence, Bowden-Jones proposed a “training gap” among UK 
based healthcare professionals, e.g. psychiatrists, psychologists, nurses etc., in the field of club drug use, 
particularly with respect to associated risks and their knowledge of treating users (Wise, 2011, p.1; Hawkes, 
2012). To overcome such a “training gap”, Bowden-Jones recommended that club drug clinics should introduce 
tailored “new models of treatments” to meet the suggested unique treatment needs of club drug users, which 
would hopefully inform professionals’ understanding when treating such users (Hawkes, 2012, p.1; NTA, 2012). 
However, Bowden-Jones did not elaborate on how the risks associated with club drug use and the knowledge 
required to treat such users were unique in comparison to that of traditional drugs and users alike.  
 In line with his medical profession, Bowden-Jones provided a medical stance when considering the 
treatment of club drug users in terms of risk and physical harms, but he did not emphasise the importance of 
also understanding the psychological harms associated with club drug use. This could be achieved by exploring 
the subjective experience of problematic club drug use. Such a holistic understanding adopts a CoP perspective 
that could contribute towards the closure of the “training gap” for professionals by providing knowledge of 
experiences of psychological effects of club drug use. 
 
 2.4.4 The specific characteristics of club drug users and their treatment needs. Club drug 
clinics were advocated as it was suggested that users represented a distinct drug group in terms of their 
sociodemographic characteristics which related to their unique treatment needs (NTA, 2012). The proposed 
sociodemographic characteristics, which were purported as being exclusive to club drug users, are described 
below. 
 
  2.4.4.1 Functionality. Based on clinical observations, Winstock (Researcher and 
Psychiatrist) and Davies (Manager at Drug Advisory Service in Haringey, London) suggested that club drug 
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users are “high-functioning addicts” in terms of their ability to maintain a job, family or social network, in contrast 
to traditional drug users (London Drug and Alcohol Network; LDAN, 2012; NTA, 2012). Simpson (a policy maker 
for LDAN; 2012) argued, based on his opinion, that since club drug users are thought to have more “recovery 
capital”, e.g. employment, social network, stable accommodation etc., than traditional drug users, they ought to 
do better in the non-specialist drug services already available. He suggested that the socio-demographic profile 
of club drug users reduces their need for psychological support in terms of promoting activity, creating 
supportive relationships or generating motivation for change, and therefore implies that their treatment needs 
are less than and not unique to those of traditional drug users. Further research is needed to establish the 
generalisability of Winstock’s and Davies’ clinical observations and Simpson’s argument. 
 
  2.4.4.2 Sexual orientation. Based on anecdotal evidence, Bowden-Jones suggested that 
“lesbian, gay and bisexual people form a large proportion” of club drug users, although the “NDTMS does not 
record enough data to confirm this” (NTA, 2012, p.6). Nevertheless, Antidote argued (from their experience as 
the UK’s only Lesbian, Gay, Bisexual and Transgender (LGBT) specialist service for substance misuse) that 
club drugs “account for almost all of our work” that is “almost exclusive ly linked to sexual use by gay and bisexual 
men” (NTA, 2012, p.6). As a result, psychological interventions have been adapted to meet the treatment needs 
of club drug users from the LGBT community, such as “motivational interviewing talks about how to achieve 
sexual intimacy without drugs” (LDAN, 2012, p.6).  
 However, Lea et al. (2013) argued that some gay and bi-sexual men inject heroin to enhance sexual 
behaviours, as well as using club drugs. Therefore, it becomes questionable as to whether the adaptati ons 
made by Antidote to particular PSIs are exclusive to the needs of club drug users. Perhaps the treatment needs 
of traditional drug and club drug users from the LGBT community do not differ. However, providing club drug 
clinics for users from the LGBT community allows them to feel “comfortable discussing LGBT issues related to 
club drug use” (CNWL, 2010, web page). To validate such propositions, further research would be required to 
explore how club drug users from the LGBT community experience and to make sense of their use. 
 
  2.4.4.3 Age. Based on statistical evidence, the NTA (2010, 2012) suggested that club drug 
users in treatment are predominantly young adults (18-to-24-year-olds), while traditional drug users are 
predominately older adults (40-year-olds and above). However, based on anecdotal evidence Davies suggested 
that many club drug users are “in their thirties” (LDAN, 2012, p.1). Further research or statistical evidence would 
be required to understand whether a specific age group is exclusively associated with problematic club drug 
use, which could have implications for treatment.  
  
 2.4.5 Summary. As explained, to examine the role and necessity of club drug clinics, further research 
is required to explore whether the specific socio-demographic characteristics mentioned are exclusive to club 
drug users and how they may relate to their proposed unique treatment needs. Perhaps by exploring the 
subjective experience of club drug users and how they make sense of their problematic use, this may harness 
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an understanding of how club drug users themselves may self-identify, how users may experience the 
psychological effects of club drugs, and their psychological motivations for use.  Such information could help 
clarify club drug user’s psychological treatment needs, facilitate the development of psychological interventions 
and contribute towards closing the “training gap” for professionals who provide treatment (Wise, 2011, p.1; Dew, 
Elifson & Sterk, 2006; Hawkes, 2012). Such an approach would facilitate a significant shift in perspective.  At 
present, the arguably dominant perspective is one that categorises club drug users’ treatment requirements in 
terms of socio-demographics. This could shift towards a more humanistic person-centred stance that engages 
with the complexity of club drug users based on individual differences and subjective experience, aligned to the 
principles of CoP (Cooper & McLeod, 2011). 
 
2.5 Focused Critique of Research Closely Related to the Present Study 
 Keeping in mind the potential for qualitative research exploring the subjective experience of 
problematic club drug, studies in club drug use were explored and critiqued in-depth while identifying gaps in 
research to support the aims of the present study. Due to limited relevant research in club drug use (to highlight 
the limited research in club drug use, see section 2.2.4, p.28-29) a range of studies are mentioned. Two studies 
are discussed in greater detail as they highlight areas relevant to this research: users’ motivat ions to use club 
drugs (Parks & Kennedy, 2004); and the experience of club drug use (Van Hout & Brennan, 2011). 
 
 2.5.1 Focused critique of relevant research in club drugs. Parks and Kennedy (2004) suggested 
that the reasons why club drugs (ecstasy, GHB, ketamine, rohypnol, methamphetamine, LSD) are used may 
be linked to the context in which they are used. This includes how the drug is used; the experience of 
psychological and physiological effects of the drug, including associated risks; and how a person’s drug use 
began. Fifty young adults (18-to-30-year-olds) were recruited from university campuses in New York, United 
States (U.S.). Each participant took part in a 60-minute face-to-face interview that involved closed questions, 
selecting an answer from several options and completing questionnaires that assessed several areas. These 
comprised: (1) personal history of substance use, (2) patterns of current club drug use, (2) context and location 
of club drug use, (3) reasons for using club drugs, (4) consequences of club drug use, and lastly (5) the presence 
of substance abuse and substance disorder, screened by the Drug Abuse Screening Test (DAST; Skinner 
1982). 
 Results were analysed using Analysis of Variance and chi-square tests, and questions regarding the 
context and positive consequences of club drug use were analysed in terms of the most common answers given 
that created a “theme” (Parks & Kennedy, 2004, p.299). The participants indicated that they predominately used 
club drugs to experiment, to feel good or high, and to socialise (Parks & Kennedy, 2004). 
 Arguably there are few cultural differences between the UK and U.S., and therefore results could be 
generalised to the UK (Firestone, 1993). Although the use of questionnaires provided “descriptive” data as 
intended (Parks & Kennedy, 2004, p.295), it did not engage with the participants’ lived experience, which 
arguably is required to establish an in-depth understanding of the phenomenon. Although, Parks and Kennedy 
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(2004) estimated the participants “problematic” club drug use by using the DAST, none of the participants self-
rated their club drug use as problematic or offered their subjective understanding, and none of the participants 
were receiving or had previously engaged in treatment. 
 To date, no research has explored the reasons why “problematic” users use club drugs, research that 
is imperative as it is these users who are most likely to access treatment. As suggested, a qualitative 
methodology could be used to access users’ subjective experiences. This could elucidate our understanding of 
users’ psychological motivations to use club drugs, how users make sense of their problematic use, and how 
club drug use is experienced, including psychological effects. Such rich and detailed qualitative information 
could be useful in suggesting what types of psychological interventions may be helpful to facilitate club drug 
users’ recovery, as well as enrich healthcare professionals’ understanding of the difficulties experienced by 
users. Due to the paucity of literature in the field of club drug use as explained, three studies exploring the 
subjective experience of PSM based on illicit drug use and alcohol misuse were discussed in section 2.2.4 
(p.28-29), and the potential biopsychosocial motives to use drugs are discussed in section 2.2.2 (p.23-27). 
 In terms of how club drug users self-identify, based on anecdotal evidence Bowden-Jones suggested 
that club drug users identify their use to be less problematic than alcohol, heroin and crack cocaine users (Royal 
College of Psychiatrists, 2014). It is suggested that this may be because club drug users, specifically 
mephedrone users, perceive mephedrone not to have undesirable effects in comparison to other drugs (Van 
Hout & Brennan, 2011). Furthermore, quantitative research suggested that ecstasy users perceive a lack of 
service provision in terms of treatment specifically for club drug users (Dew, Elifson & Sterk, 2006). This implies 
that club drug users perceive themselves to be different to traditional drug users in terms of their severity of use 
and treatment needs.  
 Further research is required to elucidate how club drug users make sense of their problematic use and 
self-identify, which could have implications for treatment. Monk and Heim (2011) proposed that a  self-image 
bias operates among those who use drugs (Hill, Smith & Hoffman, 1988). This is based on social projection 
theory that suggests that people perceive certain others as similar in terms of beliefs, feelings and behaviours 
and that they project these onto others (Krueger, 1998, 2000). For example, users are likely to attribute the 
label “addiction” towards “heavy” users rather than those perceived as “light” users (Monk & Heim, 2011).  
 
 2.5.2. Focused critique of relevant research in mephedrone use. The rationale for choosing 
mephedrone for further exploration was explained (see section 1.2.2.1.1, p.16-17). Moreover, Parks and 
Kennedy (2004) suggested the study of a club drug such as mephedrone, rather than club drugs as a collective, 
as the “consequences [of use] differed by type of club drug used… [and therefore] future research should 
explore the reasons for club drug use by individual drug” (p.301).  
 Some quantitative studies have explored the psychological and physiological effects of mephedrone 
(Carhart-Harris, King & Nutt, 2011; Dargan, Albert & Wood, 2010; Freeman et al., 2012; Kapitány-Fövény et al., 
2013; Winstock et al., 2011). Many of these studies were conducted in the UK, and suggested that mephedrone 
has empathogenic qualities similar to ecstasy. However, none of these studies used a qualitative methodology 
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to explore participants’ lived experience of mephedrone use, which would provide a more detailed, subjective 
and idiographic account.  
 The only study to have used a qualitative methodology to explore experiences of mephedrone use was 
conducted in Ireland by Van Hout and Brennan (2011). They used thematic analysis to explore the experiences 
of mephedrone use for 22 adults (18-to-35-years-old) pre-legislation. Semi-structured interviews were 
conducted with participants who had used mephedrone within the past 6 months.  Results included the following 
themes:   
(1) Mephedrone choices, experiences and outcomes highlighted participants’ initiation to mephedrone 
based on decision-making factors that included exposure, availability, curiosity, peer use, competitive 
pricing and lack of negative comedown in comparison to ecstasy and cocaine. Insufflation was 
described as the main route of administration. 
(2) Social situatedness of mephedrone use suggested that mephedrone was central to certain sub-group 
atmospheres and music types such as techno/dance. User patterns were explained as sporadic to 
weekly, and there seemed to be a perceived “degree of self-control” associated with mephedrone that 
made it attractive (Van Hout & Brennan, 2011, p.376). 
(3) Perceptions of risk and legality proposed that mephedrone was a safer alternative than illicit drugs, as 
participants observed the drug outcome to be reliable in terms of potency, quality and perceived purity.  
Since mephedrone was available in “headshops” (shops licenced to sell legal highs), it cost less and 
was easily available on the internet. 
 Nevertheless, Reid, Flowers & Larkin (2005) argued that thematic analysis provides a superficial and 
simply descriptive analysis which does not adequately represent the participants’ lived experience. Moreover, 
although beyond the scope of this research, the study failed to explore the subjective reasons or motivations 
for participants’ mephedrone use, an understanding of which could help suggest what psychological 
interventions may facilitate the treatment of users. Lastly, this study failed to explore the experience of 
“problematic” mephedrone use, which is imperative as it is these users who would most probably access 
treatment services.  
 To date, no research has explored the subjective experience of problematic club drug use, specifically 
mephedrone use. As explained earlier, such research in problematic mephedrone use would be imperative for 
elucidating the psychological motivations of users, the psychological experiences, how users make sense of 
their problematic use and how they may self-identify. Such information could be useful in facilitating their 
treatment.    
 
2.6 Research Aim and Questions 
 Hence, considering this research gap this study aims to explore mephedrone users’ experiences and 
sense-making of their problematic use by asking the following research questions: 
1) How do participants describe their experiences of mephedrone use?  
2) How do participants understand their motivations for their mephedrone use? 
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3) How do participants make sense of their problematic mephedrone use?  
 
2.7 Counselling Psychology Relevance 
 This research focuses on exploring mephedrone users’ subjective experiences and sense -making of 
their problematic use, beyond what is can be inferred from a diagnosis of PSM. This resonates with the 
principles of CoP that is concerned with respecting and valuing subjective experiences and appreciating 
individual differences “over and above notions of diagnoses” (BPS, 2005; Lane & Corrie, 2006, p.17; 
Strawbridge & Woolfe, 2010). This approach suggests that the meanings and sense-making of drug use as 
understood by the individuals whom we, as psychological practitioners, attempt to treat are more meaningful, 
helpful and informative than those meanings attributed by a medical construct (Orlans, 2013; Swanepoel, 2013). 
It is hoped that by adopting such a humanistic, exploratory approach that emphasises the idiosyncrasies and 
exclusivity of human experience, a more holistic understanding of club drug use could develop. Such an 
understanding could contribute towards the progression of psychological treatments and inform counselling 
psychologists on how best to treat club drug users. 
 Moreover, the BPS (2014) outlines the standards of competences for counselling psychologists which 
includes “developing knowledge and an understanding of equality of opportunity and diversities and how to work 
affirmatively to promote social inclusion in their clinical practice” (p.14). In line with this, this research hopes to 
achieve an understanding of club drug users who are a commonly stigmatised and marginalised proportion of 
society by members of the public and professional domain (Gourley, 2004). Furthermore, work towards 
“cultivating a deep respect for all users of therapy” despite their presenting issues, to facilitate and optimise their 
treatment (Cooper & McLeod, 2011, p.141). 
 This research also hopes to support counselling psychologists to work in the field of PSM. The BPS 
(2014) recommended that clinical as well as counselling psychologists in training should experience clients with 
specialist needs, such as those with SUDs, in order to develop imperative generalisable and transferrable skills 
and competencies. However, the Health and Care Professions Council (2012) advised that it was essential for 
only clinical psychologists to develop a standard working proficiency in the field of PSM. Perhaps this was 
because traditionally counselling psychologists were thought to work with mild mental health issues while clinical 
psychologist were thought to work with more serious mental health issues such as SUDs. Consequently, this 
research hopes to contribute towards the development of a standard working proficiency in the field of PSM  that 
is essential for counselling as well as clinical psychologists.  
 Further studies suggested that most clinical as well as counselling psychologists have no formal 
training or placement experience enabling them to understand, assess, and treat individuals with SUDs (Aanavi, 
Taube, Ja & Duran, 1999; Chiert, Gold & Taylor, 1994; Cellucci & Vik, 2001; Corbin, Gottdiener, Sirikantraporn 
& Armstrong, 2013). Anecdotal evidence from Bowden-Jones also suggested a “training gap” among UK 
healthcare professionals with respect to their knowledge of the risks associated with problematic club drug use 
and how to treat such users (Wise, 2011, p.1; Hawkes, 2012). Hence, it appears that there is an imperative 
need for further training of UK based healthcare professionals, including counselling psychologists, in the 
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treatment of PSM, particularly problematic club drug use. To further the knowledge of psychologists treating 
PSM, Miller and Brown (1997) suggested that psychologists actively contribute towards the progressi on of 
treatment systems, policy and related research. Therefore, this research hopes to adopt a scientist practitioner 
stance that contributes towards remedying the lack of evidence-based knowledge when treating club drug 
users. This would better inform counselling psychologists to work with such users and so enhance therapeutic 
efficacy.  
 Lastly, since the CoP doctorate programs uniformly have the goal of training psychologists to engage 
ethically in clinical practice, those responsible for developing and maintaining such programs bear an ethical 
responsibility for ensuring students receive PSM treatment training at least at a foundation level (Harwood, 
Kowalski & Ameen, 2004). Aanavi, Taube, Ja and Duran (1999) suggested that graduate programmes in clinical 
as well as CoP integrate PSM treatment training into their core curricula. Moreover, CoP “values a search for 
understanding” (Rafalin, 2010, p.41), and aims to “understand ways to contribute to the development and 
leadership of the counselling psychology profession” (BPS, 2014, p.14). In line with these principles, this 
research hopes to contribute towards the growing importance and promotion of counselling psychologists’ 
learning in the field of PSM, and so promote an “ethical way of working” with such a prevalent group of clients 
(BPS, 2014, p.10). 
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3. Methodology 
 
3.1 Overview 
 This section locates this study within the wider epistemological and methodological context. It outlines 
the procedures implemented to gather and analyse data, considers ethical issues and concludes with a 
methodological reflexive account. 
 
3.2 Research Design and Rationale 
 The Figure below illustrates the philosophical underpinnings of the chosen methodology and method, 
the rationale of which will be discussed throughout. 
 
Figure 2: An overview of the philosophical foundations underpinning this research study. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 3.2.1 Research paradigm. Paradigms are characterised by their ontology (beliefs about how reality 
is constructed) and epistemology (a theory of knowledge; Guba, 1990). The research paradigm of this study is 
a constructivist approach, which stems from the philosophies of phenomenology and hermeneutics (Mertens, 
2005). Husserl (1970, 1982) described phenomenology as the examination and understanding of an observable 
event in a particular context, whereas Heidegger (1927, 1962) explained hermeneutics as the theory of 
interpretation to uncover aspects of the experience in order to facilitate the understanding of the phenomenon 
under investigation. 
 The intention of constructivists is to understand the world by making sense of an individual’s unique 
lived experience. Constructivists view the individual as an inclusive part of reality, a reality that is nuanced and 
Interpretiv ist/Constructiv ist              
(Research paradigm) 
Relativ ist    
(Ontology) 
Subjectiv ist 
(Epistemology) 
Hermeneutics, Phenomenology 
(Theoretical perspective) 
 
Qualitative 
(Methodology) 
IPA 
(Method) 
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is socially and discursively constructed within a particular context. This thinking is aligned with a subjectivist 
epistemology, while an objectivist epistemology would suggest the existence of a universal reality that is stable 
and independent of the observer. Moreover, constructivists recognise that the observation of an individual’s 
experience does not exist independently from the researcher’s active interpretation, which is mediated by the 
researcher’s preconceptions. This is unlike positivists, who believe that reality can be observed in a controlled 
manner without any mediation. However, in line with constructivists an attempt to suspend the researcher’s 
preconceptions. They do so in order to sensitively get as close as possible to the participant’s lived experience, 
although they acknowledge that a genuine first-person account is unachievable (Larkin, Watts & Clifton, 2006). 
Hence, constructivists acknowledge that all individuals create their own interpretations of reality, originating from 
a relativist ontology that argues that there are as many realities as there are participants, and including the 
researcher’s. (Hansen, 2004; Morrow, 2007). Lastly, within the constructivist paradigm, research is inductive 
and patterns of meaning are established throughout the research process. By contrast, positivists begin with a 
theory in order to deduce generalised statements about a phenomenon (Creswell, 2003).  
 
 3.2.2 Research aim and questions. This study aims to explore mephedrone users’ experiences and 
sense-making of their problematic use by asking the following research questions: 
1) How do participants describe their experiences of mephedrone use?  
2) How do participants understand their motivations for their mephedrone use?  
3) How do participants make sense of their problematic mephedrone use?  
 With consideration to the constructivist paradigm, the first question is descriptive, in line with a 
phenomenological approach that frames the accounts of the participants’ lifeworld. The second and third 
questions develop the hermeneutic avenue as participants reflect on their own accounts in their attempts to 
make sense of their experiences of mephedrone use (Smith, 2008). 
 
 3.2.3 Rationale for a qualitative methodology. Quantitative research aims to develop an objective, 
quantifiable and macro-level understanding of reality uncontaminated by subjective mental processes (Willig, 
2001). However, when research is concerned with the micro-level understanding of subjective phenomenon, 
such as exploring mephedrone users’ experiences and sense-making of their problematic use, a qualitative 
approach is well suited. Qualitative methods are particularly appropriate for the exploration of phenomena that 
are complex, subtle or difficult to explore through quantitative methods (Burman, 1994). The focus of this 
qualitative research tends to be on the "quality and texture of experience" rather than "cause-effect 
relationships" and enquiry typically involves the study of people in their natural environment (Willig, 2001; p.9).  
 Moreover, qualitative research aligns itself with the constructivist research paradigm. It does so by 
aiming to understand unique versions of reality held by individuals, how these versions of reality are shaped by 
their cognitions and experiences, and the limitations and opportunities of the physical, sociohistorical and 
linguistic background and context (Yardley, 2000). While this approach applies to the beliefs and perceptions of 
the participants in the study, it also considers the views of reality held by the researcher. Hence, unlike 
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quantitative researchers who adopt impartiality and objectivity when observing a phenomenon, researchers 
recognise that they themselves are inseparable from the world that is being researched and therefore are 
impacting on the analytic process (Finlay, 2006).  
 Overall, qualitative research’s emphasis on language and thought processes makes it an intrinsically 
psychological approach to scientific inquiry (Smith, 2008). Hence, Smith’s (2008) description of an “explosion 
of interest in qualitative psychology” (p.1) depicts the welcoming of qualitative research by social sciences and 
mainstream psychology, particularly when researching substance misuse (Rhodes & Moore 2001; Nichter, 
Quintero & Nichter, 2004). Neale, Allen and Coombes (2005) suggested that qualitative methods “proved very 
valuable in demystifying drug and alcohol use and replacing stereotypes and myths about addiction with more 
accurate information that reflects the daily reality of substance users’ lives” (p.1586–87). This further supports 
the appropriateness of this methodology for this study. 
 Qualitative research has also received greater popularity and acceptability from CoP, which shares a 
common value base (McLeod, 2003). Qualitative research seeks to elucidate subjective attitudes, perceptions 
and experiences through textual analysis characterised by the exploration of rich and detailed accounts (Geertz, 
1973). This accords with the description of a CoP value set as one that “favours the person and the subjective 
alongside scientific values” (p.14) and “privileges respect for the personal, subjective experience of the client” 
(Lane & Corrie, 2006, p.17).  
 In respect of the factors outlined, a qualitative approach was deemed particularly appropriate to explore 
this study’s research questions. According to Smith, Flowers and Osborn (1997), this advantageously maintains 
flexibility and open-endedness. It also prioritises the individuality and uniqueness of the participant experience 
in order to determine the extent to which a portion of the population experiences particular issues and to 
compare these findings against established norms. This hypothesis-generating approach has the potential to 
provide crucial evidence that could inform the understanding of problematic mephedrone use. 
 
 3.2.4 Rationale for interpretative phenomenological analysis. IPA is informed by phenomenology, 
hermeneutics and ideography (Smith, Flowers & Larkin, 2009). These areas of philosophical knowledge will be 
explained below, while evaluating the suitability of IPA in comparison to other qualitative methods in ascertaining 
this study’s aim. 
 
  3.2.4.1 Interpretative phenomenological analysis. 
   3.2.4.1.1 Phenomenology. Although phenomenology suggests that an individual 
perceives and experiences reality differently depending on their orientation (a relativist ontology), it strives to 
understand the universal “essence” of a subjective phenomenon (a core understanding of an experience that is 
thought to be experienced the same by everyone) and the “intentionality” of human experience (the unconscious 
connection of an individual to their world; Husserl, 1970, 1982).  
 IPA adopts the principles of “phenomenological inquiry” by aiming to understand the lifeworld of 
individuals within a specific context by exploring their self-reflections (Smith, Flowers & Osborn, 1997). This is 
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thought to be achieved via the process of “bracketing” (the suspension of one’s own beliefs about the world in 
order to be open to the beliefs of others; Husserl, 1970; van Manen, 1990). Bracketing develops a descriptive 
account, unobstructed by the researcher’s preconceptions, that produces an “insider’s perspective” of the 
participant’s lived experience (Smith, 1996, p.264). 
 
   3.2.4.1.2 Hermeneutics. Phenomenology evolved into hermeneutics, which aims to 
offer an interpretation of the participant's descriptive account. Heidegger’s concept of Dasein or “being -in-the-
world” emphasises humans’ immersion in their surrounding world, and also that our interpretations of 
phenomena are shaped, limited and enabled by language and culture (Finlay, 2011; Heidegger, 1927, 1962). 
Additionally, individuals’ sense-making occurs in and as a result of varied relationships and social interactions 
with others (symbolic interactionism). This thinking aligns itself with a subjectivist epistemology (knowledge 
cannot exist without individuals to construct it in their unique way) and a relativist ontology (there are many 
versions of reality). 
  IPA adopts a “double hermeneutic”, where the researcher makes sense of the participant making sense 
of their own experience (Smith, Flowers & Larkin, 2009). “Hermeneutic thinking” suggests that the history of the 
researcher is as much a part of the interpretation as is the history of the creator of the text.  As a result, the 
researcher cannot completely bracket off their presuppositions to reveal the “essence” of an experience, as 
phenomenology suggests (Heidegger, 1927, 1962; van Manen, 1990). However, the researcher prioritises the 
interpretation of the lived experience from the participant’s perspective via reflexive practices (see section 1.5, 
p.19-21; section 3.5, p.53-54; section 5.8, p.90-91), which attempts to bracket off the researcher’s biases as 
much as possible in order to get as “close to the participant’s view as is possible” (Larkin, Watts &  Clifton, 2006, 
p.104).  
  
   3.2.4.1.3 Idiography. Idiography (the study of the particular) is concerned with the 
study of an individual’s account of a specific phenomenon within specific contexts as unique and nuanced, with 
the aim of accessing the participant’s lifeworld and meaning-making (Smith, 2008). This corresponds to the 
philosophical perspective of CoP, which states that counselling psychologists have a commitment to engage 
with subjectivity and to strive “to respect first person accounts as valid in their own terms” (BPS, 2005, p.1). 
IPA’s analytic process appreciates there are many unique versions of reality (a relativist ontology) by maintaining 
a level of focus on what is distinct in individual cases, while also attempting to understand shared commonalities 
across a group of participants in order to produce a detailed account of patterns of meaning for participants 
reflecting on a shared experience (Reid, Flowers & Larkin, 2005). The findings of such studies can shed light 
on the extant of existing nomothetic psychological research.  
  
  3.2.4.2 The relevance of interpretative phenomenological analysis to this current study. 
IPA was considered, since the ontological and epistemological foundations of this research make it appropriate 
that the theoretical perspectives underpinning the methodology should emanate from hermeneutics and 
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phenomenology (Krauss, 2005; for a diagrammatical understanding of the research paradigm, see Figure 2, 
p.40). Such theoretical underpinnings agree with the philosophy of CoP and the constructionist paradigm, as 
they aim to describe and explain participants’ unique subjective experiences of a particular phenomenon. 
Secondly, IPA bears intrinsic relevance to psychology at large and is deemed a "specifically psychological 
approach" (Willig, 2001; p.69). Smith and Osborn (2008) highlighted how the theoretical commitment of IPA to 
meaning-making implies a concern with cognitions and mental processes as a central feature of the analytic 
process, and hence mark a point of convergence with cognitive psychology. Thirdly, the idiographic and context-
specific focus of IPA was regarded as a useful framework in which the current topic could meaningfully be 
explored. According to Smith and Osborn (2008), the use of IPA is "partic ularly suitable where the topic under 
investigation is novel or under-researched, where the issues are complex or ambiguous and where one is 
concerned to understand something about process and change" (p.211). This corresponds with the current 
research focus on a previously unexplored dimension of problematic mephedrone use. Lastly, Shinebourne and 
Smith (2009) suggested that IPA provides a qualitative understanding and a subjective knowledge that are 
infrequently accessed in psychological accounts of addic tive behaviour. Hence, IPA is the most suitable method 
for this study’s aim. 
 
  3.2.4.3 Interpretative phenomenological analysis versus discourse analysis. Smith, 
Jarman and Osborn (1999) make the comparison between IPA and discourse analysis (DA; Potter & Wetherell, 
1987). They state that both methods share a commitment to the prioritisation of language, but that DA is more 
focused on the performative tasks of language, and that it recognises pre-existing discourses that are drawn on 
by speakers. DA regards language as behaviours in their own right warranting functional analysis, while IPA 
does not view language as the sole constructor of reality. Rather than exploring the role of language in specific 
contexts as in DA, IPA engages with the individual’s bel iefs, thoughts and lived experiences. Hence, IPA is more 
aligned with exploring this study’s research aim to understand mephedrone users’ experiences and sense -
making of their problematic use. 
 
  3.2.4.4 Interpretative phenomenological analysis versus grounded theory. Grounded 
theory (GT) and IPA share an inductivist approach; GT often requires large scale sampling that works towards 
a conceptual explanatory level analysis of individual accounts. The result is a theoretical -level account of a 
phenomenon associated with social processes, which would not fulfil this study’s aim of exploring mephedrone 
users’ experiences and sense-making of their problematic use. IPA is more likely to offer a more detailed 
analysis of the lived experience of a small number of participants with a focus on the convergence and 
divergence between participants, thus providing subjective knowledge more relevant to this study’s aim (Smith, 
Flowers & Larkin, 2009). 
 
3.3 Procedures 
 This section explores the procedures implemented to gather and analyse data. 
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 3.3.1 Materials. The materials used in the research were as follows: 
• Participant Information Sheet (Appendix J, p.119-122) 
• Informed Consent Form (Appendix K, p.123-124) 
• Demographic Questionnaire (Appendix L, p.125) 
• Interview Schedule (Appendix M, p.126-128) 
• Debriefing Form (Appendix N, p.129-130) 
• Plan of Action (Appendix O, p.131) 
• Ethical-decision Making Tool (Appendix P, p.132) 
• Distress Protocol (Appendix Q, p.133-134) 
• Digital recorder  
 
 3.3.2 Sample selection. 
  3.3.2.1 Participants. Purposive sampling was used that aligns itself with the aim of an IPA 
study to recruit a homogenous sample for which the research question is significant, and therefore gives insight 
into idiosyncratic experiences (Smith & Eatough, 2006). Six participants were recruited, as Smith and Osborn 
(2008) recommended this as a reasonable sample size for doctoral IPA research (for the demographics of 
participants, see Table 1, p.48). It allows sufficient in-depth engagement with each individual case, as well as 
detailed examination of the similarities and differences of the shared experience among participants. 
Demographic information was collected prior to interviewing each participant in order to situate the sample and 
enable assessment of the relevance of results (Elliott, Fischer & Rennie, 1999). 
 
  3.3.2.2 Inclusion and exclusion criteria. Although IPA’s epistemological stance proposes 
that results cannot be generalised to the wider population, maximal homogeneity ensures the findings’ utility in 
providing useful insights for similar groups and contexts to the one under investigation (Johnson, 1997; Yardley, 
2008). Therefore, the homogeneity of the sample was emphasised, while not restricting inclusion and exclusion 
criteria in order to maximise recruitment.  
 A summary of the main inclusion and exclusion criteria are given, together with a detailed, extensive 
list in Appendix G (p.115). Participants were excluded if they did not self-rate their mephedrone use as 
problematic, since the aim of this study was to explore subjective problematic mephedrone use. Participants 
were recruited who used mephedrone, as this is the club drug under investigation. Participants who had a 
serious co-morbid mental health condition were not recruited (Appendix G, p. 115), in order to minimise potential 
interference with their recovery and because participants may not have been competent enough to give 
informed valid consent.  
 With respect to age, gender and sexual orientation, there were no restrictions, since these factors were 
not under investigation. Moreover, since this study did not focus on participants’ experiences of mephedrone 
use within a specific time-frame, there were no restrictions concerning the length of time between when the 
participants last used mephedrone and when they spoke about their experience. Kahneman (2010) explained 
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that a participant’s experience of a particular phenomenon does not become less valid according to the longer 
ago it happened. Kahneman (2010) distinguished between, on one hand, the “experiencing-self” as fast, intuitive 
and an unconscious mode of thinking that operates in the present moment; and, on the other, the “remembering-
self” as slow, rational and a conscious mode of thinking that tells the story of our experience. While it is 
suggested that each moment of the experiencing-self lasts approximately three seconds, what gets 
remembered by the remembering-self are significant moments in the story (Kahneman, 2010). If a participant 
recalls an experience from a month ago or six years ago, their self-reflections may alter through time, because 
individuals’ attitudes and perceptions are fluid.  However, their accounts remain as valid as each other since 
there is no right or wrong experience. 
  
 3.3.3 Interview schedule. A semi-structured interview schedule was developed as a result of the gaps 
identified by the literature review. This was done by receiving feedback of four drafts from the academic 
supervisor and from an IPA regional research group meeting; and by piloting the interview with fri ends from a 
background related to neither psychology nor research.  
 Three main research questions informed nine main interview questions which aimed to explore the 
experience of mephedrone, the motivations for using mephedrone, and how the participants made sense of 
their problematic use (see Table 2, p.49). Open-ended main questions allowed the participant to set their own 
parameters for discussion, and gave a descriptive response that allowed the participant to feel comfortable 
when talking (Smith, Flowers & Larkin, 2009). Prompts allowed the researcher to probe for expansion into areas 
in a flexible manner and in an order most suited to the interviewee (Legard, Keegan & Ward, 2003). Using the 
“funnelling technique”, questions began more general and became progressively specific; moved progressively 
from the general to the specific; hence the word “problematic” does not appear until late in the interview 
schedule. This facilitated rapport and eased the participants into the interview (Smith, Flowers & Larkin, 2009). 
The tenth question is not considered a main question but acknowledges the closing of the interview, while giving 
participants the opportunity to share their final thoughts.  
 
3.3.4 Data collection. 
  3.3.4.1 Recruitment process. Participants were recruited from a primary care service for 
substance misuse from the National Health Service (NHS) located in North London, and recruitment took place 
from 26th October 2015 to 25th May 2016. 
 The Service Manager reviewed the service database to locate participants who met the inclusion and 
exclusion criteria. The Manager made initial contact with the potential participant via telephone or face -to-face 
conversation in order to deduce their interest in participating, and also provided the participant wi th an 
information sheet via email or in person. If the participant conveyed interest in participating in the study, their 
contact details were shared with the researcher, with the participant’s consent. The researcher then telephoned 
the participant, and the following areas were discussed: their interest in participating; the purpose of the study; 
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a further review of the exclusion and inclusion criteria, including screening for serious mental health issues; and 
any questions the participants had were answered. Subsequently, a consent form was emailed to the participant.  
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Table 1:  
 
Demographics of participants 
Pseudonym Age Sexual 
orientation 
Level of 
education 
Employment 
status 
Housing 
situation 
When 
mephedrone 
use began 
Other drugs used in 
combination with 
mephedrone 
When mephedrone 
was last used prior to 
the date of interview 
Robert 40 Heterosexual Level HND Volunteering Renting 2015 None 3-4 months 
Daniel 30 Bisexual GCSE Part-time Lives with 
parents 
2011 Cocaine, GHB 2 weeks 
Greg 35 Homosexual University 
degree 
Full-time Renting 2013 GHB, Marijuana, MDMA, 
Cocaine, Ecstasy 
2 months 
Josh 24 Homosexual University 
degree 
Part-time Lives with 
parents 
2013 Crystal meth, GHB, 
MDMA, Ketamine, 
Cocaine, Alcohol 
One month 
Alexander 27 Bisexual University 
degree 
Full-time Renting 2015 GHB, Crystal meth, 
Marijuana 
One month 
John 52 Homosexual A Level Self-
employed 
Renting 2010 Crystal meth, GHB, 
Cocaine, Marijuana, 
MDMA 
2 months 
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The researcher then telephoned the participant after two days to receive their final decision to participate.  
 If the participant chose to participate, a face-to-face research discussion was scheduled with the 
researcher. Prior to commencing the research interview, the researcher reviewed the information sheet, the 
consent form and the plan of action with the participant, and again answered any questions the participant may 
have had. Two signed copies of informed consent per participant were acquired in person: one copy for the 
participant and the other for the researcher’s records.  
 
Table 2:  
 
Interview questions in relation to research questions 
Research Question Interview Question (number indicative of the position in the interview 
schedule) 
How do participants 
describe their 
experiences of 
mephedrone use?
  
(2) Can you tell me about your initial experiences of using mephedrone?  
(4) Can you describe how you felt about yourself at this time in the wider 
society? 
(6) Can you describe your experiences of problematic mephedrone use? 
(8) Can you describe how you felt about yourself when your drug use was 
problematic? 
 
How do participants 
make sense of their 
problematic 
mephedrone use? 
 
(5) Can you tell me how you noticed your mephedrone use had become 
problematic? 
(6) Can you describe your experiences of problematic mephedrone use? 
(9) Can you tell me how you decided you wanted to seek help for your 
problematic drug use? 
 
How do participants 
understand their 
motivations or reasons 
for their problematic 
mephedrone use? 
(1) Can you tell me about how your mephedrone use began?  
(3) Can you tell me what role mephedrone had in your life during your initial 
stages of use? 
(7) Can you tell me what role mephedrone had in your life when your use was 
problematic? 
 
  3.3.4.2 Interview process. Interviews lasted between 40 minutes and 1 hour 35 minutes, 
averaging 57 minutes, and were audio recorded using a digital recorder. Prior to interviewing, the participant 
was socialised to the interview process by collaboratively reviewing the information sheet.  That included making 
them aware of the time it may take, that it would be more like a “conversation with a purpose” than an interview, 
and that the researcher was interested in their experiences rather than there being any right or wrong responses 
(Smith, Flowers & Larkin, 2009, p.57).  
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 The aim of the interview was to access the participant’s lifeworld. In accordance with the principles of 
IPA, the schedule was used flexibly. That enabled a “dual focus” where the interview was participant-led, since 
the participant is perceived as the experiential expert, while being guided by the researcher. The researcher 
listened and asked follow-up questions such as: “Can you tell me more about this?” The researcher asked 
further open-ended questions if relevant topics arose that were not on the interview schedule in order to better 
understand the participant’s feelings, opinions and beliefs (Legard, Keegan & Ward, 2003).  
 On the completion of the interview, the participant was verbally debriefed and given a debriefing form. 
The researcher kept a reflective diary of the interview process and noted non-verbal information that informed 
the analytic process (Smith, Flowers & Larkin, 2009). 
 
3.3.5 Analysis. 
  3.3.5.1 Transcription. The interviews were transcribed verbatim with the semantic record of 
every word uttered. O’Connell and Kowal (1995) suggested that it is unnecessary to transcribe prosodic 
information – pauses and non-verbal utterances – which will not be analysed, as it is the content of the 
participant’s account that is favoured in IPA. Therefore, only relevant non-verbal utterances were recorded via 
bracketed text, e.g. (laughter) (Smith, Flowers & Larkin, 2009). Each turn of phrase was numbered for ease of 
reference, and the margins were widened for ease of coding (see Appendix R, p.135-136). 
   
  3.3.5.2 Analytic process. Smith, Flower and Larkin’s (2009) recommendations for analysing 
data was adopted. To immerse oneself in the participant’s lifeworld, the transcript was read and the interview 
recording listened to several times. A core phenomenological approach was taken, with the left-hand margin 
used for free textual analysis. This involved descriptive comments on the content of what the participant said, 
linguistic comments on the participant’s use of specific language, and conceptual comments that formed a more 
interrogative and theoretical approach to the data (see Appendix R, p.135-136). A hermeneutic approach 
followed, with the right-hand margin used to mark emerging themes. This involved forming connections between 
the initial notes in order to produce statements that were grounded in the participants’ account.  
 The emergent themes were then written on pieces of paper, and possible connections between them 
inferred which resulted in a more theoretical ordering. Themes were clustered using mainly the strategies of 
abstraction (grouping themes with a similar meaning), subsumption (the emergent theme itself becoming a 
master theme), polarisation (examining oppositional relationships), and numeration (looking at the frequency at 
which a theme emergences; Smith, Flowers & Larkin, 2009). Some emergent themes were omitted if they did 
not “fit well in the emerging structure nor are rich in evidence within the transcript” (Smith & Osborn, 2008, p.72). 
A table of superordinate themes was constructed for each participant. Subsequent participants were 
systematically analysed in the same manner, while bracketing out findings of previous participants as much as 
possible.   
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 Each superordinate theme table was then analysed together in order to identify patterns across 
participants. Higher order superordinate themes were reconfigured and relabelled in order to produce a final 
Master table of themes (see Table 3, p.55; Appendix S, p.137-144). 
 
3.4 Ethical Consideration and Validity 
 This section describes the ethical issues and the validity of the study. 
 
  3.4.1 Ethical consideration. Ethical approval was achieved from Research Ethics 
Committees at London Metropolitan University (see Appendix H, p.116) and Derby NHS (see Appendix I, p.117 -
118). 
 A mobile telephone number and e-address solely for this research were displayed on materials in order 
to maintain the professional boundaries between participant and researcher. In accordance with the principle of 
respect for the autonomy and dignity of persons as described in the Code of Ethics and Conduct (BPS, 2009), 
the information sheet included sufficient details regarding the exclusion and inclusion criteria which enabled 
participants to make an informed decision as to whether it was appropriate for them to participate. 
 Prior to interview, participants were provided with a range of information, starting with an explanation 
of the purpose of the study. They were informed that they were under no obligation to participate and that not 
participating would not affect their treatment; that breaks could be taken whenever necessary during the 
interview; that they could refuse to answer any questions; and that they could withdraw from the study up to 6 
weeks after interview or until data analysis had begun (whichever length of time was the greater), at which point 
their data would be destroyed. Participants were also informed that they would be unable to participate while 
under the influence of any intoxicants, on the grounds that this may have affected the validity of the consent 
given and the reliability of the results, as participants would be deemed incompetent and might not be able to 
give coherent responses (Walker, 2008). Participants were not able to participate if they were diagnosed with a 
serious mental health problem, as this could potentially interfere with their recovery. As well as the Manager of 
the service screening for serious mental health problems, further screening was conducted by the researcher 
during initial telephone contact, when questions were asked such as: “Have you ever been diagnosed with a 
serious mental health disorder or otherwise? If yes, what was this?” and “Are you currently experiencing 
symptoms associated with this mental health condition? What are these?” 
 Permission was requested for the interview to be audio-recorded, and for selected anonymised 
verbatim comments to be used for illustrative purposes. Participants were assured that all data would remain 
anonymous, as personal identifying information would be removed from transcripts, recordings and throughout 
the study write-up. Under NHS ethical guidelines, audio recordings of the interview were stored in a safety 
deposit box located in a locked filing cabinet within the service, and audio recordings located on the researcher’s 
laptop that were password protected. Participants were informed that data would be kept for a maximum of five 
years, in case of publication, after which it would be erased.  Participants were informed that the confidentiality 
of participants would be breached if information was disclosed that indicated an imminent risk of harm to 
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someone else or themselves (BPS, 2010; Daley, 2009). Also, participants were shown and explained the plan 
of action (see Appendix O, p.131), namely a flow diagram corresponding to the course of action taken to inform 
the appropriate authorities if any information causing a breach of confidentiality was disclosed (Walker, 2008). 
This included: the possession of illegal drugs; the supply of illegal drugs; and information about activitie s such 
as theft or prostitution that may be used to fund their SM (Walker, 2008). Prior to contacting the authorities, 
each case would be evaluated on its own merits, with the first supervisor using an adapted version of Robert 
and Dyer’s (2004) ethical decision-making tool (see Appendix P, p.132). In general, confidentiality was not 
broken when discussing the illicit use of drugs, as participants were recruited to discuss this topic and were 
seeking treatment for their PSM where the disclosure of their ill icit drug use ought to be respected (Roberts, 
2008). 
 For the participants’ wellbeing, their Keyworker was informed of their participation in the study, although 
no data was shared with their Keyworker, who in any case was not present at the interview. A d istress protocol 
(Cocking, 2008; see Appendix Q, p.133-134) was also implemented in case a participant became distressed 
during the interview. Interviews were conducted at the treatment service, which is a safe, clinical environment 
for this vulnerable client group. At the end of the interview, participants were given a written debriefing form 
(Appendix N, p.129-130), which included contact details of helplines should the participant require further 
support, together with information about how to make a complaint if the participant felt the interview was 
conducted inappropriately. 
 
 3.4.2 Validity. In line with a pluralistic and rigorous stance, Smith, Flowers and Larkin (2009) suggested 
Yardley’s (2000) four principles for assessing the quality of qualitative research, which are discussed with 
relevance to this study. 
 
  3.4.2.1 Sensitivity to context. To maintain sensitivity to this study’s theoretical context, 
research questions originated from identifying gaps in the literature review (Yardley, 2000; for focused critique 
of literature, see section 2.5, p.35-37). IPA was chosen since it drew upon subjective knowledge, which is 
infrequently accessed when researching the field of addictions (Shinebourne & Smith, 2009). Interviews were 
conducted sensitively, respecting each participant and trying to facilitate rapport so that participants felt 
comfortable. This reflects the subjectivity and intersubjectivity values of CoP (BPS, 2005). Similarly, sensitivity 
was given during the write-up of the research by carefully using relevant verbatim extracts and through offering 
“interpretations as possible readings grounded in the data” (Shinebourne, 2011, p.27)  
 
  3.4.2.2 Commitment and rigour. Commitment was demonstrated by the researcher’s 
continuous engagement with the study through the difficult process of recruiting participants, attention to the 
participants during the interview process and personal dedication to the topic. In terms of rigour, participants 
were carefully selected to be a homogenous sample that would adequately address the research questions. 
Also, great effort was taken to sustain the quality of the interview, as numerous drafts of the interview schedule 
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were produced. Analysis of each case involved “prolonged contemplative and empathic exploration ” that 
addressed the complexity and variation within each account (Yardley, 2000, p.222). Moreover, a theoretical 
audit ensured that themes were well matched and grounded in verbatim extracts, giving participants a voice (for 
superordinate theme with participant quotes, see Table 8, Appendix S, p.137-144). 
 
  3.4.2.3 Transparency and coherence. An “audit trail” offering documentation pertaining to 
all analytic stages of research was retained in order to allow the reader to verify and scrutinise the researcher’s 
decision-making and theme-generating process (Lincoln & Guba, 1985). The consistency between the research 
paradigm and chosen method is explored (for discussion of the research design, see section 3.2, p.40-44). 
Personal reflexivity has been engaged in and commented upon throughout the research process (see section 
1.5, p.19-21; section 3.5, p.53-54, section, p.5.8, p.90-91), highlighting how the researcher’s assumptions, 
engagement with the participant, experiences of the research process and so forth could potentially impact 
upon the research. 
 
  3.4.2.4. Impact and importance. The importance of this research is commented on during 
the conclusion of the review of relevant literature (see section 2, p.22-39) and CoP relevance section (see 
section 2.7, p.38-39), and its impact is deduced in the discussion and implications of findings (see section 5, 
p.75-90) further illustrating the validity of this study. 
 
3.5 Methodological Reflexivity 
 This section gives a reflexive account concerning the implementation of the chosen method. 
 
 3.5.1 Reflexive statement: Part two. I will attempt to outline the potential impact I had as a researcher 
on the development of the interview schedule and analysis, further facilitating the study’s rigour (Willig, 2001). 
One of my initial assumptions was that the experience of problematic mephedrone use differed from problematic 
traditional drug use, in that traditional drug use is more debilitating.  
 Through reflexivity I realised that I was imposing this presupposition on the initial drafts of the interview 
schedule. My initial interview questions were structured and leading, perhaps aiming to ensure that participants 
would express a difference in their experiences of problematic use. Re-drafting the interview schedule became 
an iterative process, as questions were reformulated following feedback received from supervision and the IPA 
regional research group in order to avoid “blocking the participants voice” (Finlay, 2002, p.41). When 
constructing the interview schedule, I also sensitively considered my use of language. I avoided using 
stigmatising language such as “addiction” (for an understanding of the stigmatising implications of the term 
addiction, see section 2.2.3, p.27-28) and, in turn, used the term “problematic use”. I hoped that this would allow 
participants to freely discuss their subjective experience without the influence of associated stereotypes. 
Therefore, the interview schedule was constructed to prioritise participants’ experiences.  
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 I read my reflexive journal prior to interviewing in order to enhance my ability to bracket my 
assumptions. I attempted to interview as a naïve researcher respecting each participant’s unique experiences, 
thus upholding my profession’s values (Orlans & van Scoyoc, 2008). While conduc ting interviews, I understood 
well the principle of the interview schedule being a guide rather than each question needing to be followed in 
sequence. I learned to become flexible with my questioning and, in turn, left the “research world and came 
around the hermeneutic circle to the participant’s world” (Smith, Flowers & Larkin, 2009 p.64).  
 I found analysis a time-consuming though interesting experience while I explored participants’ life 
stories. I was aware that due to my personal experience of substance misuse, a third layer of interpretation 
would be added to the two-stage hermeneutic process that takes place in IPA (Smith, 2008). In this way, not 
only would the participants be making sense of their experiences, but I would be interpreting their exper iences 
from my standpoint as both counselling psychologist and researcher and as someone with a personal 
experience of substance misuse. I monitored this by employing reflective practice (see section 1.5, p.19 -21) to 
ensure I remained as close as possible to the participants’ lifeworld.   
 Following several attempts at analysis, my themes moved from being descriptive in nature to more 
interpretative. I struggled to form adequate master theme titles that I felt encapsulated the experience of the 
participant and “knowing what does make a piece of work good enough” (Smith, Flowers & Larkin, p.184). I 
managed my anxieties by consulting my supervisor, and believe that because of such struggles, I developed 
as a reflexive researcher.  
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4. Results 
 
4.1 Overview 
 Table three conveys the final three superordinate and nine subordinate themes, which are translated 
into a narrative account and dispersed with verbatim extracts. The themes are presented in a sequence which 
is intended to convey the progression from reasons for using mephedrone to the experiences of using 
mephedrone and finally to the sense-making and realisation of problematic mephedrone use. All six participants’ 
accounts both converge and diverge so as to contribute to all subordinate themes, which are evidenced with at 
least three participants to promote “sufficient sampling” (Smith, 2010, p.17).  Table 8 (see Appendix S, p.137 -
144) includes quotations partially referenced, or not referenced, in the results section due to limited word -count.   
 
Table 3: 
 
Final superordinate and subordinate themes 
Superordinate Theme Subordinate Theme 
1) Mephedrone as a credulous 
fix for ongoing identity 
vulnerability and distress, 
initiating a vicious cycle of 
deliberate use 
 
1a) A way of connecting that creates a false sense of belonging 
1b) The externalisation of “deep psychological damage” allows for 
short-lived appeasement 
1c) An attempt to create an empowered, idealised false-self 
through calculated mephedrone use 
 
2) The paradoxical experiences 
of progressive mephedrone 
use 
2a) “Love at first sight” versus a devilish mistake 
2b) Naive control versus a sense of being out of control 
2c) A desirable need versus a “pointless” activity 
 
3) Making sense of one’s 
problematic mephedrone use 
via self-reflective processes 
3a) Stigmatising beliefs assist in the self-identification of 
problematic mephedrone use 
3b) A critical incident that triggers the self-evaluation of one’s 
mephedrone use as subjectively problematic 
3c) An internal debate between desires versus values and beliefs 
that motivates change 
 
 4.2 Exploration of Themes 
 4.2.1 Superordinate theme 1: Mephedrone as a credulous fix for ongoing identity vulnerability 
and distress, initiating a vicious cycle of deliberate use. This superordinate theme includes three 
subordinate themes that explore the motivations of participants to use mephedrone, which perpetuated a vicious 
cycle of use. 
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  4.2.1.1 Subordinate theme 1a: A way of connecting that creates a false sense of 
belonging. Daniel explained that his parents divorced when he was an adolescent and that during his twenties 
he divorced his wife after the birth of their son. He felt an unreciprocated care towards his friends, and three 
months prior to using mephedrone he “got left redundant…and erm, ended up partying a lot more” (p.5, L48). 
Due to these experiences, Daniel may have felt excluded or rejected from mainstream society and this resulted 
in feelings of loneliness, low-self-esteem, and identity confusion. This may have caused his vulnerability towards 
using mephedrone as a way of fulfilling unmet attachment needs and of renegotiating his identity by connecting 
to a new drug subculture. Daniel explained: 
 
 “I felt like a kid again, I felt like being back in school. I was around a lot of people, we was all around the same 
age, a bit younger. We were like a big crew, was like a big family and erm (…) nobody could tell us nothing, and 
we were just having the best, we were having the best amount of times. Erm people was like taking pictures, it 
was just like, people, everyone, like, became, everyone was defending each other. Like people would buy each 
other drinks, and just like, as much as it sounds trivial now it’s really really really (..) a life that would love as a 
kid. Like whoever’s in school now, if you got friends like the friends that I had back then, that was so supportive 
of you, made you feel like you’s a part of something, and you was erm, you was, you was wanted, and that’s 
how they made you feel and that is that, that’s exactly the thing I holded onto.” (p.11, L76) 
 
 Daniel described himself as a “kid” among his peers who formed a “big crew”, which suggested feelings 
of invisibility, support and trust, e.g. “defending each other”, fun, e.g. “having the best amount of times”, 
belonging, e.g. being “part of something”, and acceptance, e.g. feeling “wanted” by others. A sense of naivety 
was also created as Daniel described himself as a “kid” who believed that via the connection with mephedrone 
and subsequently others that used it, he would have a long-term resolution to his feelings of social exclusion 
from mainstream society. Daniel proposed that in the mephedrone-using community he got his “feelings 
and…your worries answered, so [laughs] you are gonna gravitate towards people like that, that are actually 
listening to you” (p.12, L78), which mirrored the qualities of a quasi-support group or surrogate “family” (p.11, 
L76). Feelings of importance, care, acceptance and belonging are suggested, which appeared to have 
harnessed a positive sense of self, and replaced the painful “void” (p.12, L78) of loneliness with a sense of 
inclusion and secure attachments. To “hold onto” (p.11, L76) the gravitational allure of such positive feelings 
and therefore his membership of the mephedrone-using community that contained his fragile sense of self, 
Daniel continued using mephedrone, and this subsequently formed part of his new, adopted identity.  
 Josh’s family rejected him when he disclosed his sexual identity as being “gay” (p.8, L64). 
Consequently, Josh used mephedrone to facilitate chemsex, which promoted feelings of belonging and the 
acceptance of his sexual identity. Josh explained: 
 
“…I remember the fire burning rush that comes up the body, through the heart it spreaded out instantly . It made 
me addictive to want him, erm want everything. I became, it it’s everything people said that was gonna happen. 
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My inhibitions my went down, my I mean my inhibitions were already low (laughs), as so at that age, but erm 
(..) yeh I yeh as soon as I took mine he took his (..) it was, we just went off on one, we couldn’t stop. I didn’t 
want to stop. I felt loved really and I think that was, I knew that back then and I knew that now, and that was my 
problem, erm…” (p.2, L18) 
 
 Josh described how mephedrone “spreaded out” around his body, which created an image of warmth 
and embrace. This highlighted Josh’s connection with the drug itself, which appeared to create a sense of 
containment of Josh’s fragile sense of self (for the changing connection or rela tionship participants shared with 
mephedrone, see section 4.2.2.2 p.64-65). This theme of intimacy and containment was continued by the 
heightened sexual arousal between Josh and “him”, “him” being a stranger at a sex party, which proved 
uncontrollable as Josh was “addictive to want him”, thus illustrating the potent effects of mephedrone. Josh’s 
“inhibitions” were lowered and he was enabled to express his true sexual identity. Consequently, Josh felt 
“acceptance love” (p.10, L72), which harnessed a positive sense of self as his sexual identity was accepted by 
others and which in turn produced feelings of belonging that replaced his feelings of loneliness and rejection. 
Josh explained: 
 
“…It made me feel like I had a circle of friendship. Even though I had friends before the drugs, I felt accepted, I 
think that’s, that’s what I had to admit to myself. I didn’t really accept myself as being gay, and it didn’t help my 
family, they didn’t support me…” (p.8, L64)  
 
However, Josh later recognised that this feeling of love was not authentic but “false love” (p.10, L72), a term 
that depicted the false nature of his intimate relationships during chemsex as they were manufactured by the 
effects of mephedrone. Nevertheless, Josh continued to use mephedrone as it temporarily and superficially 
masked his painful reality of loneliness and rejection with a false sense of belonging that allowed him to freely 
unveil and explore his true sexual identity. 
 This false sense of belonging, acceptance and mutual support initially created by participating in the 
mephedrone-using community was short-lived for both Daniel and Josh.  It was replaced by a lack of care and 
distrust as their connection or relationship with mephedrone became problematic and was prioritised over their 
relationships with other mephedrone users. Daniel explained that “all drug users…they’re not really friends” 
(p.21, L118), and Josh reiterated that “…people don’t really care of other people’s feelings. They only want what 
they want…” (p.28, L162). These realisations were triggered by witnessing others participating in deceitful 
actions to selfishly obtain mephedrone, or by taking such actions themselves. Daniel described how he would 
when “nobody’s looking…scrape some off the top and put it in some tissue” (p.12, L80). Moreover, authentic 
relationships with family members and long-term friends outside the mephedrone-using community broke down, 
as the “drug life” (Daniel, p.12, L78) of participants was prioritised and kept “secret” (Daniel, p.14, L86).  
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 Greg explained that he missed family “birthdays”, his “grandad’s funeral (laughs) just for drugs…” 
(p.10, L72) and lost his “real friends” (p.8, L86). So he, too, had initial feelings of being “alone” (Greg, p.16, 
L137), rejected and excluded from mainstream society which created identity distress and vulnerability. For all 
three participants, this was exacerbated as they were now rejected from their inner circle and newly adopted 
drug subculture (for participants’ heightened sense of identity issues following mephedrone use, see section 
4.2.3.3, p.72-73). 
 Ultimately, using mephedrone was naively thought to solve the participants’ enduring identity issues.  
In fact, it deceptively lured participants into a false sense of belonging that was short-lived, to the point where 
the only connection or relationship that was left was to the drug itself (for further discussion of the implications 
of the prioritisation of mephedrone, see sections 4.2.2.2 p.64-65 and 4.2.2.3 p.65-67). This made participants 
more dependent on the use of mephedrone to subdue their heightened psychic pain, thus creating a vicious 
cycle of use. 
 
  4.2.1.2 Subordinate theme 1b: The externalisation of “deep psychological damage” 
allows for short-lived appeasement. John has had “internalised homophobia” (p.15, L69) since childhood that 
has resulted in a continuous struggle to accept his sexual identity. John perceived his sexual identity as an 
“unacceptable” or a “subconscious” (p.6, L33) facet of his identity that led to him “self-loathing” (p.6, L33). 
Perhaps John’s rejection of his unacceptable sexual identity resulted from him being teased during his childhood 
for being “gay” (p.15, L69), which made John feel different or excluded from mainstream society. John explained 
that “just being born gay in a world where everybody’s straight…that’s enough to do the damage” (p.15, L69); 
“damage” in this sense resembling “deep psychological damage” (p.15, L69) associated with feeling somewhat 
inadequate. John likened this psychic pain to the researcher’s assumed social exclusion from mainstream 
society based on her ethnicity:  
 
“Same as your race, everybody else is white, would be enough for you to have damage, some sense that you’re 
not the same, and maybe not as good as everybody else.”  (p.15, L69) 
 
Perhaps this highlighted John’s attempt to relate to the researcher, the implications of which are explained in 
section 5.8, p.90-91.   
 To manage John’s identity distress, related to his sexuality, he participated in a masochistic form of 
chemsex:  
 
“…it’s based on get it high use it like a piece of meat infect it, destroy it…use it like a piece of meat, lock you in 
a dungeon, just fuck it, fuck it, fuck it till it’s dead.” (p.14, L67) 
 
John allowed himself to be used “like a piece of meat”, “destroyed” and “infected” by others who were HIV 
positive until he was mentally “dead”. John was also HIV positive, which represented another unacceptable 
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facet of his identity. The repeated use of expletives suggests the destructive action of this version of chemsex, 
in which John appeared powerless, defenceless, senseless and insignificant. Furthermore, this form of chemsex 
seemed to have had an element of secrecy, as John was metaphorically locked “in a dungeon”, and perhaps 
this symbolised John’s figurative compartmentalisation of his psychic pain.  
 This masochistic form of chemsex resembled a form of self-harm, facilitated by mephedrone use and 
the actions of others. The use of mephedrone allowed John to “act out this damaged” (p.6, L33) or to actively 
reject the unacceptable parts of himself that he loathed and perceived as inadequate. This in turn encouraged 
his unacceptable self to be deservedly “used” (p.4, L25) and punished by others during sex and so provide him 
with temporary relief from his psychic pain. 
 However, it appeared that John’s mephedrone use ironically heightened his identity distress. John 
described: 
 
“…I’ve got this beautiful life, the drug use is incongruence within my life and I know it’s damaged, it’s sexual 
damage from my childhood if you like, that I’m acting on, that it doesn’t fit with who I am. I’m a kind caring 
person, and yet I take a bit of this drug and I suddenly want to be used like a piece of meat. It’s like Jekyll and 
Hyde.” (p.4, L25) 
 
John recognised that his mephedrone use was an externalisation of his psychic pain, stemming from his sexual 
identity distress, which allowed him to objectify his unacceptable self that “doesn’t fit with who I am” (p.4, L25). 
However, John acknowledged that his mephedrone use ironically exacerbated his identity distress and dislike 
for himself, as his drug use constituted another unacceptable facet of his identity (for further discussion of 
participants’ heightened identity distress because of mephedrone use, see section 4.2.3.3, p.72 -73).  
 The exacerbation of John’s psychological distress by mephedrone was further illustrated by his 
analogy of mephedrone as an “evil temptress” (p.20, L89) that harmed him, himself being “Alice”, who was 
innocent, friendly and naive. John explained: 
 
“…you go to wonderland, you come home in the morning with your dress shredded and your knickers in tatters.” 
(p.20, L89)  
 
Although mephedrone was initially used to rid John of his unacceptable self that he loathed, both the 
“acceptable” self, signified by the “dress” that could be seen, and the unacceptable self, signified by the 
“knickers” that were hidden, are destroyed in the end. This depicted the destructive nature of mephedrone and 
the further psychological damage that resulted from its use, representing a “huge price tag” (p.20, L91) to pay 
in exchange for part-time relief by visiting “wonderland”. “Wonderland” symbolised the alluring, short-term 
positive qualities produced by mephedrone. To defend against John’s heightened psychic pain, further 
mephedrone was used with naïve optimism in order to provide a quick-fix in the hope of appeasing John’s 
enduring identity distress, although not to resolve it. 
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 Robert explained that he arrived in the UK from Brazil and at the time he was unemployed while being 
faced with the responsibility of providing for his family. Due to “little prospect” (p.8, L80), Robert became 
depressed and felt “out of control” (p.3, L26) or unsettled, feelings that may have manifested themselves 
because of the identity distress experienced while he transitioned between two different cultures. 
 To manage his feelings of depression, instability, hopelessness and identity distress, Robert used 
mephedrone as a naïve quick-fix to the enduring process of acculturative stress. Robert described how 
mephedrone would “numb the problem[s]” (p.24, L210) he faced. An image was created of Robert being in 
“another world” (p.5, L54) where he felt “mellow” (p.14, L132) and his psychic pain was temporarily appeased. 
This image was reinforced as Robert explained that mephedrone would “block you out the reality, so you don’t 
have to face your problems no more” (p.7, L76). Mephedrone appeared to function as an avoidance strategy, 
as it acted as a metaphorical “mask” (p.15, L140) so that Robert no longer “face[d]” his problems, and as a 
“shield” (p.7, L76) that metaphorically defended or protected Robert against his negative feelings.  
 However, Robert explained: 
 
“…thing is you keep using that because of the depression, when…you wake up and then you feel that 
depression like the emptiness, then you go after it again.” (p.11, L118) 
 
Robert acknowledged that the appeasement of his depression was short-lived, and was exacerbated as he 
suffered from the negative side-effects of mephedrone use. This perpetuated further mephedrone use as an 
external method to instantly self-medicate against his negative feelings rather than to explore a reflexive process 
that would result in long-term resolution. This culminated in a vicious cycle of mephedrone use. 
 
  4.2.1.3 Subordinate theme 1c: An attempt to create an empowered, idealised false-self 
through calculated mephedrone use. Greg was the second youngest child of seven siblings and had one 
eldest brother and five sisters. His father passed away during his pre-teens and his mother remarried. During 
Greg’s adulthood, he moved from Brazil to Spain and currently lives in the UK. Greg explained that his drug use 
began in Brazil and that he moved countries with the purpose of achieving abstinence. Greg described how he 
felt unhappy, like he was “achieving nothing” (p.4, L40) and was not “happy about myself” (p.4, L40). Greg also 
described how “as a personality I’m paranoid” (p.13-14, L116), which may have contributed towards his lack of 
“confidence to talk to other people” (p.2, L20).  
 Alexander moved to the UK from Syria during which time he experienced acculturative stress, which 
included missing his family and friends, as well as difficulties in finding employment and establishing a new 
supportive network in the UK. Alexander described himself as “shy” (p.5, L40) and unable to express himself 
sexually and verbally as he desired. As a result of Greg’s and Alexander’s experiences, they may have both 
experienced identity distress and a reduced sense of self-efficacy and self-esteem. 
 To contain their fragile sense of selves, they both used mephedrone as a way of creating an 
empowered, idealised self that had the qualities they wished they organically possessed. Greg explained:  
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 “…at work if you use mephedrone and you’re dealing with customers, it just blank yourself, you don’t care about 
other things, it just like…it doesn’t matter. I don’t care. You keep going and you feel strong, and then you, no 
don’t paranoia about washing, they think clean or what. Sometimes you have an awkward moment with the  
customer, you know I should have said that or I shouldn’t have, but then there I times when I think, good, I said, 
I said whatever, I don’t mind, why you think like that, it’s okay, it’s up to you (laughs).” (p.13-14, L116) 
 
Alexander explained: 
 
“Feels like you need to use that drugs to have confidence. And when you use that drugs somehow you are 
smart, you know how to talk. I don’t know where the thoughts come from, but it helps with conversation and 
stuff…” (p.19, L124) 
 
 “Cos er with mephedrone you do things that you would never do in terms of sex and stuff…” (p.22, L146) 
 
 Mephedrone use may have provided a quick-fix that allowed participants to temporarily escape their 
insecure true-selves by offering an idealised false-self with a superficially increased self-esteem and self-
efficacy. But prolonged mephedrone use resulted in the heightened fragility of their true-selves. As Greg’s 
mephedrone use progressed, he explained that he “felt like I was going to kill myself cos I really feel like 
paranoid” (p.17, L52); he experienced increasing depression and felt “…complete stuck, at work I feel stuck, 
with the drugs I feel stuck…” (p.7, L74). The image of metaphorically being “stuck in the mire” comes to mind, 
suggesting that Greg was unable to achieve what he wanted in his life. Alexander explained that “…now I’m 
paranoid” (p.18, L118), and due to the worsening “comedowns” (p.10, L92), he missed days of work. As a 
consequence of such negative side-effects, participants’ initial feelings of discontent concerning their true-
selves were exacerbated, and this motivated the continuous use of mephedrone, resulting in a vicious cycle.   
 
  4.2.1.4 Summary. The data identified that negative life experiences resulted in identity issues 
that influenced the development of the vulnerability to use mephedrone. Generally, participants had difficulties 
forming a sense of self or identity for a number of reasons: loss of relationships; familial rejection that resulted 
in unmet attachment needs; social exclusion from mainstream  society; identity issues resulting from 
acculturative stress; difficulties accepting one’s sexuality; and a discomfort with their true -self associated with 
low self-esteem and self-efficacy. 
 Mephedrone use had a range of functions and motivations.  One was to create a sense of belonging 
and acceptance via the participation, support and adoption of a new identity as part of the mephedrone-using 
community. A second was to provide a strategy to avoid psychic pain and to allow the appeasement or 
compartmentalisation of psychic pain via self-medication and self-harming behaviours. A third was to allow the 
creation of an empowered, idealised false-self that enabled users to escape their fragile and loathed true-selves.  
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 The use of mephedrone acted as an externalised method of coping that provided a credulous quick-
fix for participants’ psychological issues that was short-lived and superficial. It did not allow participants to 
confront and resolve their psychological issues via a method based on an internal, deep reflexive exploration of 
their fragile true-self or psychic pain. Participants’ misplaced and naïve optimism in the use of mephedrone to 
resolve their psychological distress in fact deceptively resulted in its exacerbation. Participants became 
increasingly lonely as they were rejected by their inner circle and the mephedrone-using community. Their 
identity distress, coupled with the fragility of their true-selves, was exacerbated by further self-loathing of their 
newly adopted stigmatised drug-using identity and by the negative side-effects of problematic mephedrone use. 
As a consequence, further mephedrone was naively used with the secondary motivation to “blank” (Greg, p.13-
14, L116) out their perpetuated psychological issues, which instigated a vicious cycle of use. 
 
 4.2.2 Superordinate theme 2: The paradoxical experiences of progressive mephedrone use. 
This superordinate theme includes three subordinate themes that explore the changing experiences, 
perceptions of and relationship with mephedrone, as its use progresses from recreational to problematic. 
  
  4.2.2.1 Subordinate theme 2a: “Love at first sight” versus a devilish mistake. The 
experience of using mephedrone before it became problematic resembled the pinnacle of happiness. Josh 
described recreational use as the “…most amazing time of my life…” (p.6, L50), “…the peak of my happiness…” 
(p.31, L179), while Daniel explained it as the “…best time of my life…” (p.7, L51). Participants’ perceptions of 
mephedrone before problematic use appear to be positive and safe, as mephedrone depicted “everything good” 
(Daniel, p.7, L58) and reflected a source of “happiness” (Greg, p.21, L22). Furthermore, mephedrone was 
perceived as uniquely “powerful” (Alexander, p.3, L20) as it was described “like nothing, no other drugs” (Robert, 
p.5, L54) when compared to cocaine, MDMA or crystal meth. It was thought that mephedrone could maintain 
the potent qualities of traditional drugs without its associated negative implications.  
 The relationship between mephedrone and user was described as an ultimate attraction since it “was 
love at first, first sight, I loved it” (Daniel, p.11, L74). Daniel explained that mephedrone “gnaws your brain, like 
I’m gonna look after you” (p.21, 118). An image was created of a powerful animal that overtook the brain, an 
organ that controlled the mind and body, which made the recipient feel safe and secure. This related to 
subordinate theme 1a (section 4.2.1.1, p.56-58), which described the feelings of belonging and acceptance 
created by even the connection with mephedrone alone. 
 In summary, it seemed that during the initial stages of mephedrone use, the first phase of use, 
participants experienced a sense of awe, euphoria and peace. Participants appeared to perceive mephedrone 
as safe and fun, which depicted their trusting and secure relationship with the drug. These preliminary positive 
experiences highlighted participants’ primary motivations to use mephedrone in order to appease their 
psychological distress, as discussed in superordinate theme 1 (section 4.2.1, p.56-62). 
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 As mephedrone use proceeded, the problematic nature of mephedrone became a reality, the second 
phase of mephedrone use. During problematic mephedrone use, participants’ experiences of mephedrone 
changed for the “worse” (Robert, p.15, L140). Mephedrone was interpreted as the “biggest mistake” (John, p.3, 
L32), the “biggest regret” (Josh, p.31, L174), life was described as a “struggle” (Josh, p.10, L74), “bad” (Robert, 
p.14, L138), and as “life is going down” (Robert, p.19, L178). Participants’ perceptions of mephedrone appeared 
negative, as a “hate” (Robert, p.20, L186) developed towards mephedrone, where mephedrone resembled an 
“enemy” (Robert, p.20, L186). Josh described mephedrone as a powerful “tool” (p.23, L136) formed by the 
“devil” (p.23, L136) to facilitate evil doings that were inflicted upon Josh, rather than mephedrone being willingly 
used for its potent effects. Hence, mephedrone was still perceived as powerful, although its powerful nature 
was now experienced negatively as it was associated with the negative implications naively thought not to exist 
during initial use (examples of a loss of relationships, see section 4.2.1.1, p.56-58, and implications at work, 
university and financial strain, see section 4.2.3.3, p.72-73). Such negative implications appeared to lower 
participants’ self-esteem, making them feel powerlessly dependent upon mephedrone. 
 Josh described his relationship with mephedrone:  
 
“I felt like it was a baby you can’t get rid of.” (p.23, L136) 
 
“Erm, I mean, I say it in that analogy because if, to put it simply if you’re pregnant and you had the option of 
abortion and you were okay with it you would abort it. If I knew I was addicted to drugs before I took drugs I 
would abort that mind. I would aborted the, get rid of that mind-set, and I would have moved on quickly.” (p.23, 
L138) 
 
Josh likened the mind-set of being dependent on mephedrone to a “baby”, which in this sense was perceived 
as a burden that he would have preferred to “abort” if he had known, prior to taking mephedrone, the reality of 
suffering its negative implications.  
 In summary, as problematic mephedrone use developed, the second phase of mephedrone use, 
participants experienced a sense of survival and feelings of remorse and helplessness. Such feelings were 
associated with the exacerbated fragility of their true-self because of problematic mephedrone use (discussed 
in superordinate theme 1, see section 4.2.1, p.55-62). The benign identity of mephedrone, initially perceived 
and created through participants’ narrative of mephedrone as safe and fun, was tarnished with the reality that 
mephedrone was powerfully problematic, like traditional drugs. Participants began to perceive mephedrone as 
evil and intrusive, and feelings of hate and rejec tion towards mephedrone developed. As mentioned by 
participants, if they had been aware of the problematic nature of mephedrone prior to its use (for reasons why 
participants do not know about the problematic nature of mephedrone, see section 4.2.2.2, p.64-65), it would 
have deterred them from using mephedrone in the first instance. What followed were feelings of deep regret, 
as the use of mephedrone transformed from an innocent, harmless recreational activity to a destructive, 
unsuspecting mistake. 
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  4.2.2.2 Subordinate theme 2b: Naive control versus a sense of being out of control. 
During the initial use of mephedrone, the first phase of mephedrone use, participants socially constructed an 
image of mephedrone as safe (for the participants’ positive perception of mephedrone, see section 4.2.2.1, 
p.62-63), which allowed them to “…think you can control” mephedrone (Alexander, p.16, L104). This socially 
constructed image of mephedrone was maintained through various processes, discussed in the following 
paragraphs, that maintained participants’ naivety towards the problematic nature of mephedrone use.  
 Firstly, participants did not know what mephedrone was. Alexander explained he would “see them 
having a small bag with white powder, I never know what is inside” (p.1, L4) and he “thought all the powders 
are one kind of powder, I didn’t know mephedrone was a specific kind of one. Before I know nothing…” (p.3, 
L22). Secondly, participants lacked knowledge concerning the problematic nature of mephedrone. Robe rt 
explained: 
 
“…they don’t know there is a problem, that’s the battle with this drug, they don’t know there is a problem… But 
you don’t feel that you are addicted to that…” (p.6, L68) 
 
Thirdly, the socially constructed image of mephedrone as benign, safe and fun was not refuted by participants 
as they tended not to discuss the destructive effects associated with problematic mephedrone use due to the 
stigma of appearing “weak” (Daniel, p.35, L204). Daniel explained: 
 
“It’s not something that you’d discuss really…Some of them see it as a weak link, like ‘oh my god I didn’t know 
it was that bad’…” (p.35, L204) 
 
Not discussing the problematic nature of mephedrone perpetuated the “battle with this drug” (Robert, p.6, L68). 
This was a battle or conflict between, on one side, the socially constructed image of mephedrone as safe, which 
was misleading and encouraged its use by unsuspecting hopefuls; on the other, the contradicting actuality of 
the problematic nature of mephedrone that resulted in destruction and feel ings of deep regret (see section 
4.2.2.1, p.62-63). Lastly, it appeared that the perception of mephedrone as safe was maintained by users of 
mephedrone, as it was described as “not addictive” (p.14, L94), and by professionals or the NHS, who were 
assumedly complicit (see section 4.2.3.1, p.68-70). Alexander further explained: 
 
“Even mephedrone, people will say just use it, it’s not addictive. When you google that, NHS or anything like 
that, it’s not addictive, it’s not addictive so you keep using.” (p.14, L94) 
  
 As mephedrone use progressed, there was a transitional period where individuals noticed their loss of 
control. Robert explained: 
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“Yeh, the first time I really like it and I can control it then. It becomes like once in a week then, once in a 15, 15 
days, once in a week. Then I notice, it was like I was deeply in that, getting deeper and deeper in that…”  (p.5, 
L52) 
 
“…the small amounts will get more intense to the point you cannot control it any more…” (p.15, L144) 
 
 A sense of drowning was created in what seemed to be the progressive or “deeper” use of mephedrone, which 
became more “intense” and overwhelmingly uncontrollable. It seemed that the “balance” (Greg, p.11, L96) or 
the “juggle” (Josh, p.10, L72) between their non-drug-using life and “drug life” (Daniel, p.21, 118), which 
participants thought was initially achievable, was in fact unattainable as mephedrone use eventually became 
physically addictive. 
 Daniel likened his feeling of a lack of control to that of reciprocated abuse from mephedrone: 
 
“…cos I abused that, so now it should start to abuse me.” (p.21, L118) 
 
This analogy mirrored Daniel’s early life experiences, in which he witnessed his mother and experienced himself 
being physically and mentally abused by his father. Perhaps in this instance mephedrone metaphorically 
became the “other”, the abuser, and therefore his dysfunctional relationship style was emulated. Greg further 
explained how he experienced feeling out of control, as if mephedrone was “controlling” him (p.16, L104). This 
emphasised an image of mephedrone as dominating, powerful or abusive and the user as submissive, 
controlled or the abused.  
 This relationship dynamic was further highlighted as mephedrone was described as a “trap” (Robert, 
p.20, L186), “the drug that caught me!” (Robert, p.16, L156) or “hooked me” (Robert, p.6, L68), a drug that 
“haunts” me (Alexander, p.19, L124), and that “doesn’t let you eat” (Robert, p.15, L148). Life was now described 
as a “struggle” (Josh, p.10, L74) and a “fight” (Greg, p.4, L40). A sense of feeling at war with mephedrone 
manifested itself, which perhaps resembled a battle to regain some sense of control or autonomy over their 
lives, but which was lost along with their sense of self and self-esteem as they became helpless victims. What 
appeared to be safe and fun, taken originally with the idea to appease their identity issues by creating an 
empowered idealised self (see section 4.2.1.3, p.60-61), was in fact destructive and heightened the fragility of 
their sense of self (reiterated in sections 4.2.1, p.55-62, and 4.2.2.1, p.62-63), which perpetuated further 
mephedrone use. 
 
  4.2.2.3 Subordinate theme 2c: A desirable need versus a “pointless” activity. During 
participants’ progressive use of mephedrone, it was initially described as a  basic need. Alexander likened 
mephedrone to food: 
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“I have a bit like at 10 o’clock in the morning, and maybe I take a few lines, then at one o’clock lunch. It’s like 
food.” (p.8, L62) 
 
“…If you go in my room, at that time on my table, like an oyster card one, two, three, four lines ready. So when 
I go inside the house, because I work like five minutes from my house. So when I have a break I go home to 
eat and come back. So if I do one line when I am at home, I go to work.” (p.15, L98) 
 
“It is like chocolate.” (p.7, L52) 
 
Mephedrone became part of Alexander’s everyday life, which he consumed in a casual, recreational manner 
throughout the day during his breaks at work like “food”, particularly “chocolate”. The euphemisms used to 
describe mephedrone coincided with the socially constructed image of mephedrone as safe and fun (for further 
exploration of the socially constructed image of mephedrone, see sections 4.2.2.1, p.62-63; 4.2.2.2, p.64-65; 
4.2.3.3 p.72-73). Moreover, mephedrone appeared to take on the role of emotional sustenance required for 
users to survive.  
 As mephedrone use progressed, the desire for it heightened in line with a growing tolerance towards 
it. Daniel described his desire for mephedrone as a “need” (p.19, L178) and “want” (p.19, L178) as his tolerance 
increased. The increased desire for mephedrone became apparent as it was acquired in a “hustling, survival 
type way” (Daniel, p.8, L66). Daniel further created the image of competitive survival as he explained that he 
sought out mephedrone “like a hawk in the sky” (p.6, L52). An image was created of Daniel as a bird that was 
agile and strong and could scope out its prey, namely mephedrone, and that could attack it and obtain it to 
survive (this relates to the uncontrollable use of mephedrone, see section 4.2.2.2, p.64-65). 
 As a tolerance or “resistance” (Robert, p.6, L64) towards lower doses of mephedrone built, Robert 
described his body as being “chemically…hooked” (Robert, p.19, L182). It seemed that mephedrone became 
an increasing priority in Robert’s life as “…you keep searching for more and more and more” (Robert, p.22-23, 
L198) beyond the scope of his personal safety and wellbeing. This related to the ironic twist (described in 
subordinate theme 1a, section 4.2.1.1, p.56-58) from the sense of belongingness created by mephedrone to 
the ensuing lack of distrust among mephedrone users as mephedrone becomes the priority. 
 However, as problematic mephedrone use further ensued, participants explained that mephedrone 
use felt like a pointless activity. Josh highlighted that he felt like he was “wasting my life…” (p.19, L104) and 
that he now perceived mephedrone as “a pointless drug” (p.27, L160). Josh explained: 
 
“…we didn’t even had sex and we just took it, watched family guy. I guess that even made it even worse, taking 
drugs and doing nothing with it (laughs), it’s not fun.” (p.17, L92) 
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Josh appeared to have had an epiphany, as he noticed that he was now taking mephedrone outside of his usual 
context of chemsex. He questioned the purpose of his mephedrone use, and realised he may have become 
dependent. This process was reiterated by Greg as he described: 
 
“So you start to realise all these things, after all those uses, all these nightlife, all these enjoyable ones that I’m 
not getting nothing out of it, I’m just destroying myself, I’m not getting nothing, and it’s really really painful 
like…it’s really painful.” (p.7, L64)  
 
Furthermore, Alexander explained: 
 
“Probably when you come down off these drugs you feel bad because you waste how many days, you don’t go 
to work. You’re gonna upset your manager and you have too many appointments you miss them, too many 
parents call you never answer.” (p.17, L110) 
 
Greg and Alexander shared Josh’s epiphany that mephedrone use had become fruitless. It appears that the 
perception of mephedrone changed to something that was unwanted and worthless instead of contributing 
towards their life positively. This corresponded to the subordinate theme 2a (section 4.2.2.1, p.62-63) and 2b 
(section 4.2.2.2, p.64-65), where their perception of mephedrone changed to something negative, an experience 
that is rarely discussed among users. 
 
  4.2.2.4 Summary. Initially mephedrone, during the first phase of use, was perceived and 
experienced by users as positive, safe, fun and non-problematic, which promoted its innocent use in an 
accepted and recreational manner. This positive socially constructed image of mephedrone appeared to be 
maintained by several factors: (1) participants did not know what mephedrone was; (2) parti cipants had no 
knowledge of the problematic nature of mephedrone; (3) professionals were perceived to be complicit with the 
promotion of mephedrone as safe; and (4) lastly, users of mephedrone did not openly discuss their negative 
experience of problematic mephedrone use. 
 Mephedrone was initially used to appease or escape psychological distress, thus representing 
emotional sustenance likened to food that offered security, containment and happiness. However, participants 
experienced the harsh, unsuspecting and contrasting reality of problematic mephedrone use. This second stage 
of mephedrone use was associated with negative, destructive experiences, and participants’ relationship with 
and perception of mephedrone changed to one of evil, hate and insecurity. The participants’ paradoxical shift 
in their experience of mephedrone was accompanied by exacerbated feelings of a loss of autonomy, sense of 
self and self-esteem, as users resembled helpless victims of abuse by mephedrone (the abuser). 
 The paradoxical experiences described as mephedrone use progressed from recreational to 
problematic use highlighted the deceptive nature of mephedrone. For instance, mephedrone hid behind its 
socially constructed façade as a recreational, safe drug that was as potent as traditional drugs, but could be 
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used in a controllable manner as it was naively perceived as unproblematic and harmless. Mephedrone was in 
fact as problematic and destructive as traditional drugs but by the time this was realised, participants were 
chemically dependent. It seemed that mephedrone underwent its own identity distress, a conflict between the 
safe, benign identity of mephedrone and its realistic destructive identity.   
 Eventually, participants realised that their mephedrone use had become a wasteful, pointless activity, 
which could be likened to the contemplative stage of the process of change, and this was a stark contrast to 
their initial desire that drove their dependent use of mephedrone. 
 
 4.2.3 Superordinate theme 3: Making sense of one’s problematic mephedrone use via self-
reflective processes. This superordinate theme includes three subordinate themes that explore the self-
reflective processes undertaken by participants as they made sense of their problematic mephedrone use and 
consequently decided to change it. 
 
  4.2.3.1 Subordinate theme 3a: Stigmatising beliefs assist in the self-identification of 
problematic mephedrone use. Participants made sense of their mephedrone use by self-identifying, i.e. 
attributing certain characteristics or qualities of other types of drug user to themselves. This reflective process 
was affected by the participants’ awareness of the stigmatising beliefs held by society and the drug -using 
community.  
 Alexander explained: 
 
“…when I see someone smoke weed I say this is a bad person, but now me I am taking the drugs that are 
powder, powder is something that is very, very bad.” (p.4, L36) 
 
Alexander associated substance misuse with being a “bad person”, whereas not using drugs was associated 
with being a good person. Perhaps Alexander’s perspective manifested itself because of his religious beliefs as 
a Muslim that prohibited substance misuse (for further discussion of the impact of religious beliefs on 
mephedrone use, see section 4.2.3.3 p.72-73). Or perhaps it did so or because of participants’ perspective “that 
society doesn’t really deem erm [substance misuse] sensible (laughs)” (Josh, p.4, L30), and therefore substance 
misuse is deemed socially stigmatised. Furthermore, Alexander rationalised his mephedrone use as being 
worse than smoking “weed” that is organically produced from a plant, whereas mephedrone is a chemically 
manufactured “powder”. Therefore, not only was Alexander considered a “bad person” as defined by society 
and his religion, but he perceived his mephedrone use as “very bad” due to its manufactured origin.  
 Although participants realised their substance misuse was “bad”, users within the drug-using 
community identified their mephedrone use as less problematic when compared to traditional drug use. Daniel 
explained:  
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“Yeh, because their lifestyle’s completely different. You’ve gotta have, from what I’ve learnt, you’ve got to have, 
erm, a lot of money to supply that that addiction, and that means you man rob people’s houses and their rob 
cars and st-, and their phones and stuff. You’re even robbing at erm at the cash point. You’re not gonna get 
someone on mephedrone tryna rob you at the cash point, or trying to erm, they haven’t got to, they haven’t got 
a £300 a day drug addict. It’s £20 for a gram, [laughs] it’s a bit of difference in the, in the value. And by the way 
they take it as well, and the way that erm heroin is easier easier easier to pass away on that drug…” (p.27, 
L154) 
 
Daniel related traditional drug use to negatives such as crime such as robbing, the stigmatised term “addiction”, 
a financial burden, a greater risk to health and generally a completely different lifestyle. Users of traditional 
drugs were also referred to by the derogatory terms “druggies” (Daniel, p.21, L118) and “…addicts [that are] 
are very like… loud” (Daniel, p.31, L180). In contrast, mephedrone was frequently referred to as a “party drug” 
(John, p.3, L15), used commonly within the contexts of “chill-outs or sex parties” (Alexander, p.14, L92), and on 
the “weekend” (Josh, p.5, L50), and was associated with “more fun” (Alexander, p.5, L38) than the use of 
traditional drugs.  
 As a consequence of the terminology used to describe mephedrone, it was socially constructed as 
safe and fun in comparison to traditional drugs. The professional arena appeared to be complicit in maintaining 
this, as the terms “club drug” or “party drug” are used to define such drugs. Nevertheless, club drugs were 
associated with normative recreational contexts of parties or clubs. This provided a further mechanism that 
dissociated club drugs from their true destructive and problematic nature, hence maintaining its benign identity 
(for other processes by which the benign identity of mephedrone was maintained, see section 4.2.2.2, p.64 -65). 
As a consequence, mephedrone users self-identified with a lifestyle that was socially constructed as much less 
problematic (for the social construction of mephedrone as less problematic, see section 4.2.2, p.62 -68), 
controllable, recreational and fun, in contrast to the lifestyle of traditional drug use that was constructed and 
perceived as uncontrollable, problematic and stigmatised. However, mephedrone use could result in the loss of 
relationships, harm to one’s wellbeing and financial strain (for the negative consequences of mephedrone use, 
see sections 4.2.1.1, p.56-58 and 4.2.3.2, p.70-71) in the same way as traditional drug use, although the 
destruction caused by mephedrone use was not commonly discussed. This further helped to uphold the socially 
constructed image of mephedrone as safe or as safer than traditional drugs (for the processes that socially 
constructed mephedrone as safe, see section 4.2.2.2, p.64-65).  
 Moreover, there appeared to be a hierarchal system that operated within the drug-using community, 
where the increasing price of a drug related to its increasing potency and therefore problematic nature. Daniel 
explained that because mephedrone was “cheaper” (p.25, L140) than cocaine, it was thought to be less 
problematic than cocaine. Beyond cocaine Daniel explained: 
 
“Yeh, then you get called a crackhead, then then the heroin, then you’re a heroin user [conveys hierarchal levels 
using hand gestures].” (p.27, L160) 
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Daniel explained that crack cocaine was more expensive/problematic than cocaine, while  heroin was the most 
expensive and therefore problematic drug. Daniel’s reference to users of crack cocaine as “crackheads” further 
depicted the stigmatising perspective of traditional drugs within the drug-using community.  
 Lastly, although mephedrone use was deemed the least stigmatised and problematic by the drug-
using community in contrast to traditional drugs, it seemed that there were social divides that operated within 
the mephedrone-using community. These were based on the route of administration of mephedrone that 
correlated with its problematic nature. Josh explained: 
 
“So maybe that’s it actually we just figured it out (laughs) erm you always, you associate it with something in 
your mind with something’s that’s bad, and it’s ridiculous to be honest, and especially in this country a lot of 
people do judge life on television, I don’t know about the rest of the world, I haven’t been, but they do judge life 
on television and East Enders, things like that (laughs).” (p.30, L172) 
 
 Josh explained how the commonality of seeing drugs “snorted” on television socialised it as the “norm” 
in relation to administrating drugs, and therefore “snorting” was associated with less PSM by society. By 
contrast, injecting drugs was rarely televised and maintained a common association with heroin use that 
appeared to be the most stigmatised by society and those within the drug-using community. Injecting or 
“slamming” (Josh, p.2, L10) mephedrone was associated with the stigmatising connotations associated with 
heroin use, and was therefore identified as problematic mephedrone use. Furthermore, Josh described injecting 
mephedrone as the “final hurdle” (p.29, L168) into the realms of PSM since the potency of the drug became 
“100%” (p.29, L168), and there were greater risks of “catching hepatitis C and HIV” (Alexander, p.21, L140). 
Such harms were also associated with traditional drug use which was perceived as more problematic. 
Therefore, users within the mephedrone-using community self-identified their mephedrone use as problematic 
if they injected, because injecting was stigmatised, associated as it was with the increased likelihood of risk, 
greater potency and heroin use. 
 
  4.2.3.2 Subordinate theme 3b: A critical incident that triggers the self-evaluation of 
one’s mephedrone use as subjectively problematic. All participants experienced a critical incident that 
triggered them to reflect on their mephedrone use, and to recognise how it was personally problematic for them 
beyond physical and psychological dependency.  
 Alexander explained: 
 
“And er I work at *** cutting car parts, and once I cut my finger holding a glass, I cut my finger and blood started 
to go, so when I washed my hand then the blood didn’t stop, when I pressed on it, you know I think some blood 
was there, I got the taste of mephedrone, it tasted like mephedrone and smelled like mephedrone in my blood. 
That’s when I knew, I’m using too much. Erm my job is like dangerous because I need to carry glass the okay 
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and er you need to concentrate. If you are falling asleep because you were awake last night or something, it’s 
dangerous.” (p.8, L68) 
 
Alexander detected mephedrone in his blood, which indicated to him that he was “using too much” since it 
became physically a part of his body. What followed was the further realisation that his accident at work was 
caused by him “using too much” mephedrone, which reduced his concentration and alertness. Alexander 
realised that such incompetence was detrimental or “dangerous” for his work, which could lead to him losing 
his job and his financial stability. This signified his subjective understanding of how his mephedrone use had 
become problematic for him. 
 John explained: 
 
“Financially, I’ve used savings with all this using, its costs me 26 grand in two years, I’ve only got 10 grand left. 
It’s got to be reversed now. I mean not all of it is drug use, I mean I’ve been on quite a few nice holidays but I 
can’t afford this to carry on, because if all my savings are gone. I’ll be depressed. So it’s a bit critical.”  (p.12, 
L53) 
 
John’s increasing mephedrone use caused him to use his savings, which he had planned to keep as his pension. 
Without his savings, he was aware that he could become depressed, due to financial pressure. Again, it was 
the potential financial instability that signified his subjective understanding of mephedrone as problematic. 
 Greg explained: 
 
“July, no, no July. Was the last time when I did, which was that weekend. I spent all weekend doing sex and 
then did have a small fracture. I had to go to hospital and at that point I said ‘no’. I really have to stop now 
because going to needles now, is going beyond my, it’s going too far. I’m thinking going too far with the drug 
usage. I have to stop.” (p.16, L134)  
 
Due to Greg’s increased sexual activity at “gay pride festival”, spurred by mephedrone use, he fractured his 
penis. This conveyed the potent nature of mephedrone and its potential damaging effects on users’ wellbeing, 
since “when you’re doing drugs you don’t think about anything, you don’t think about condoms  you don’t thinking 
about protecting yourself, you just don’t, you just think about the, the sex” (p.7, L68). This, coupled with Greg’s 
progression of mephedrone use from insufflation to injecting, made him feel that his mephedrone use was going 
beyond his acceptable limit. Perhaps this was because Greg had subconsciously adopted the stereotypical 
perception that injecting drugs was associated with heroin use, and therefore deemed more problematic in 
comparison to snorting (for further exploration of stigmatising beliefs, see section 4.2.3.1, p.68-70). So, it was 
the consequential negative effects of mephedrone on Greg’s wellbeing and his progression to  “slamming” (Josh, 
p.2, L10) that signified to him that his mephedrone use had become problematic.  
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  4.2.3.3 Subordinate theme 3c: An internal debate between desires versus values and 
beliefs that motivates change. As participants realised their mephedrone use was problematic they continued 
to make sense of their problematic mephedrone use. By undertaking an internal debate between their desires 
to continue their problematic mephedrone use and their conflicting values and beliefs, participants realised that 
their mephedrone use took them further away from their true-selves, hence exacerbating their identity distress 
and propelling their motivation to change (this refers to the contemplative stage of change that is highlighted 
section 4.2.2.3, p.65-67). 
 Josh explained: 
 
“You know when they tell you, you have the good voice and the bad voice on your shoulder, I can identify which 
one it is. I can identify when the bad is telling me, and the strong of reason is telling you not to. Sometimes if I 
can’t, I’ll take a moment to think hold on let’s think about this, and stop those voices and think it myself on my 
own self would you want to do that? What is going to happen? Erm so it was those, it was it was I guess my 
subconscious of my mind telling me again, alright now it’s time to come out.” (p.18, L96) 
 
Josh described the internal debate he underwent between his “good voice” encouraging him not to use 
mephedrone, and his “bad voice” encouraging him to fulfil his desire to use mephedrone. Josh explained how 
he tried to regain objectivity from his internal voices that almost resembled “others” and tried to decipher what 
his true-self valued. He realised that although he may have consciously desired mephedrone and wanted to 
use it, subconsciously he appreciated that he should no longer use mephedrone as it had become problematic 
for him. Moreover, Josh explained: 
 
“I almost let down my mum, the head lecturer and myself, they put, the head lecturer put his neck out for me, 
my mum I can’t let her go through that again.” (p.15, L86) 
 
Josh contemplated who he would “let down” if he surrendered to his “bad voice”: his mother who had provided 
emotional support, and his university lecturer who supported his decision to repeat his last year of university 
that he had failed because of missing lectures due to using mephedrone. Coupled with his own realisation that 
his mephedrone use had become problematic, it seemed that it was the prospect of letting others down that 
created feelings of guilt for Josh, and this motivated him to change his problematic mephedrone-using 
behaviour. 
 Alexander explained: 
 
“I say okay this is the last time I’m going to use it, and er you know I think it comes back to a religion thing. 
Because even there are Muslims dealing, they are doing partying, gay and still practice, still Muslim. So always 
you know it’s bad and you’re doing it. You know you shouldn’t be doing it and it makes you feel guilty.” (p.17, 
L114) 
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Alexander’s religious beliefs appeared to be ever-present in his thoughts while he was participating in the 
prohibited acts of mephedrone use and “doing partying, gay”, which triggered an internal conflict between his 
desires to use drugs and his religious values as a Muslim. It was this identity distress that made Alexander feel 
guilty, and subsequently motivated him to want to change his problematic mephedrone-using behaviour. 
 John explained: 
 
 “…I’m spiritual and more interested in having a cup of coffee and a conversation then going out and getting 
slaughtered. So I complete, the drug side of me and my sexually identity don’t fit with me at all, its two different 
people.” (p.6, L31) 
 
John understood that his “spiritual” self, who seemed calm and civilised, was incongruent with the “drug side of 
me”, who wanted to get “slaughtered”. Although the colloquial definition of the word “slaughtered” translated to 
the intoxication by the misuse of substances, an uncivilised image comes to mind, of animals being unwillingly 
killed, that conjures feelings of being trapped and helpless. Ultimately, John realised that using drugs has not 
brought himself closer to his true-self or resolved his sexual identity distress, but that his “drug side of me” has 
drawn him further away from his “spiritual” self. It was this realisation that motivated him to want to retreat from 
the “drug side of me”. 
 
  4.2.3.4 Summary. Participants made sense of their mephedrone use via various self-
reflective processes, including self-identifying, self-evaluation and internal debate. The process of self-
identifying reflected how participants often referred to specific drug types or characteristics as a way of defining 
who they were. This process seemed to be affected by participants’ awareness of the stigmatising beliefs held 
by both society and the drug-using community.  
 While mephedrone users seemed to share the societal perception that substance misuse was bad, 
they felt club drug use offered a sense of belonging as a reaction to feeling excluded from mainstream society. 
Moreover, a socially constructed image of mephedrone as safe and fun (initially recreational and part of a 
relatively superficial and escapist “party” environment) was formed by participants, which was in direct 
contradiction to the problematic and stigmatised perception of traditional drug use, a lifestyle mephedrone users 
did not self-identify with. Social divisions were also created within the mephedrone-using community itself, 
where injecting was associated with problematic use due to its association with heroin use.  
 Participants subjectively made sense of their problematic mephedrone use via the prompting of a 
critical incident, which motivated them to self-evaluate their mephedrone use. They did this in respect of their 
personal beliefs and ideas concerning what was important in their lives, stereotypes they had, and their 
contextual circumstances. Further contemplation occurred as participants entered an internal  debate between 
their desire to continue their problematic mephedrone use (“the drug side of me”; John, p.6, L31) and their 
conflicting spiritual or religious beliefs. It was through the process of this heightened identity distress that 
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participants re-evaluated their values and beliefs. This motivated participants to decide what self they most want 
to accept, nurture and like, and led to them challenging their problematic mephedrone use in the hope of 
abstaining.  
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5. Discussion and Conclusions 
 
5.1 Overview 
 This study aimed to explore mephedrone users’ experiences and sense-making of their problematic 
use by asking the following research questions: 
 
1) How do participants understand their motivations for their mephedrone use? 
2) How do participants describe their experiences of mephedrone use? 
3) How do participants make sense of their problematic mephedrone use?   
 
 The use of semi-structured interview questions, with a specific focus on the research questions, 
enabled participants to share their lived experiences of problematic mephedrone use. IPA was used to analyse 
data that highlighted participants’ psychological motivations to use mephedrone. Their vulnerability towards 
problematic mephedrone use was based on negative life events that resulted in difficulties forming a sense of 
self. To resolve such a psychological deficit, participants strived to form connections with others in a recreational 
context in order to create a superficial sense of belonging, acceptance and support. The participants tried to 
temporarily compartmentalise, avoid and defend themselves against their psychological distress by using self-
medicating and self-harming behaviours. Lastly, participants attempted to create an empowered, idealised 
false-self to escape from their fragile true-self. Participants’ misplaced optimism in this externalised method of 
coping via substance misuse provided a credulous quick-fix for their psychological issues. This prevented them 
from confronting and resolving their issues via a method based on internal, deep reflexive exploration of their 
fragile true-self or psychic pain. It seemed that participants’ initial innocent and recreational mephedrone use 
resulted in the ironic exacerbation of their psychological distress, whic h promoted a vicious cycle of problematic 
mephedrone use. These findings are explored under the research question: “How do participants understand 
their motivations for their problematic mephedrone use?” (p.76-80).  
 The findings also suggested how participants experienced, related to and perceived mephedrone itself. 
Prior to and during the initial stages of mephedrone use, participants perceived mephedrone as positive, safe, 
fun and non-problematic, which promoted its innocent use in an acceptable recreational manner. Initially, 
mephedrone was experienced positively, was “loved” (Daniel, p.11, L74) and perceived as emotional 
sustenance, similar to food, that fulfilled the participants’ primary motivations to use it in order to escape their 
psychological distress (as explained in the paragraph above). However, as participants entered the problematic 
stage or second phase of mephedrone use, they described mephedrone as their enemy, and that it was 
destructive, uncontrollable and negative. Despite this, participants were motivated to continue their mephedrone 
use in order to appease their negative withdrawal symptoms, the result of becoming physically dependent. 
Consequently, participants experienced an exacerbated lack of autonomy, identity distress and low sel f-esteem, 
as they now resembled helpless victims of the eventual abuser, mephedrone. Since participants did not publicly 
speak of such negative experiences, mephedrone’s socially constructed image as safe, fun and non -
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problematic was maintained. Moreover, participants’ lack of knowledge concerning mephedrone and 
professionals’ use of terminology to describe it, e.g. club drug or party drug, helped to maintain and promote 
mephedrone’s positive image. Thus, it appeared that mephedrone itself underwent its own  identity distress 
between mephedrone’s perceived safe identity and its actual problematic identity, which included negative and 
destructive experiences similar to those of traditional drugs. These significant findings are discussed under the 
research question: “How do participants describe their experiences of mephedrone use?” (p.80-82).  
 Lastly, the findings suggested how participants made sense of their mephedrone use via various self-
reflective processes, including self-identifying, self-evaluation and internal debate. Self-identifying reflects how 
participants referred to specific characteristics of users of different types of drugs. This offered a way of defining 
who they were as a user of drugs, rather than being categorised in terms of socio-demographics. This process 
seemed to be affected by participants’ awareness of the stigmatising beliefs held by society and the drug -using 
community. Furthermore, participants appeared to subjectively make sense of their problematic mephedrone 
use via a critical incident such as an accident at work which motivated them to self-evaluate their mephedrone 
use. This involved contemplating the conflict between their desire to continue their problematic mephedrone 
use (“the drug side of me”; John, p.6, L31) and their spiritual or religious beliefs.  Eventually, users realised that 
their mephedrone use had become a wasteful, pointless activity, in stark contrast to the initial desire that drove 
their mephedrone use. These significant findings are addressed under the resea rch question: “How do 
participants make sense of their problematic mephedrone use?” (p.82-85). 
 
5.2 Findings 
 In this section, the findings of this research are discussed in relation to existing literature. 
 
 5.2.1 How do participants understand their motivations for their mephedrone use?  
  5.2.1.1 The relationship between the development of identity, self-esteem and 
attachments.  An unstable sense of self or identity may originate from negative life events, which could increase 
the likelihood of substance misuse (Etherington, 2006; Bruce, 1990; Larkin & Griffith, 2002). These negative life 
events e.g., abuse, could result in maladaptive attachments e.g., child-parent, which could hinder the 
development of one’s identity and self-esteem. Research has proposed that attachment theory provides a 
foundation for social and personality development which is key in the formation of identity (Pittman, Keiley, 
Kerpelman & Vaughn, 2011). Moreover, research has suggested that child-parent interaction constitutes the 
basis for development of one’s early sense of self-esteem (Arbona & Power, 2003; Laible, Carlo & Roesch, 
2004), which is a precursor to the development of identity (Berzonsky & Admans, 1999; Campbell, 1990; Cast 
& Burke, 2002). Hence, there is a bidirectional relationship between the development of attachments, self-
esteem and identity, that if impaired by negative life experiences could precipitate substance misuse. 
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Figure 3: The relationship between the attachments, identity and self-esteem 
 
 
 
 Since all the participants said they experienced negative life events that resulted in unmet attachment 
needs and lowered self-esteem, it could be proposed that this impaired participants’ development of their 
identity, which increased their vulnerability towards problematic mephedrone use. For example, Daniel, Josh 
and Greg experienced difficulties in their familial relationships. Daniel’s parents divorced when he was younger 
and his father was physically abusive towards him. Josh’s parents divorced when he was younger and his father 
was also physically abusive. Josh felt rejected by his family after he explained to them that he was “gay” (Josh, 
p.8, L64), and Greg’s father died when he was young.  
 Research has proposed that negative familial relationships could lead to the formation of low self-
esteem and consequently an unstable sense of self (Archer, 2008; Berzonsky & Adams, 1999). Conversely, 
healthy identity development is suggested to be strongly influenced by parental acceptance and encouragement 
(Arnett, 2001), and that nurturing family factors e.g., affective responsiveness and involvement, communication 
and problem solving, are positively correlated to self-esteem and identity development in emerging adulthood 
(Schumacher & Camp, 2010). Such research could help to explain how participants’ negative life experiences 
concerning their family, may have resulted in low self-esteem and difficulties in forming a stable identity, which 
could have increased their vulnerability towards substance misuse. 
 In different ways, participants also experienced the negative life event of being excluded from 
mainstream society. For example, Daniel was made redundant. Strain theory (Merton, 1968) proposed  that 
when mainstream society popularises aspirations e.g., wealth, which are unattainable by some i.e., 
marginalisation, occurs. Due to such marginalisation, identity distress can be experienced by individuals who 
do not feel accepted by mainstream society (Anderson & Mott, 1998; Sam & Berry, 1995). Greg, Robert and 
Alexander also experienced marginalisation, as they felt like an ethnic minority in the UK. Such marginalisation 
could have resulted in a form of identity distress known as acculturative stress (Nouroozifar & Zangeneh, 2006), 
as they had not yet adopted to the new culture of the UK whilst simultaneously experiencing a loss of cultural 
contact with their traditional culture (Berry et al., 1992). Lastly, John was stigmatised by society for being “gay” 
(p.8, L64). Minority stress theory (Meyer, 1995) proposed that individuals who experience stigmatising beliefs 
Sense of self or 
identity 
Self-esteem 
 
Attachments 
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held by society or family members concerning their sexual orientation, may internalise such opinions that could 
manifest in “internalised homophobia” (John, p.15, L69; DiPlacido, 1998). This could result in feelings of guilt, 
self-loathing, shame, low self-esteem and a delay in identity formation (Allen & Oleson, 1999; Grossman & 
Kerner, 1998; Shidlo, 1994). Thus, these examples of exclusion from mainstream society, illustrate how they 
could have negatively impacted on an individual’s self-esteem and sense of self or identity, which could have 
increased one’s vulnerability towards substance misuse. 
 
  5.2.1.2 The function of mephedrone use. This section explores participants’ motives to use 
mephedrone as a potential fix for a sense of identity distress.  
 
    5.2.1.2.1. A primary function of mephedrone use: the superficial sense of 
belonging, acceptance, support and empowerment. Social identity theory (Tajfel & Turner, 1979) suggested 
that because of social exclusion, from mainstream society or family as explained, individuals may search for a 
new identity by adopting the beliefs and practices of a drug subculture known as social identification. This can 
result in a perceived sense of belonging, acceptance and a sense of empowerment (Dodes, 2002; Anderson & 
Mott, 1998; Moshier et al., 2012). Within Marcia’s (1966) identity status paradigm this is also known as the stage 
of moratorium, where an individual is experiencing identity distress and explores different identities to reduce 
their stress and create a sense of belonging. This corresponds to the findings of subordinate themes 1a (section 
4.2.1.1, p.56-58) and 1c (section 4.2.1.3, p.60-61), where Daniel recalled that belonging to the mephedrone-
using community felt like being part of a “big family” (p.11, L76), Josh “felt accepted” (p.8, L64), and Alexander 
experienced an increased sense of “confidence” (p.19, L124). Qualitative research has a lso suggested that 
drug-using peers offer emotional support like that of self-help groups (Neale, 2002; Suh, Mandell, Latkin & Kim, 
1997). For example, Daniel described that he felt he got his “feelings and…your worries answered, so [laughs] 
you are gonna gravitate towards people like that, that are actually listening to you” (p.12, L78). This new identity 
also reflected an empowered and idealised false-self, that contained their fragile sense of selves and reduced 
their sense of identity distress, following their rejection from family or mainstream society (see section 4.2.1.3, 
p.60-61; Winnicott, 1960).  
 A significant finding of this research was that not only did the connections participants make with fellow 
mephedrone users help them manage their psychological distress, but that this was also facilitated by the initial 
positive connections participants made with mephedrone itself (explained in sections 4.2.1.1, p.56 -58 and 
4.2.2.1, p.62-63). For example, Josh described how mephedrone “spreaded out” (p.2, L18) around his body, 
which created an image of embrace and warmth. Moreover, Daniel described his connection with mephedrone 
as if it “was love at first, first sight, I loved it” (p.11, L74). It seems mephedrone underwent a process of 
anthropomorphism, the attribution of human qualities to a non-human entity, that helped signify the intense, 
intimate relationships participants formed with mephedrone that allowed participants to feel a sense of belonging 
and containment. 
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    5.2.1.2.2 A primary function of mephedrone use: the avoidance and 
appeasement of psychic pain. Mephedrone use appeared to facilitate self-harming and self-medicating 
behaviours, which allowed participants to appease or avoid their psychological distress associated with their 
identity issues (see section 4.2.1.2, p.58-60). For example, John participated in a self-harming form of chemsex 
that involved him being used “like a piece of meat”, “destroyed” and “infected” (John, p.14, L67) by others that 
were HIV positive, until he was mentally “dead” (John, p.14, L67). This form of chemsex allowed for John’s 
perception of the unacceptable aspects of himself e.g., being gay, that he loathed and perceived as inadequate, 
to be “used” (John, p.4, L25) by others, which provided him with temporary re lief from his internalised 
homophobia. Shaw (2012) explained how sadistic and masochistic forms of sexual behaviour, could be used to 
externalise psychological distress e.g., sexual identity distress, by inflicting pain upon oneself where the pain 
could eventually become cathartic. 
 Alternatively, Robert experienced depression because of the acculturative stress he experienced, 
which propelled him to use mephedrone to metaphorically “mask” (Robert, p.15, L140) his problems, and 
“shield” (Robert, p.7, L76) him from his negative feelings. Hence, mephedrone facilitated Robert’s temporary 
avoidance of his depression, which he experienced because of his identity distress as he transitioned between 
cultures. This coincides with the self-medicating hypothesis (Khantzian, 2003) that suggested substance misuse 
provided individuals with a coping strategy to appease the symptoms of mental health issues and negative life 
events. 
 
   5.2.1.2.3 The secondary function of mephedrone use: the appeasement of the 
negative consequences of problematic mephedrone use. Although, participants used mephedrone to cope with 
their feelings of loneliness, rejection and exclusion from mainstream society and family, such feelings were 
ironically exacerbated. Participants described how their loneliness and sense of exclusion increased as their 
authentic relationships disintegrated, as their mephedrone use became the highest priority in their lives, which 
paralleled Hsieh et al.’s (2015) findings. For example, Greg explained that he missed fam ily “birthdays”, his 
“grandad’s funeral (laughs) just for drugs…” (p.10, L72) and lost his “real friends” (p.8, L86) as drugs were 
prioritised. Participants may have also felt, at times, rejected by their newly adopted drug subculture. For 
example, Josh explained that “…people don’t really care of other people’s feelings. They only want what they 
want…” (p.28, L162). Hence, the newly adopted identity of participants as a mephedrone user, was also 
challenged as drugs were prioritised; consequently, their superficial sense of belongingness and acceptance 
within the mephedrone-using community was challenged, that may have contributed towards the exacerbation 
of their identity distress. 
 Participants also experienced the negative side-effects of mephedrone on withdrawal, which 
exacerbated participants psychic pain. For example, Robert explained that the “…thing is you keep using that 
[mephedrone] because of the depression, when…you wake up and then you feel that depression like the 
emptiness, then you go after it again” (p.11, L118). Further negative side-effects are discussed in research 
question 2 (see section 5.2.2, p.80-82), and the experience of participants heightened identity distress is 
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discussed in research question 3 (see section 5.2.3, p.82-86). Although, mephedrone was primarily used to 
naively appease participants psychic pain associated with their identity distress (see sections 5.2.1.2.1, p.78 
and 5.2.1.2.2, p.79), it seems to have ironically exacerbated participants’ identity distress as outlined above and 
further distanced participants from their true selves (Winnicott, 1960). This perpetuated further mephedrone use 
(secondary mephedrone use) by participants as a way of appeasing their heightened psychological distress, 
which concluded a vicious cycle of use. Shinebourne and Smith (2009) proposed that the initial use of alcohol 
was perceived as enabling, as it appeared to provide a route from experiencing psychic pain, though long -term 
use resulted in negative side-effects on withdrawal which ironically exacerbated psychic pain though 
perpetuated further use. 
 What is unique to this piece of research, is that participants seemed to naively believe that mephedrone 
could rapidly provide a harmless cure for their ongoing psychological distress. Such a belief may have been 
influenced by the socially constructed image of mephedrone as safe, fun and innocent, which is further explored 
in the next section.  
 
 5.2.2. How do participants describe their experiences of mephedrone use?  
  5.2.2.1 The socially constructed image of mephedrone as positive. A unique and 
significant finding of this research, was that mephedrone was found to be socially constructed by participants 
as safe, fun and non-problematic. This socially constructed image of mephedrone was achieved and maintained 
by several processes: (1) due to a lack of available knowledge, participants suggested that they did not know 
of any negative effects of mephedrone prior to themselves using it, and therefore naively thought mephedrone 
could be used in a controlled manner (see section 4.2.2.2, p.64-65). Alexander explained that “…even 
mephedrone, people will say just use it, it’s not addictive. When you google that, NHS or anything like that, it’s 
not addictive, it’s not addictive so you keep using” (p.14, L94). A study conducted by Van Hout and Brennan 
(2011) suggested that mephedrone users think there are no undesirable effects of mephedrone, and therefore 
participants maintain an internal ideology of a perceived control; (2) participants explained that they did not 
know what mephedrone was e.g., “see them having a small bag with white powder, I never know what is inside” 
(Alexander, p.1, L4); (3) participants did not speak of their negative experiences of mephedrone use to others 
e.g., family, friends or fellow users; (4) the operationalisation of stigmatising beliefs within the drug-using 
community, naively presented mephedrone as the least problematic drug in comparison to traditional drugs (for 
further discussion of this see research questions 3, section 5.2.3, p.82-85), and lastly, (5) professionals 
appeared to be unintentionally complicit with the construction of mephedrone as positive by the use of their 
language to describe such drugs e.g., club drugs, party drugs.  
 Drug policy has introduced the terms “club drugs” and “party drugs” to describe non-traditional drugs, 
with the aim of reducing the potential stigma felt by individuals using such drugs and enable them to access 
treatment. Although there may not be any direct drug harms associated with the introduction of such 
terminology, there is an unintended collusion with the socially constructed image of mephedrone as safe as 
suggested by the participants of this study. It could be argued that the use of such terminology presents 
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mephedrone as a recreational drug used within an acceptable recreational context, and research has suggested 
that representing drugs as recreational appears to normalise their use, which makes them seem less 
problematic and more appealing (Cieslik & Pollock, 2002; Parker, 1997; Shiner & Newburn, 1997). Hence, it 
could be argued that the use of such terminology could unintentionally discourage non-traditional users from 
accessing treatment. 
 It could also be argued that participants could have known of the harms associated with mephedrone 
via the prohibition of it 2010 and numerous negative media representations, and that perhaps the participants 
attempt to socially construct the image of mephedrone as safe, fun and non-problematic may have been their 
attempt to justify their use. However, IPA aims to focus on the subjective experience of the participant that is 
not generalisable to all mephedrone users. Using the data collected it would not be possible to justify such a 
claim, however perhaps this introduces scope for further research into the purpose of the narratives participants 
construct in relation to their drug use using discourse analysis. 
 In summary, socially constructed image of mephedrone as safe, fun and non-problematic appears to 
have encouraged mephedrone’s use, though in reality once mephedrone had been used its true destructive, 
uncontrollable and problematic nature was revealed. Such paradoxical experiences highlighted the deceptive 
nature of mephedrone as it seemed to undergo its own identity confusion between its benign safe identity, a 
façade that encouraged its use, versus its realistic destructive identity that “hooked” (Robert, p.6, L68) the user. 
To resolve this identity distress perhaps the true destructive nature of mephedrone could be highlighted, which 
may discourage its use or encourage at least the informed use of such a drug (see section 5.6, p.87-88). 
 
  5.2.2.2 The paradoxical experience of mephedrone use. During the initial phase of 
mephedrone use, participants described their experiences as commonly positive (see section 4.2.2.1, p.62-63). 
For example, the “…most amazing time of my life…” (Josh, p.6, L50), “…the peak of my happiness…” (Josh, 
p.31, L179), and the “…best time of my life…” (Daniel, p.7, L51). However, during the second phase of 
mephedrone use or as it became progressively problematic, participants described their experiences as 
paradoxically negative. For example, as a metaphorical burden e.g., “…a baby you can’t get rid of” (Josh, p.23, 
L136), an “intrusion” in one’s life (John, p.8, L37) and a “struggle” (Josh, p.10, L74; see section 4.2.2.1, p.62-
63). Rather than feelings of “love” (Daniel, p.11, L74) towards mephedrone during its initial use, “hate” (Robert, 
p.20, L186) eventually developed as mephedrone became problematic and was perceived as the “enemy” 
(Robert, p.20, L186).  
 These paradoxical experiences resembled that of Hsieh et al.’s (2015) findings, who proposed that as 
drug use dominated participant’s lives, they were trapped in a cycle of love, a desire to use drugs for their 
positive effects, and hate, upon the negative withdrawal of the drug, that motivated further use. Furthermore, 
these paradoxical experiences could be explained in line with social learning theory (Bandura, 1977). Wikler 
(1984) argued that the euphoric effects of a drug can reinforce its initial use via the method of operant 
conditioning (Skinner, 1938). However, as drug use becomes problematic or chemically addictive, as suggested 
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by the disease model (Muller & Hombery, 2015), the emergence of negative withdrawal symptoms can also 
encourage its further use in order to appease such effects (Sussman & Ames, 2001; Wikler, 1984). 
 The paradoxical experiences of mephedrone use were expressed further, as participants described 
their changing relationship with mephedrone as their drug use progressed. During the initial use of mephedrone, 
participants perceived mephedrone to be a natural source of nourishment, a source of emotional sustenance 
that created positive feelings (“It is like chocolate”; Alexander, p.7, L52). The euphemisms used to describe 
mephedrone coincided with the socially constructed image of mephedrone as positive (for how the positive 
perception of mephedrone was socially constructed, see section 4.2.2.2, p.64-65). However, as mephedrone 
use progressed, participants became “chemically…hooked” (Robert, p.19, L182), and the “need” or “want” 
(Daniel, p.19, L178) for mephedrone became uncontrollable and increased to the point it was described as 
“survival” (Daniel, p.8, L66). This uncontrollable use of mephedrone that participants described could be 
corroborated by Hsieh et al.’s (2015) suggestion that users of illicit drugs generally feel a lack of control 
concerning their problematic drug use (see section 4.2.2.2, p.64-65) This is perhaps due to underlying 
neuroadaptations that may have occurred because of prolonged drug use and that may inhibit one’s self-control 
(Gorwood et al., 2012).  
 Eventually, the participants in this study no longer perceived their mephedrone use as safe, but instead 
described their problematic mephedrone use as the “biggest mistake” (John, p.3, L32), the “biggest regret” 
(Josh, p.31, L174), and as a “tool” (Josh, p.23, L136) formed by the “devil” (Josh, p.23, L136) to facilitate evil 
doings that were inflicted upon the participant, rather than mephedrone being willingly used for its potent effects. 
These findings are similar to those of Shinebourne and Smith (2010), who also identified the experience of 
alcohol “addiction as an affliction”. Furthermore, mephedrone was metaphorically described as an abuser (see 
section 4.2.2.2, p.64-65) that ironically “doesn’t let you eat” (Robert, p.15, L148). It appeared that everything 
rapidly became food for the drug, and the participants’ sense of self, autonomy and livelihood (even the ir 
sexuality) was metaphorically eaten away by the drug itself. What began as being fed (the user) quickly 
becomes the one being devoured, as the initial rescuer (mephedrone) progressively becomes the persecuting 
enemy in a tragic drama perpetrated upon oneself to avoid inner pain. Mephedrone, the source of hoped-for 
mastery and control, becomes the destructive master out of one’s control. In terms of Maslow’s (1943, 1954) 
hierarchy of needs, mephedrone could initially be likened to the provider of one’s “basic needs” such as food 
that facilitates personal growth. Instead it deceptively becomes the destroyer, preventing not only the 
development of one’s “psychological needs” such as a sense of belonging or self-esteem, but even the 
maintenance of one’s basic  needs such as physical wellbeing. 
 
5.2.3 How do participants make sense of their problematic mephedrone use? 
  5.2.3.1 Self-identification via stigmatising beliefs within the drug-using community. A 
unique finding of this study was how participants made sense of their mephedrone use by self-identifying, 
attributing certain characteristics or qualities of other types of drug user to themselves (see section 4.2.3.1, 
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p.68-70). This reflective process was affected by the participants’ awareness of the stigmatising beliefs held 
within the drug-using community.  
 Although participants realised their substance misuse was “bad” (Robert, p.14, L138), participants 
within the drug-using community identified mephedrone use as less problematic or as recreational in 
comparison to traditional drug use. Participants associated traditional drug use with crime such as robbery, the 
stigmatised term “addiction”, a financial burden and a greater risk to one’s health, and generally with the view 
that their “lifestyle’s [are] completely different” (Daniel, p.27, L154). Participants referred to users of traditional 
drugs by stigmatising terms such as “druggies” (Daniel, p.21, L118) or “crackheads” (Daniel, p.27, L160), and 
stereotypes, e.g. “…addicts [that are] are very like… loud” (Daniel, p.31, L180). In contrast, mephedrone was 
commonly referred to as a “party drug” (John, p.3, L15), used within the contexts of “chill-outs or sex parties” 
(Alexander, p.14, L92) or on the “weekend” (Josh, p.5, L50), and was associated with “more fun” (Alexander, 
p.5, L38) than traditional drug use.  
 It was evident that the terminology used by participants helped reinforce the stigmatising beliefs 
present with the drug-using community, namely that traditional drug use was problematic and that mephedrone 
use was recreational and non-problematic. Research suggests that society, as well as professionals, perceive 
recreational drug use as more acceptable and as a normalised behaviour (Cieslik & Pollock, 2002; Gourley, 
2004; Lloyd, 2013; Parker, 1997; Shiner & Newburn, 1997). It appears that the language used by participants 
and mephedrone users alike facilitated the social construction of mephedrone as safe, fun and non-problematic. 
The professional arena was complicit too, as the terms “club drug” or “party drug” are used to classify such 
drugs. This coincides with the constructivist research paradigm of this study, which suggests reality is socially 
and discursively constructed within a particular context.  
 Further exploration demonstrated that a hierarchal system operated within the drug-using community 
regarding the price of drugs, which related to their problematic nature. Daniel explained that because 
mephedrone was “cheaper” (p.25, L140) than cocaine, it was thought to be less problematic than c ocaine, 
followed by crack cocaine, and lastly by heroin, which was the most expensive and therefore perceived as the 
most problematic drug of all. Such findings were similar to that of Power, Power and Gibson (1996) who 
proposed that heroin users are perceived as more negative than those who use cocaine within the drug-using 
community. 
 Although mephedrone use was deemed the most acceptable and least problematic drug by the drug-
using community in contrast to traditional drug use, it seemed there were social divides within the mephedrone-
using community itself. These were based on the route of administration that identified whether an individual’s 
mephedrone use was problematic or not. Participants explained that those who injected mephedrone were 
perceived as problematic users in comparison to those who snorted it. This was because participants associated 
injecting with a greater risk to one’s wellbeing and with greater potency, whereas the socialisation of snorting 
was portrayed by media images as the norm.   Perhaps this coincided with the social learning theory (Bandura, 
1977) that contended that beliefs concerning PSM could be learned via television or actors in films (Sulkunen 
2007; Waylen, Leary, Ness, Tanski, & Sargent, 2011). Furthermore, participants appeared to associate injecting 
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as a common route of administration for the most problematic and stigmatised drug, namely heroin; therefore, 
injecting symbolised problematic drug use. It could be that a self-image bias operated within the mephedrone-
using community, since heroin users were perceived as the most problematic drug user. As a result, any 
behaviour that was attributable to a heroin user implied that one’s own drug use was problematic (Hill, Smith & 
Hoffman, 1988).  
 
  5.2.3.2 The contemplative stage of change. In line with subordinate theme 3 (see section 
4.2.3, p.68-74), it appeared that participants began to realise that their drug use was “pointless” (Josh, p.27, 
L160), since it no longer resembled a source of happiness. Feelings of unproductivity were exacerbated by, for 
example, missing work due to negative withdrawal symptoms. In line with the transtheoretical model (Prochaska 
& Diclemente, 1983), although participants may not have been ready for treatment, their change in perception 
of mephedrone use from safe to problematic could have reflected their initial acknowledgement of the 
disadvantages of using mephedrone as they entered the contemplation stage of change.    
 Participants continued to progress through the contemplative stage, evidenced as they spoke of a 
critical incident that prompted the initial self-evaluation of their mephedrone use (see section 4.2.3.1, p.68-70). 
Participants identified how their mephedrone use had become subjectively problematic in their lives. 
Participants recalled the negative impact of mephedrone on their wellbeing and employment, together with a 
loss of social network and depreciating financial status. This was inconsistent with the image of high -functioning 
addicts that mephedrone users were suggested to be (LDAN, 2012; NTA, 2012), and that perhaps in turn upheld 
the socially constructed image of mephedrone as safe. Nevertheless, it appeared that the negative impacts of 
mephedrone use were the same as those of traditional drug use (JCPMH, 2013). Therefore, Bowden-Jones’ 
suggestion that club drug users’ psychological treatment needs were unique (Wise, 2011) appears to be 
incorrect in this instance, as does Simpson’s claim that their psychological treatment needs would be less than 
those of traditional drug users (LDAN, 2012).  This suggests that the psychological support required to treat 
mephedrone users, e.g. in terms of promoting activity, creating supportive relationships or generating motivation 
for change, is the same as that of traditional drug users. 
 Participants contemplated further as they underwent an internal debate between their desires to use 
mephedrone and their values and beliefs that argued against their mephedrone use. Josh described the internal 
debate between his “good voice” (Josh, p.18, L96) encouraging him not to use mephedrone, and his “bad voice” 
(Josh, p.18, L96) encouraging him to fulfil his desire to use mephedrone. This mirrored Hsieh et al.’s (2015) 
findings that participants who used illicit drugs experienced a tug of war between oscillating thoughts involving 
the desire to use the drug and the desire to quit it. Participants of this present study also experienced an internal 
conflict between their many selves that maintained different values and beliefs. For example, Alexander 
experienced a conflict between religious identity as a Muslim and with his mephedrone-using identity, and John 
understood that his “spiritual” self (p.6, L31), who seemed calm and civilised, was incongruent with the “drug 
side of me” (p.6, L31), who enjoyed “getting slaughtered” (p.6, L31). Perhaps this signified the moral model that 
accounted for religiosity as a protective factor against the use of drugs (Yeung, Chan & Lee, 2009). Furthermore, 
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such findings corroborated Shinebourne and Smith’s (2009) findings that explored participants’ “perception of 
the self”, and identified that participants experience a mixture of conflicting selves: one self acknowledges that 
the problematic use is destructive and wants to stop, while the other self enjoys engaging in the positive qualities 
associated with their PSM. However, it is the participants’ realisation that using drugs has not brought them 
closer to their true-self, a further disadvantage, which further motivates them to want to abandon the “drug side 
of me” (John, p.6, L31). 
 
5.3 The Use of Metaphors 
  Lakoff and Johnson (1980) believed that “metaphor is one of our most important tools for 
trying to comprehend partially what cannot be comprehended totally: our feelings, aesthetic experiences, moral 
practices, and spiritual awareness” (p.193). The present study captured metaphorical expressions embedded 
in participants’ accounts, which enabled a richer understanding of the participants’ experience (example of a 
metaphor, p.85). Schon (1993) referred to metaphors as a “process by which new perspectives on the world 
come into existence” (p.137). The use of metaphors by participants, in this study, during interviews may have 
highlighted signiﬁcant episodes where a participant was engaging in expressing or making sense of a previously 
unexpressed or unexplored aspect of their experience (Shinebourne & Smith, 2010). IPA is well suited to 
exploring both the experiential dimension of metaphors through phenomenological analysis, and hermeneutic 
possibilities emerging through the capacity of metaphors to make connections between different ideas and 
concepts (Shinebourne & Smith, 2010). 
 An example of the use of metaphor in this study includes Daniel describing his feelings of a lack of 
control regarding his problematic mephedrone use, as that of reciprocated abuse from mephedrone: 
 
“…cos I abused that, so now it should start to abuse me.” (p.21, L118) 
 
What is being expressed here is the participant’s powerful biopsychosocial experience causing him psychic 
pain. It is acknowledged that Daniel in turn may identify as a victim, though the experience outlined is personal 
to his subjective experience. His metaphor moves beyond generalisable concepts such as identity that relate to 
grand narratives but, in line with the essence of IPA, access the participant’s lifeworld to gather rich data, not 
only of influential social processes, but of real life events e.g. financial strain. 
 
5.4 Limitations of this Research 
 In this study participants were all male and predominantly from the LGBT community (see Table 1, 
p.48). Although this demographic group was not deliberately sought out, existing evidence can suggest why 
this may have occurred. Research has evidenced that out of the general population in the UK, men (1.3%) were 
significantly more likely to have used an NPS, including club drugs, compared to women (0.4%; Lader, 2015). 
Moreover, evidence suggests that gay and bisexual men surveyed by the CSEW (2014) were more likely to 
have used drugs in the last year compared to heterosexual men. This could be because the UK and international 
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evidence suggests that rates of substance misuse are higher amongst the LGBT groups than in the general 
population, where LGBT people have also been ‘early adopters’ of some new drug trends, such as club drugs 
(Measham, Wood, Dargan & Moore, 2011). 
 It was explained to the participants in the consent form (Appendix K, p.123-124) that confidentiality 
would be broken if the participants disclosed the following: the possession of illegal drugs, the supply of illegal 
drugs and information about activities (e.g. theft, prostitution) that they may have engaged in to fund their drug 
use. This requirement was deemed necessary by Derby NHS ethical committee to manage risk while conducting 
this research. This requirement is not introduced during treatment, to allow the client to freely express 
themselves with regards to the activities outlined that are thought to be commonly associated with drug use. 
The introduction of such a requirement in this research, could have potentially limited how much information the 
participants disclosed when they discussed their mephedrone use, as they may have been concerned with 
potential punishment. Consequently, this may have limited the researcher’s understanding of the participants 
subjective lifeworld, and limited the material collected and the research outcomes. As discussed earlier (section 
2.2.3, p.27-28) club drug users are often suppliers themselves, it appears to be an integral process in 
understanding problematic club drug user. It could be that the narratives that reflect mephedrone as harmless, 
as highlighted in this study, could be generated via the user’s relationship with their supplier which could warrant 
further research. 
 Furthermore, as suggested by Derby NHS ethical committee, in an effort to manage risk, research 
interviews were conducted at a drug treatment service in North London where the participants were having or 
had had treatment. This may have primed the participants to provide responses in relation to the treatment 
setting, a process referred to as ‘subject-expectancy effects’. Participants may have also been reluctant to 
discuss their potential negative experiences of treatment; however, this was not a topic of interest in this 
research. Despite holding interviews within a treatment setting, what was evident and welcomed was the 
participants’ forthcoming nature to disclose and explore difficult topics. It could be argued that having held 
interviews within a treatment setting could have also affected how the researcher responded to the data, 
perhaps as a practitioner. However, the researcher’s responses were monitored by employing reflective 
practices (see section 1.5, p.19-21) to ensure the researcher remained as close as possible to the participants’ 
lifeworld, while acknowledging that it is impossible for a reflexive researcher to be completely objective (Milton, 
2010). 
 
5.5 Recommendations for Future Research  
 Future research could focus on the stigmatising beliefs that operate within the drug-using community 
that prevent mephedrone users from self-identifying with PSM, which further discourages mephedrone users 
from accessing services where treatments are based on traditional drug use. As Adlaf, Hamilton, FeiWu and 
Noh (2009) explained, little research has explored how such stigma could be managed in order to reduce its 
effects as a barrier to seeking treatment. 
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 Although not included as a significant feature in the results of this study, some participants explained 
how they felt treatment was not readily available for club drug users. 
 
“I think they believe there is no help for people [that] take mephedrone…” (Daniel, p.34, L196) 
 
Perhaps further research could explore how club drug users perceive the current treatment available, and how 
such treatment could be made more accessible or be improved. 
 Further research could adopt a discursive approach that could shed light on the use of language in the 
social construction of mephedrone as safe and fun, and highlight further implications of this in terms of the 
beliefs held with the drug-using community and the wider society. This could highlight the importance of 
language and help establish an understanding of how language could be used to reframe the image of 
mephedrone and club drugs alike. 
 Future research may also explore how individuals experience marginalisation, a common precipitating 
factor to substance misuse, in relation to acculturative stress, stigmatising beliefs in relation to their sexual 
orientation and financial difficulties. Findings could develop professionals’ understanding of such experiences 
so that they can better help clients develop healthier strategies to enhance their self-esteem and sense of self. 
 This study focused on mephedrone use specifically. However, since the “consequences [of use] 
differed by type of club drug…future research should explore the reasons for club drug use by individual drug” 
(Parks & Kennedy, 2004, p.301). Perhaps further studies could explore the use of other club drugs to help 
establish commonalities or differences among experiences and motivations to use different club drugs. Such 
research could also help shed light upon whether a hierarchal belief system operates within the club drug -using 
community, which could elucidate whether such beliefs prevent or encourage individuals to use certain club 
drugs, how users develop ideas concerning the harms of club drugs, and how such thoughts may encourage 
or prevent them from identifying their PSM and subsequently accessing appropriate treatment. 
 Lastly, it appeared that difficulties in identity development greatly impacted users’ vulnerability towards 
recreational drug use, seeing it as a hope for a “quick-fix” or a way to quickly escape from their identity distress. 
Further quantitative research could potentially help to validate such a relationship, perhaps by exploring the 
relationship between identity distress and PSM. 
 
5.6 Recommendations for Training, Practice and Policy 
 Training ought to be provided to professionals working with club drug use concerning the harms 
associated with mephedrone use, e.g. loss of social network, negative impacts on one’s wellbeing, financial 
strain, its addictive nature, and its similarity in terms of its negative impact to that of traditional drugs. As a 
consequence, it is hoped that the “training gap” (Wise, 2011, p.1) among professionals in the UK will be 
addressed, and support provided for psychological practitioners to improve their psychoeducation for 
mephedrone users. It is also hoped that users’ lack of knowledge concerning mephedrone use as highlighted 
by this study will be addressed. That could demystify the extremely seductive and false mythology that continues 
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to be socially constructed by the users of the drugs and the influence of the contexts within which it is used (i.e. 
recreational party spaces). 
 In line with this study’s findings, psychological practitioners may find that clients experience an 
ambivalence while debating whether to change their problematic mephedrone use (examples of ambivalence, 
see section 4.2.3.3, p.72-73). Ambivalence can be defined as the recognition that a change in behaviour is 
necessary, but causes distress in an individual; and that individuals alternate between approaching and avoiding 
the tasks necessary for change (Arkowitz, 2002). Psychologists are reminded to provide clients with guidance 
in acknowledging, confronting and coping with their ambivalence (Glidden-Tracy, 2005). 
 Moreover, this study highlighted that issues concerning identity development were the primary 
motivation to use mephedrone (examples of difficulties in identity development, see section 4.2.1, p.55-62). 
Psychological practitioners could view the therapeutic relationship as a transitional identity which may serve to 
change the client’s identity from that of a drug user (Kellog, 1993). A positive therapeutic relationship will 
enhance collaboration, with the result that ambivalence and challenges are likely to be expressed more openly 
by clients. Studies have shown that through having an emotional bond with a therapist, clients can begin to 
internalise a belief in “alternative selves” (Kellog, 1993). Some literature suggests a need for continued identity 
work extending years into recovery from PSM (Koski-James, 2002). Therefore, the formation of structured 
support groups orientated towards the use of club drugs, mirroring the supportive environment fostered by the 
mephedrone-using community, could provide a place for continued self-reflection, support and growth. 
 It is suggested that government policy be introduced that serves to reframe the socially constructed 
image of mephedrone as safe, an image which influences society’s perception of mephedrone and the 
stigmatising belief system that operates within the drug-using community. Such a reframing of perspective could 
be reinforced by changing the terminology used by professionals to classify such drugs, e.g. “club drugs”, “party 
drugs” and “legal highs”, by using a name that reflects the potential harms of such drugs. Moreover, it is 
proposed that primary prevention interventions be introduced to offer education concerning the harms of club 
drug use, in order to increase the awareness of the problematic nature of such drugs before they are used. 
Again, hopefully this could demystify the safe and fun image associated with club drugs so that individuals 
consider the reality of the negative impacts of such drugs prior to their use.  If done post-use, this could enable 
them to feel less individualised and isolated by their own painful experience of mephedrone use. 
 
5.7 Summary and Conclusions 
 To summarise, this research presented an interpretative account of the data collected through semi-
structured interviews. The data was analysed using IPA in order to explore how mephedrone users experience 
and make sense of their problematic use. T hree superordinate themes were identified: (1) mephedrone as a 
credulous fix for ongoing identity vulnerability and distress, initiating a vicious cycle of deliberate use, (2) the 
paradoxical experiences of progressive mephedrone use, and (3) making sense of one’s problematic 
mephedrone use via self-reflective processes. This study attempted to provide the reader with a sense of the 
relationships and similarities between these themes and the subordinate themes that support them. 
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 This study highlighted that individuals may use club drugs who do not represent the typical profile of a 
club drug user (see section 1.2.3, p.18; see Table 1, p.48). Perhaps this shows the necessity for this qualitative 
research, which looks beyond specific socio-demographic characteristics to achieve an understanding of club 
drug use and users alike. As a consequence, this study also highlighted that club drug use may not be motivated 
primarily by age-specific issues such as peer pressure, but could be related to wider concepts that are significant 
in the area of substance misuse. For example, this data suggested that issues concerning difficulties in identity 
formation were the primary motivation to use mephedrone, a common reason found for substance misuse 
including traditional drug use (Etherington, 2006; Bruce, 1990; Larkin & Griffith, 2002). The secondary 
motivation to continue mephedrone use was to appease the symptoms of withdrawal, a common reason for 
PSM (Hsieh et al., 2015; Shinebourne & Smith, 2009; Shinebourne & Smith 2010). 
 The subjective experience of mephedrone use appeared to be similar to that of traditional drugs, when 
compared with research concerning the experience of PSM and its negative impacts. This implied that club drug 
users were not “high-functioning addicts” as Winstock suggested (LDAN, 2012; NTA, 2012), and that club drug 
use did negatively affect relationships, wellbeing, and ability to maintain a job. Hence, club drug users appeared 
to have the same amount of recovery capital, not more as suggested by Sim pson (2012), as that of traditional 
drug users and, therefore, their psychological treatment needs also appeared to be similar. 
 The findings of this research suggested that the necessity for club drug clinics was not so much related 
to the proposed uniqueness of treatment needs of club drug users, as suggested by Bowden-Jones (Hawkes, 
2012, p.1; NTA, 2012), but was because of significant barriers that prevented club drug users accessing 
treatment. This study found that stigmatising beliefs operated within the drug-using community and, more 
significantly, in the mephedrone-using community, that promoted the misleading perception that traditional drug 
use was more problematic than club drug use; and these prevented club drug users from self-identifying with 
the stereotypical perception of a problematic drug user. This stereotypical perception potentially inhibited 
mephedrone users from accessing generalised treatment services based on the needs of traditional drug use, 
as they thought such services were not equipped to meet the assumed different needs of mephedrone users. 
However, as this research confirms, the psychological treatment needs of club drug users are similar to that of 
traditional drug users, although club drug clinics allow such users to acc ess treatment without the stigma 
associated with traditional drug use. This identifies the need for further research exploring how such stigmatising 
beliefs could be managed in order to reduce their effects as a barrier to seeking treatment, and perhaps also 
how club drug users perceive club drug clinics.  
 A unique and significant finding of this study was that mephedrone may be socially constructed by 
users and professionals alike as benign, non-addictive, recreational, and safe (or at least qualitatively different 
from other “more serious” drugs that are widely associated with the stereotypical perception of an “addict”). This 
research suggests that stigmatising beliefs held within the drug-using community, the lack of information 
available concerning the harms associated with mephedrone use, and the terminology used when describing 
such drugs, all helped to maintain mephedrone’s seductive position in the substance misuse landscape as safe 
and fun. Importantly, this study has also highlighted the paradoxic al dynamics by which users related to 
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mephedrone that may have also actively contributed to the social construction of the “benign” and “recreational” 
false-identity of the drug, which could indeed subtly mirror the identity predicament of users. While thi s warrants 
further research, it also suggests three significant steps that should be taken.  These are, firstly, the need for 
reframing the public image of club drugs by the sensitive use of language by professionals when describing 
such drugs; secondly, the implementation of primary prevention interventions associated with the promotion of 
information concerning the harms associated with club drug use, and thirdly, the training of psychological 
practitioners to provide psychoeducation to users of the harms associated with club drugs.  
 
5.8 Reflexive Section: Part Three 
 Conducting this research has been a difficult learning journey of becoming and transforming 
(Etherington, 2004). I aspire to what Carl Rogers refers to as immersing ourselves as researchers in phenomena 
under study and “this means a tolerance for ambiguity and contradiction, a resistance for closure, the valuing 
of unbridled curiosity” (Rogers, in Kirschenbaum & Henderson, 1996, p.269). The process of research taught 
me to tolerate contradictions and uncertainties, and to embrace my “unbridled curiosity” in how mephedrone 
users experience their problematic use. 
 Receiving ethical approval for this research was the most difficult process in my research journey. I 
underwent many administrative difficulties while awaiting ethical approval, although I persevered in a systematic 
and rigorous manner. During this time, I learned to tolerate uncertainty about the likelihood of the fruition of my 
pending research and this further enriched the “process of becoming a reflexive researcher” as I wrote my 
worries in my reflective journal (Etherington, 2004, p.81).   
 During the research process, I noticed how I could establish rapport with participants with ease. This 
was signified by the participants wanting to relate to me, specifically John (example, see section 4.2.1.2, p.58-
60). Reflecting on this incident, I noticed how my involuntary self-disclosure of my ethnicity, evidenced by the 
colour of my skin, positively affected the interview process. It could be assumed that participants, particularly 
John, felt that I could associate with their experience of marginalisation as I may have experienced 
marginalisation due to my ethnicity, hence facilitating rapport between us. Nevertheless, I made it a priority to 
maintain the boundaries within my professional relationships with participants. I did so by not disclosing any of 
my personal experiences, by sensitively redirecting questions back to the participant to understand the 
significance of what they were trying to communicate, and by recording and exploring my feelings regarding 
such incidents to make sure they did not impact on the research. 
 I recall my assumption prior to conducting this research that club drug users were different from 
traditional drug users in terms of their treatment needs, since traditional drug use appeared to be more 
debilitating than club drug use, which is why different types of services were suggested. Using my reflexive 
journal and discussions during supervision, I feel I successful ly bracketed this assumption and allowed the 
research to be guided instead by the experience of participants. I found it interesting to acknowledge that club 
drugs were as debilitating as traditional drugs, and that I was also duped by the socially constructed image of 
club drugs as safe, fun and non-problematic. This led me to reflect on two further conclusions.  Firstly, there a 
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stigmatising belief system operating within the drug-using community in terms of how problematic a drug is 
perceived relative to traditional drugs. Secondly, this belief system may operate within the professional arena 
and is promoted using language such as club drugs.   
 Lastly, all the participants expressed their gratitude towards this research, and they were also 
appreciative of the opportunity to voice their experiences. The participants’ enthusiasm was a great inspiration 
and motivation for me to complete this research. They enabled me, and hopefully other counselling 
psychologists and mental health practitioners, to better understand club drug use. I hope this better 
understanding can help implement findings and improve treatment provided for club drug users. 
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Appendix A 
DSM-4 (APA, 1994) definition of problematic substance misuse 
 
Table 4: 
 
DSM-4 Criteria for Substance Dependence and Substance Abuse (APA, 1994). 
Dependence  
(3 or more in a 12-month period) 
Abuse  
(1 or more in a 12-month period) 
Symptoms must never have met criteria for 
substance dependence for this class of 
substance. 
Tolerance (marked increase in amount; marked 
decrease in effect) 
 
Recurrent use resulting in failure to fulfill major role 
obligation at work, home or school 
 
Characteristic withdrawal symptoms; substance 
taken to relieve withdrawal 
 
Recurrent use in physically hazardous situations 
 
Substance taken in larger amount and for longer 
period than intended 
 
Recurrent substance related legal problems 
Persistent desire or repeated unsuccessful 
attempt to quit 
Continued use despite persistent or recurrent social 
or interpersonal problems caused or exacerbated by 
substance 
Much time/activity to obtain, use, recover  
Important social, occupational, or recreational 
activities given up or reduced 
 
 
Use continues despite knowledge of adverse 
consequences (e.g., failure to fulfill role 
obligation, use when physically hazardous) 
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Appendix B 
WHO (2010) definition of problematic substance misuse 
 
Substance dependence 
ICD-10 Clinical description 
A cluster of physiological, behavioural, and cognitive phenomena in which the use of a substance or a class of 
substances takes on a much higher priority for a given individual than other behaviours that once had greater 
value. A central descriptive characteristic of the dependence syndrome is the desire (often strong, sometimes 
overpowering) to take psychoactive drugs (which may or may not have been medically prescribed), alcohol, or 
tobacco. There may be evidence that return to substance use after a period of abstinence leads to a more rapid 
reappearance of other features of the syndrome than occurs with nondependent individuals. 
 
ICD-10 Diagnostic guidelines 
A definite diagnosis of dependence should usually be made only if three or more of the following have been 
present together at some time during the previous year: A strong desire or sense of compulsion to take the 
substance; difficulties in controlling substance-taking behaviour in terms of its onset, termination, or levels of 
use; a physiological withdrawal state when substance use has ceased or have been reduced, as evidenced by: 
the characteristic withdrawal syndrome for the substance; or use of the same (or closely related) substance with 
the intention of relieving or avoiding withdrawal symptoms; evidence of tolerance, such that increased doses of 
the psychoactive substance are required in order to achieve effects originally produced by lower doses (clear 
examples of this are found in alcohol- and opiate-dependent individuals who may take daily doses sufficient to 
incapacitate or kill nontolerant users); progressive neglect of alternative pleasures or interests because of 
psychoactive substance use, increased amount of time necessary to obtain or take the substance or to recover 
from its effects; persisting with substance use despite clear evidence of overtly harmful consequences, such as 
harm to the liver through excessive drinking, depressive mood states consequent to periods of heavy substance 
use, or drug-related impairment of cognitive functioning; efforts should be made to determine that the user was 
actually, or could be expected to be, aware of the nature and extent of the harm. 
 
Harmful use 
ICD-10 Clinical description 
A pattern of psychoactive substance use that is causing damage to health. The damage may be physical (as in 
cases of hepatitis from the self-administration of injected drugs) or mental (e.g. episodes of depressive disorder 
secondary to heavy consumption of alcohol). 
 
ICD-10 Diagnostic guidelines 
The diagnosis requires that actual damage should have been caused to the mental or physical health of the 
user. Harmful patterns of use are often criticised by others and frequently associated with adverse social 
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consequences of various kinds. The fact that a pattern of use or a particular substance is disapproved of by 
another person or by the culture, or may have led to socially negative consequences such as arrest or marital 
arguments is not in itself evidence of harmful use. Acute intoxication, or ‘hangover’ is not in itself sufficient 
evidence of the damage to health required for coding harmful use. Harmful use should not be diagnosed if 
dependence syndrome, a psychotic disorder, or another specific form of drug- or alcohol-related disorder is 
present. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
THE EXPERIENCE AND SENSE MAKING OF PROBLEMATIC MEPHEDRONE USE       109 
 
 
 
 
Appendix C  
DSM-5 (APA, 2013) definition of problematic substance misuse 
 
1. Taking the substance in larger amounts or for longer than the you meant to 
2. Wanting to cut down or stop using the substance but not managing to 
3. Spending a lot of time getting, using, or recovering from use of the substance 
4. Cravings and urges to use the substance 
5. Not managing to do what you should at work, home or school, because of substance use 
6. Continuing to use, even when it causes problems in relationships 
7. Giving up important social, occupational or recreational activities because of substance  
 use 
8. Using substances again and again, even when it puts you in danger 
9. Continuing to use, even when the you know you have a physical or psychological  
 problem that could have been caused or made worse by the substance 
10. Needing more of the substance to get the effect you want (tolerance) 
11. Development of withdrawal symptoms, which can be relieved by taking more of the 
 substance. 
 
The DSM-5 allows clinicians to specify how severe the ‘substance use disorder’ is, depending on how many 
symptoms are identified. Two or three symptoms indicate a ‘mild substance use disorder’, four or five symptoms 
indicate a ‘moderate substance use disorder’, and six or more symptoms indicate a ‘severe substance use 
disorder’. Clinicians can also add “in early remission,” “in sustained remission,” “on maintenance therapy,” and 
“in a controlled environment.”
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Appendix D 
Mirza and Mirza (2008) stages of substance misuse 
Table 5: 
  
Stage of drug use (Mirza & Mirza, 2008). 
Stage of drug 
use 
Motive Setting Frequency Emotional impact Behaviour Impact of functioning 
Experimental Curiosity and risk 
taking 
Alone or with peer 
group 
Rarely or very 
occasionally 
Effect of drugs is usually 
very short-term 
No active drug seeking 
behaviour 
Relatively little; may rarely result in 
dangerous consequences. 
Social Social acceptance Usually with peer 
group 
Occasional Mind altering effects of 
drugs are clearly recognised 
No active drug seeking 
behaviour 
Usually no significant problems, but some 
can go on to show features of the early at 
risk stage   
Early at risk 
stage   
 
Social acceptance / 
peer pressure / 
beliefs valuing 
substance-led 
experiences, based 
on pleasurable early 
experiences 
Facilitated by peer 
group 
Frequent, but 
variable, 
depending on 
peer group 
Mind altering effects 
of drugs are clearly 
recognised and sought    
No active drug seeking 
behaviour – but develops 
a regular 
pattern of drug use   
Associated with 
significant dangers 
problems associated 
with acute intoxication 
(e.g. accidents related to 
recurrent binge drinking) 
Late at risk 
stage 
(substance use 
is dominating 
mental state) 
Cope with negative  
emotions or 
enhancing  
pleasure through 
wider 
experimentation 
Alone or with an  
Altered /-selected 
peer group (e.g.  
drug or alcohol 
using) 
Frequent / regular 
use 
  
Uses drugs to alter mood or 
behaviour 
Active drug seeking 
behaviour is a key  
indicator of this stage   
May be impairment in  
functioning in some areas  
(e.g. school and family) 
Table continued overleaf… 
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Stage of drug use Motive Setting Frequency Emotional impact Behaviour Impact of functioning 
Harmful use or 
substance abuse 
(similar 
to ICD-10 or DSM-4)   
Drug use is the primary 
means of 
recreation, coping with 
stress or both 
Alone or with an altered 
peer group (alcohol or 
drug- using) 
Regular use, despite 
negative consequences 
Negative effects on 
their emotions and 
ability to 
function 
Active drug seeking 
behaviour, despite 
negative consequences  
across many areas of 
life 
Impairment in almost 
all areas of life and or 
distress within families 
or 
close relationships   
Dependence 
(Similar to ICD-10 and  
DSM-4) 
To deal with withdrawal 
symptoms, and stop 
craving. 
Alone or with 
likeminded peer 
Group 
Compulsive, regular or 
often daily use to 
manage withdrawal 
symptoms 
Emotional impacts of 
drugs are very 
significant. Withdrawal 
symptoms prominent 
Active drug seeking 
behaviour, often loss of 
control over 
use, pre-occupation 
with drug use, 
craving, and behaviour 
may involve criminality 
Physical and 
psychological 
complications, 
impairment in all areas 
of life   
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Appendix E  
 
Transtheoretical model (Prochaska & DiClemente, 1983; Prochaska, DiClemente, & Norcross, 1992) 
 
These stages include: 
(1) Pre-contemplation: Individuals may be under informed of the consequences of their substance misuse, 
and do not intend to act in the foreseeable future. 
(2) Contemplation: Individuals intend to change their problematic substance misuse behaviour in the next 
six months. They are more aware of the pros of changing, but are also acutely aware of the cons. This 
weighing between the costs and benefits of changing can produce profound ambivalence that can 
cause people to remain in this stage for long periods of time. This phenomenon is often characterised 
as chronic contemplation.  
(3) Preparation: Individuals intend to act in the immediate future, usually measured as the next month.  
(4) Action: Individuals have made specific overt modifications in their lifestyles within the past six months 
e.g., access treatment services and engage in psychosocial interventions. 
(5) Maintenance: Individuals have made specific overt modifications in their lifestyles and are working to 
prevent relapse of their problematic substance misuse. 
(6) Relapse: Individuals may relapse, and the cycle of change starts over again. 
Often, individuals recycle through the stages or regress to earlier stages from later ones.
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Appendix F 
Summary of evidence for the effectiveness of psychosocial interventions for substance misuse 
Table 6: 
 
Summary of evidence for the effectiveness of PSIs for substance misuse 
Document Content and conclusions 
NICE (2007a; 2007b; 
2012) recommendations 
on drug misuse 
Brief interventions (motivational interviewing) 
Information on self-help groups 
Behavioural couples therapy 
Contingency management 
Evidence-based PSI for co-occurring psychological problems 
 
Government clinical 
guidelines on drug 
misuse (Department of 
Health and the Devolved 
Administrations, 2007) 
NICE 51 plus: 
CBT-based relapse prevention 
Community reinforcement approaches 
Social behaviour network therapy 
Family therapy 
Psychodynamic therapy 
 
NICE (2013) 
recommendations on 
alcohol misuse 
Motivational interviewing 
Information on self-help groups 
CBT-based relapse prevention 
Behavioural therapies 
Social network and environmental therapies 
Behavioural couples therapy 
Evidence-based psychosocial interventions for co-occurring 
psychological problems 
 
Cochrane reviews: 
Smedslund et al. (2011) 
and Knapp, Soares, 
Farrel & Lima (2007) on 
cocaine and psycho-
stimulants 
Motivational interviewing 
Contingency management 
CBT 
Community reinforcement approach 
 
Table continued overleaf… 
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Document Content and conclusions 
National Treatment Agency 
(2005) 
 
 
 
 
 
 
 
 
CBT – coping skills 
Motivational interviewing 
Relapse prevention 
Community reinforcement 
Contingency management 
Supportive expressive psychotherapy 
Family therapy 
Social behaviour network therapy# 
 
NICE (2014) Proven behaviour change techniques: 
goal setting and planning 
feedback and monitoring 
social support 
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Appendix G 
 
Inclusion and exclusion criteria 
 
• Participants that were not fluent in English were excluded. The importance of the richness and meaning of 
language is emphasised in qualitative research, which is in jeopardy of being lost if a translator is used 
(Smith, Flowers & Larkin, 2009). 
• Participants were excluded if they did not self-rate their mephedrone use as problematic, since the aim of 
this study was to explore subjective problematic mephedrone use. 
• Participants were recruited that were engaged with a treatment service, giving participants a point of contact 
if they became distressed or required further support. 
• Participants were not required to have had psychological treatment, since the aim of this research was to 
explore their experience of problematic mephedrone use, not their experience of treatment. 
• Participants were recruited that used mephedrone, as this is the club drug under investigation. It is unlikely 
that a participant will use one drug in isolation due to polydrug use. Therefore, like other studies, participants 
were recruited where their primary drug of choice was mephedrone i.e., the most frequently used or 
favoured drug (Sumnall, Woolfall, Edwards, Cole & Beynon, 2008; Winstock et al., 2011; Reynaud -
Maurupt, Pierre-Yves, Akoka & Toufik, 2007). 
• Participants were recruited if their keyworker and participant felt that their substance misuse and recovery 
was stable, in order to minimise any potential interference this study may have caused to the participant’s 
recovery. For example, the participant would have well-developed coping strategies to manage the 
potential triggering of cravings when discussing their experience of problematic mephedrone use. 
• Participants that had a serious co-morbid mental health condition were not recruited, to minimise potential 
interference with their recovery and since participants may not have been competent enough to give 
informed valid consent. There is no agreed definition of the term ‘serious’ mental health problem (NHS, 
2014a), though for the purpose of this study a serious mental health disorder was defined as any mental 
health disorder that: 
o causes substantial disability such as an inability to care for themselves independently, sustain 
relationships or work; 
o results in the current display of obvious and severe symptoms; 
o results in continuous remitting/relapsing; 
o causes recurring crisis leading to frequent admission/intervention; 
o results in the significant risk to their own safety and that of others (NHS, 2014b). 
o All of these factors do not have to be experienced simultaneously for the participant’s mental 
health problem to be deemed serious. Examples of serious mental health problems include 
psychotic disorders e.g., schizophrenia, bipolar disorder or personality disorders (NHS, 2014a). 
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Appendix H 
London Metropolitan ethical approval 
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Appendix I 
National Health Service ethical approval 
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Appendix J 
 
Participant Information sheet 
 
 
 
Participant Information sheet 
 
Study Title: Individuals’ experiences and sense-making of problematic mephedrone use. 
Name of Researcher:  Gurjeet Bansal 
 
I would like to invite you to take part in this research study. Before you decide I would like you to understand 
why the research is being done and what it would involve for you. I will go through the information sheet 
with you and answer any questions you have. This may take about 15 minutes. Talk to others about the 
study if you wish. If you are unclear on any of the information or require more details, you are welcome to 
contact me or my Research Supervisor (contact details are available at the end of this form).  
 
What is the purpose of this study? 
Very little is known about mephedrone use, so this study hopes to achieve an understanding of how you have 
experienced mephedrone use, what your motivations were to use mephedrone in particular; how you noticed, 
understood and identified that your drug use had become problematic which prompted you to seek treatment. 
 
Such information could potentially benefit healthcare professionals when trying to understand and support 
individuals who experience problems with mephedrone use and perhaps suggest how psychological 
interventions might be useful.  
  
Why am I being approached for this study? 
You are being approached to take part in this study, by the Line Manager, as you have had an experience of 
problematic mephedrone use. Therefore, your views and experiences are important to this study. In total, 6 
participants will be recruited for this study. 
 
Am I obliged to take part in this study? 
It is solely your decision to part in this study or not. In the case that you agree, you will be requested to sign a 
consent form. If you decide to withdraw from the study following the interview, you can do so up to 6 weeks 
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after interview or until data analysis has begun (whichever length of time is the greater). If you decide to withdraw 
from the study this will not affect the standard of care you receive. Anything you have said during the interview 
will not be used in the study and will be destroyed. 
 
What will happen if I decide to take part and what will I have to do? 
I will contact you to discuss your interest in participating, answer any questions you may have about taking part 
in the study and to schedule a time so that we can meet so we can talk about your experiences. I will try to 
schedule appointments at your convenience. Before participating you will be asked to sign a consent form, 
which I will talk you through. You will attend one meeting, at the service, which will involve an interview where I 
will ask you questions about your experiences of problematic mephedrone use. This will last approximately an 
hour.  
 
It is important that you understand that this interview is not a therapy session. If you would like therapy, then is 
advisable that you contact your General Prac titioner or consult online mental health support. I am happy to 
provide you with further information regarding this should it be necessary. 
 
Expenses 
No expenses will be paid.   
 
What are the possible risks or disadvantages of taking part? 
It is unlikely that the issues discussed will evoke distressing thoughts and feelings, though in the event that this 
should occur you can take small breaks during the interview to help you feel more relaxed. Both you and I, the 
researcher, will have the right to end the interview if at any point, you become unduly distressed whilst talking 
about your experiences. This is to ensure that your wellbeing is safeguarded at all times. 
 
It is possible that taking part in this study may bring about some upsetting feelings in you as you are asked to 
share your experiences of dealing with your problematic mephedrone use. In this case, information will be 
provided to you regarding relevant support services that you may wish to access. These will include drug support 
services, and helplines. 
 
It is advised that you ought not to take part in this study if you have a serious mental health condition. This can 
be discussed further if you are unsure what a serious mental health condition may entail. 
 
What are the benefits of me taking part? 
I cannot promise the study will help you personally, but the information gathered from this study could help 
improve the treatment of people with problematic mephedrone use. 
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What if there is a problem? 
Any complaint about the way you have been dealt with during the study or any possible harm you might suffer 
will be addressed. If you wish to make a complaint about any aspect of the study, please contact myself or my 
Research Supervisor, Dr Philip Hayton at London Metropolitan University or please contact PALS, an 
independent service (please see the contact details at the end of this form). 
 
Will my taking part in the study be kept confidential? 
With your permission, the interview will be audio-taped, transcribed and segments of this may be incorporated 
into a report that will be accessible to other individuals such as my Research Supervisor and other tutors who 
will be formally assessing the report. However, you will remain completely anonymous i.e., your name and 
identity will not at any point be made available and will be kept separate from the findings of the interview. No 
one will have access to this information except me.  
 
All information that you provide will be secured in a safe place by the researcher. The tapes used to record the 
interview will be destroyed following transcription and once the study has been assessed and marked. 
Transcripts of the interview will be kept for a maximum period of 5 years in case the study is published and will 
then be destroyed. For your wellbeing, your Key worker will be aware that you are taking part in the study, 
though will not be present at interview. 
 
However, confidentiality will be broken if any information is disclosed suggesting an imminent risk of harm to 
you or others, which includes the disclosure of information provided regarding the following: the possession of 
illegal drugs, the supply of illegal drugs and information about activities (e.g. theft, prostitution) that you may 
have engaged in to fund your drug use. If you have more questions about what this m eans, please do not 
hesitate to ask. 
 
What will happen to the results of the research study? 
If you wish to obtain a copy of a summary of the findings, please provide your contact details. These details will 
be kept separate from the material that you provide me during our interview. The results of the study may be 
published in a journal, and be accessible at the University Library. However, no information identifying you as 
a participant will be included. 
 
Who is organising and funding the research? 
This research is being carried out as part of my doctoral training in Counselling Psychology and is not receiving 
any external funding.   
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Who has reviewed the study? 
All research in the NHS is looked at by independent group of people, called a Research Ethics Committee, to 
protect your interests. This study has been reviewed and given favourable opinion by the East Midlands Derby 
Research Ethics Committee. 
 
  
I am happy to answer any questions or queries you may have relating to the study. 
 
Thank-you 
 
Further information and contact details 
1. General information about research. 
http://www.hra.nhs.uk/patients-and-the-public-2/types-of-study/ 
 
2. Specific information about this research project. 
Researcher: Gurjeet Bansal   Email: clubdrugs@outlook.com 
Mobile number: 07553241270 
 
Research Supervisor: Dr Philip Hayton  Email: p.hayton@londonmet.ac.uk 
Contact number: 0207 133 2685 
 
3. Advice as to whether they should participate. 
Researcher: Gurjeet Bansal   Email: clubdrugs@outlook.com 
Mobile number: 07553241270 
 
4. Who they should approach if unhappy with the study. 
Research Supervisor: Dr Philip Hayton  Email: p.hayton@londonmet.ac.uk 
Contact number: 0207 133 2685 
 
Patient advice and liaison services (PALS): Moorfields At St Ann's Hospital 
Contact Telephone Number: 020 7211 8323 
Address: St. Ann's Hospital, St. Ann's Road, London, Greater London, N15 3TH 
 
 
 
 
 
THE EXPERIENCE AND SENSE MAKING OF PROBLEMATIC MEPHEDRONE USE       123 
 
 
 
 
Appendix K 
 
Informed Consent Form 
 
 
 
Patient Identification Number for this research: 
 
Informed Consent Form 
 
Study Title: Individuals’ experiences and sense-making of problematic mephedrone use. 
Name of Researcher:  Gurjeet Bansal 
 
 This consent form is to ensure that you are happy with the information you have received with respect 
to this study. It is also important to check that you are aware of your rights as a participant to confirm that you 
wish to take part in the study. 
 
To be completed by the participant: 
 Please read the following statements and initial the box.  
 
1. I am presently not under the influence of any intoxicants e.g. drugs or alcohol. 
 
2. I confirm that I have read and understand the participant information sheet dated 21 September 2015 
(Version 2.0) for the above study. I have had the opportunity to consider the information, ask questions and 
have had these answered satisfactorily in order for me to decide whether I want to take part in the above 
study. 
 
3. I understand that all the information I provide will be kept confidential. However, I understand that 
confidentiality will be broken if the disclosure of any information appears to be an imminent risk to myself 
or someone else. This includes information provided regarding the following: the possession of illegal 
drugs, the supply of illegal drugs and information about activities (e.g. theft, prostitution) that you may have 
engaged in to fund your drug use.   
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4. I have been shown and understand the plan of action, dated 21 September 2015 (Version 2.0). 
 
5. I understand that for my wellbeing my Key worker will be aware that I am participating in this research 
though will not be present at interview. 
 
6. I understand that I will remain completely anonymous and that my name and identity will not be revealed 
at any point and that this consent form will be kept separate from the transcript and findings of this study. 
 
7. I understand that my participation is voluntary. I am free to refuse to answer any question and that I am 
free to withdraw up to 6 weeks after interview or until data analysis has begun (whichever length of time is 
the greater), without giving any reason, without my medical care or legal rights being affected. 
  
8. I am clear that both the researcher and I have the right to terminate the interview if undue distress to me is 
evident. 
 
9. I agree for the researcher to audio-record my conversation, to allow the research to use verbatim quotations 
from my speech, which will be anonymised, in the writing up or publication of this study. 
 
10. I agree that my taped conversation and transcript will be kept up to a period of five years in case the study 
is published. 
 
11. I understand that the terms of this engagement are one of researcher and participant not therapist and 
client. 
 
12. I consent to take part in this study. 
_____________________ _____________    ________________ 
Name of Patient   Date      Signature 
_____________________ _____________    ________________ 
Name of Person   Date      Signature 
taking consent 
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Appendix L 
 
Demographic Questionnaire 
 
 
 
 
Demographic Questionnaire 
 
Title of research: Individuals’ experiences and sense-making of problematic mephedrone use. 
   
Researcher:  Gurjeet Bansal 
 
1. Age:  
 
2. Gender: 
 
3. Sexual orientation: 
 
4. Other drugs used: 
 
5. Education 
 
6. Housing situation: 
 
7. Employment status: 
 
8. Mephedrone use:  
A. Length of time: 
B. Current usage (frequency, quantity):  
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Appendix M 
 
Interview Schedule 
 
 
 
 
Interview Schedule 
  
1. Can you tell me about how your mephedrone use began?  
• Event  
• What was life like for you at the time? - stressors, peer pressure, relationships with family and friends, 
psychological, physiological, economic status, employment etc., and their effect 
• What were your initial motivations to use mephedrone? 
 
(Aim: creates context, assists rapport by allowing the participant to describe an event, and establishes the 
participants’ initial motivations to use mephedrone) 
 
2. Can you tell me about your initial experiences of using mephedrone? 
• What did it feel like in your body/mind? – thoughts/feelings  
• What were its effects? - positive/negative 
• How did you take mephedrone? - frequency, quantity, route of administration, pattern of usage, in 
combination with other drugs, context 
 
(Aim: creates context by gaining an understanding of the practices implemented when using mephedrone and 
ascertains the participants’ initial experiences of using mephedrone) 
 
3. Can you tell me what role mephedrone had in your life during your initial stages of use?  
• How do you cope? 
• What were your motivations to keep using mephedrone at this time? - social, psychological, 
physiological 
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(Aim: establishes an understanding of the participants’ motivations/reasoning to take mephedrone prior to 
their problematic use) 
 
4. Can you describe how you felt about yourself at this time in the wider society? 
• Self-image and perception of society at the time 
 
(Aim: to position the participant within their lifeworld, to gain understanding of their identity and experience of 
the world prior to their problematic use) 
 
5. Can you tell me how you noticed your mephedrone use had become problematic?  
• Yourself or someone else 
• A particular event or a gradual process 
• What was life like for you when your mephedrone use was problematic? - stressors, peer pressure, 
relationships with family and friends, psychological, physiological, health, economical status, 
employment, housing etc., and their effect 
 
(Aim: creates context and draws upon how the participant began to make sense of their problematic 
mephedrone use) 
 
6. Can you describe your experiences of problematic mephedrone use? 
• What did it feel like in your body/mind? – thoughts/feelings  
• What were its effects? - positive/negative/ risks 
• How did you take mephedrone? - frequency, quantity, route of administration, pattern of usage, in 
combination with other drugs, context 
• Liken experience of problematic mephedrone use to any traditional drug, or other drug 
 
(Aim: draws upon the participants’ experiences of problematic mephedrone use) 
 
7. Can you tell me what role mephedrone had in your life when your use was problematic? 
• How do you cope? 
• What were your motivations to keep using mephedrone at this time? - social, psychological, 
physiological 
 
(Aim: establishes the participants’ motivations to continue using mephedrone problematically) 
 
8. Can you describe how you felt about yourself when your drug use was problematic?  
• Self-image and perception of society at the time 
THE EXPERIENCE AND SENSE MAKING OF PROBLEMATIC MEPHEDRONE USE       128 
 
 
 
 
 
(Aim: to position the participant within their lifeworld, to gain understanding of their identity and experience of 
the world whilst using mephedrone problematically) 
 
9. Can you tell me how you decided you wanted to seek help for your problematic drug use? 
• What thoughts went through your mind when you were considering to stop? -readiness, fears 
• What were your motives for stopping to use? -relationships, health, financial status, the effects of the 
drug, drug tolerance, loss of time, critical incident etc. 
 
(Aim: understands how the participant concluded their usage was problematic enough to seek help) 
 
10. Is there anything else you might like to add, about your experience or understanding of 
mephedrone use, which you think is important that we have not spoken about?  
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Appendix N 
 
Debriefing Form 
 
 
 
 Written Debriefing Form  
 
Title of research: Individuals’ experiences and sense-making of problematic mephedrone use. 
Name of Researcher:  Gurjeet Bansal 
 
 Thank-you for your participation in this study. This debriefing is given as an opportunity for you to learn 
more about this research study, how your participation plays a significant part in this research and why this 
research is important. 
 Club drugs have many detrimental psychological, physiological and social implications. In the UK, 
there has been an increasing prevalence of club drug use, in particular mephedrone use despite its legislation. 
Club drug clinics have opened across the UK that are thought to cater to the specialised needs of problematic 
club drug users, which are thought to be different from traditional drug users (heroin and crack cocaine users). 
However, since each club drug has different psychological and physiological effects, it is thought that each club 
drug may be associated with different reasons for use that may have different treatment implications. 
 Little is known about the subjective experience of mephedrone use, and what can become problematic 
about the use of mephedrone. By exploring the thoughts and experiences of problematic mephedrone users, it 
is thought that a better understanding may be established about why mephedrone is used and how it is 
problematic. Such information could be useful when suggesting the psychological interventions that may benefit 
the recovery of problematic mephedrone users, and inform healthcare professionals that work within the area 
of substance misuse. 
 I understand that it may have been difficult at times to answer the questions as part of this research 
and your generosity and willingness to participate in this study are greatly appreciated. I do however ask that 
you do not discuss the nature of this study with others who may participate in it, as this could affect the validity 
of the research conclusions. 
 Sometimes people find the subject matter of these interviews difficult. If answering any of the questions 
has resulted in any distress, upset or concern and you would like to speak to someone about your thoughts and 
concerns, I have enclosed a list of useful counselling/therapeutic and substance misuse support services that 
you might find useful. 
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 As explained, the information that you will provide will be kept anonymous. Thus, there will be no 
information that will identify you, i.e. pseudonyms will be used. The results of this study may be presented at 
academic conferences or published as an article. If you would like to receive a summary of the findings of this 
study or have any individual questions, you may contact either myself or my supervisor. Contact de tails are: 
 
 
Contact details 
Researcher: Gurjeet Bansal    Email: clubdrugs@outlook.com 
Mobile number: 07553241270 
 
Research Supervisor: Dr Philip Hayton   Email: p.hayton@londonmet.ac.uk 
Contact number: 0207 133 2685 
 
Support services 
Samaritans 
Website: www.samaritans.org 
Contact number: 08457 90 90 90 
 
Club Drug Clinic 
Email: clubdrugclinic.cnwl@nhs.net 
Contact number: 020 3315 6111 
 
Westminster Drug Project 
Email: enquiries@wdp-drugs.org.uk 
Contact number: 020 7421 3100 
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Appendix O 
Plan of Action 
 
 
The Plan of Action 
 
Confidentiality will be breached if the disclosure of the following information is made: the possession of illegal 
drugs, the supply of illegal drugs and information about activities (e.g. theft, prostitution) that addicts may be 
engaging in to fund their problematic substance misuse (Walker, 2008).  
 
Figure 4: Plan of action. 
 
 
 
 
 
 
 
    
 
 
 
 
 
Disclosure of information 
Contact supervisor, evaluate 
case using decision-making 
tool  
Unnecessary to contact 
authorities 
Necessary to contact 
authorities 
Police 
Healthcare 
services 
Social services 
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Appendix P 
Adapted version of the ethical-decision making tool (Roberts & Dyer, 2004) 
 
 
 
Table 7: 
 
Adapted version of ethical decision-making tool (Roberts & Dyer, 2004) 
Factor Case 
Medical facts 
• Diagnoses 
• Treatment history 
• Comorbidity 
 
Participant preferences 
• Informed consent 
• Decisional capacity 
• Surrogate decision makers 
 
Interests of other parties 
• Family 
• Health care providers 
• Public 
• Researcher 
 
Information disclosed 
• Risks 
• Authorities to be informed 
 
 
 
 
 
 
 
 
 
THE EXPERIENCE AND SENSE MAKING OF PROBLEMATIC MEPHEDRONE USE       133 
 
 
 
 
Appendix Q 
Distress Protocol 
 
 
 
 
Distress Protocol to follow if participants become distressed during participation 
This protocol has been devised to deal with the possibility that some participants may become 
distressed and/or agitated during their involvement in this research. There follows below a three-step protocol 
detailing signs of distress that the researchers will look out for, as well as action to take at each stage. It is not 
expected that extreme distress will occur, nor that the relevant action will become necessary. However, it is 
included in the protocol, in case of emergencies where professionals cannot be reached in time. 
Mild distress: 
Signs to look out for: 
1) Tearfulness 
2) Voice becomes choked with emotion/ difficulty speaking 
3) Participant becomes distracted/ restless 
Action to take: 
1) Ask participant if they are happy to continue 
2) Offer them time to pause and compose themselves 
3) Remind them they can stop at any time they wish if they become too distressed 
 
Severe distress: 
Signs to look out for: 
1) Uncontrolled crying/ wailing, inability to talk coherently 
2) Panic attack e.g., hyperventilation, shaking, fear of impending heart attack  
3) Intrusive thoughts of the traumatic event e.g., flashbacks 
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Action to take: 
1) The researcher will intervene to terminate the interview/experiment. 
2) The debrief will begin immediately 
3) Relaxation techniques will be suggested to regulate breathing/ reduce agitation 
4) The researcher will recognise participants’ distress, and reassure that their experiences are normal 
reactions to abnormal events and that most people recover.  
5) If any unresolved issues arise during the interview, accept and validate their distress, but suggest that 
they discuss with mental health professionals and remind participants that this is not designed as a 
therapeutic interaction 
6) Details of counselling/therapeutic services available will be offered to participants 
 
Extreme distress: 
Signs to look out for: 
1) Severe agitation and possible verbal or physical aggression 
2) In very extreme cases- possible psychotic breakdown where the participant relives the traumatic 
incident and begins to lose touch with reality 
 
Action to take: 
1) Maintain safety of participant and researcher 
2) If the researcher has concerns for the participant’s or others’ safety, he will inform them that he has a 
duty to inform any existing contacts they have with mental health services, such as a Community 
Psychiatric Nurse or their General Practitioner. 
3) If the researcher believes that either the participant or someone else is in immediate danger, then he 
will suggest that they present themselves to the local Accident and Emergency Department and ask 
for the on-call psychiatric liaison team. 
4) If the participant is unwilling to seek immediate help and becomes violent, then the Police will be called 
and asked to use their powers under the Mental Health Act to detain someone and take them to a 
place of safety pending psychiatric assessment. (This last option would only be used in an extreme 
emergency)     
 
© Chris Cocking, London Metropolitan University Nov 2008
THE EXPERIENCE AND SENSE MAKING OF PROBLEMATIC MEPHEDRONE USE      135 
 
 
 
 
Appendix R 
A worked example of Daniel’s transcript
THE EXPERIENCE AND SENSE MAKING OF PROBLEMATIC MEPHEDRONE USE       136 
 
 
 
 
THE EXPERIENCE AND SENSE-MAKING OF PROBLEMATIC MEPHEDRONE USE      137 
 
 
 
 
 
Appendix S 
Superordinate theme table with quotes 
 
Table 8: 
 
Superordinate themes with quotes  
Superordinate theme Subordinate theme Quotes 
1) Mephedrone as a credulous fix for 
ongoing identity vulnerability and 
distress, initiating a vicious cycle of 
deliberate use 
 
1a) A way of connecting that creates a 
false-sense of belonging 
 
“I felt like a kid again, I felt like being back in school. I was around a lot of people, we was all around the 
same age, a bit younger. We were like a big crew, was like a big family and erm (…) nobody could tell us 
nothing, and we were just having the best, we were having the best amount of times. Erm people was like 
taking pictures, it was just like, people, everyone, like, became, everyone was defending each other. Like 
people would buy each other drinks, and just like, as much as it sounds trivial now it’s really really really (..) 
a life that would love as a kid. Like whoever’s in school now, if you got friends like the friends that I had 
back then, that was so supportive of you, made you feel like you’s a part of something, and you was erm, 
you was, you was wanted, and that’s how they made you feel and that is that, that’s exactly the thing I 
holded onto.” (Daniel, p.11, L76) 
1b) The externalisation of “deep 
psychological damage” allows for short-
lived appeasement 
 
“You know just use more and get high (laughs), yeh then all these thoughts are gone.” (Alexander, p.18, 
L120) 
 
“And then they use that as an excuse as well to go on and on and on to numb you, block you out the past, 
block you out the reality, so you don’t have to face your problems no more. Like any particular drug, like 
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every drug that people use as an excuse, as a shield to be behind that drug, you know, as an excuse.” 
(Robert, p.7, L76) 
1c) The attempt to create of an 
empowered, idealised false-self through 
calculated mephedrone use 
 
“For me what I, because I did physics in Brazil for one year, to me it was good, cos I like the drug because 
of what it was does to my brain (..) it bombs my brain, my brain was like if I, there’s a certain amount that 
drug that makes your brain like better. For example, calculus, I studied calculus it was 1996, between 96 
yeh, I did, I did physics in one university, I did half a year for computers in another university. That’s two 
courses at the same time. So when I was doing the calculus, calculus is very heavy at university, so I 
remember calculus since I put that drug back. So my brain was, that’s the thing, I love the drug, because 
my intelligence, my brain was working like it never had before.” (Robert, p.10, L100) 
 
“…you feel like your your mind is expanded too where you, erm, able to express yourself in the way you’ve 
always wanted to be able to express yourself, erm you get back to everyone’s messages, then you may 
have been avoiding, emails that you haven’t been getting back too, job erm, app- applications that I’d been 
wanting to fill out but didn’t have the confidence.” (Daniel, p.7, L58) 
 
“At first, it was, I can do anything erm, I was stupid but I went to class, a dance class, erm high, because it, 
I was finishing a party, what we call a party or session, and I had to get to class, because I was missing 
classes a lot, so I got to class and (..) I did the class and somehow after class everyone said that was 
amazing, you done the best you ever could, but I was high on mephedrone (laughs), and other drugs too, 
but I was really high, erm so it was kinda, it didn’t help (laughs) it didn’t help that my mind honestly went 
“ah I could do more”, and so I kept that’s, I kept taking it, I kept taking it as if its fine…” (Josh, p.10, L72) 
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“Well it can go, also for example, if you feel, I already been paranoid little bit, as a person, as a personality 
I’m paranoid. But at work if you use mephedrone and your dealing with customers, it just blank yourself, 
you don’t care about other things, it just like…it doesn’t matter. I don’t care. You keep going and you feel 
strong, and then you, no don’t paranoia about washing, they think your clean or what. Sometimes you have 
an awkward moment with the customer, you know I should have said that or I shouldn’t have, but then there 
I times when I think, good, I said, I said whatever, I don’t mind, why you think like that, it’s okay, it’s up to 
you (laughs).” (Greg, p.13-14, L116) 
2) The paradoxical experiences of 
progressive mephedrone use 
2a) “Love at first sight” versus a devilish 
mistake 
 
“…most amazing time of my life…” (Greg, p.6, L50) 
 
“It was love at first, first sight, I loved it. I loved it above everything else…” (Daniel, p.10, L74) 
 
“I don’t wanna, I don’t wanna do this, I kept fight against that.” (Josh, p.4, L40) 
 
“Oh at this point I start hate it. That’s the time I started hating, and that the time I I face the drug, not like a 
good feeling for doing it anymore, but as a trap. So I faced it as an enemy.” (Alexander, p.20, L186) 
2b) Naive control versus a sense of 
being out of control 
 
“…the small amounts will get more intense to the point you cannot control it anymore…” (Robert, p.15, 
L144) 
 
“…yeh I always have the thought that you’re controlling it, when you want to stop, you stop but the 
mephedrone is controlling you…” (Alexander, p.11, L82) 
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“I was, there was bags of it, and we would, er, it took like two of us, just going through it, going through it, 
it was more than 100grams I could go through…” (Daniel, p.15, L88) 
 
“I can control it I can control it, I can juggle it both, and it started getting to the point, I started realising you 
can’t juggle it both…” (Greg, p.10, L72) 
2c) A desirable need versus a “pointless” 
activity 
 
 
 
“…meph is addictive you have to have it, that’s the upgrade, because when you have it it’s amazing! Your 
fulfilling you want it more.” (Josh, p.27, L158) 
“Snorting its erm, you see mephedrone you might say it’s not addictive, but if you take it, you feel like er 
you have to do it again.” (Alexander, p.16, L106) 
 
“…hustling, survival type way, because you know you’re gonna want this substance to last for as…” (Daniel, 
p.8, L66) 
 
“…and we didn’t even had sex and we just took it watched family guy. I guess that even made it even 
worse, taking drugs and doing nothing with it (laughs) it’s not fun.” (Josh, p.17, L92) 
 
“I’m wasting my life…” (Alexander, p.19, L104) 
 
“So you start to realise all these things, after all those uses, all these nightlife, all these enjoyable ones that 
I’m not getting nothing out of it, I’m just destroying myself I’m not getting nothing…” (Greg, p.7, L64) 
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3) Making-sense of one’s problematic 
mephedrone use via self-reflective 
processes 
3a) Stigmatising beliefs assist in the self-
identification of problematic mephedrone 
use 
“Oh it’s still looked at. Its different stages I mean, I would say, erm the straight community or the world in 
general look at injecting as bad I can’t blame them, injecting drugs that sounds bad, straight away… When 
you snort with the same straw, (laughs) you might as well, it’s the same thing as passing a needle, and I’ve 
had huge arguments about it because people don’t see it like that. And the gay community most people 
see it bad as well. There’s only a handful of people that inject…” (Josh, p.29, L164) 
 
“Oh it’s still looked at. Its different stages I mean, I would say, erm the straight community or the world in 
general look at injecting as bad I can’t blame them, injecting drugs that sounds bad, straight away… When 
you snort with the same straw, (laughs) you might as well, it’s the same thing as passing a needle, and I’ve 
had huge arguments about it because people don’t see it like that. And the gay community most people 
see it bad as well. There’s only a handful of people that inject…” (Josh, p.29, L164) 
“Yeh, because their lifestyles completely different. You’ve gotta have, from what I’ve learnt, you’ve got to 
have, erm, a lot of money to supply that that addiction, and that means you man rob people’s houses and 
their rob cars and st-, and their phones and stuff. You’re even robbing at erm at the cash point. You’re not 
gonna get someone on mephedrone tryna rob you at the cash point, or trying to erm, they haven’t got to, 
they haven’t got a £300 a day drug addict. Its £20 for a gram, [laughs] it’s a bit of difference in the, in the 
value. And by the way they take it as well, and the way that erm heroin is easier easier easier to pass away 
on that drug…” (Daniel, p.27, L154) 
3b) A critical incident that triggers the 
self-evaluation of one’s mephedrone use 
as subjectively problematic 
 
“And when I got home, my mum was like “you look tired and grey”, I’m like “Oh what do you expect, I just 
came back, I’ve been partying for 6 days”. I’m saying it so casually like it’s the normal thing. Erm I ended 
up going to sleep, and I just felt my body just go so limp, and I was like “oh mum what’s going on” and I can 
remember hearing voices of my mum screaming when she was erm, being attacked by her boyfriend before 
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when I was younger. And I’m like “oh my god why could I hear that”, I need to get up and help her, but I 
couldn’t move.  I was like “what? What is going on here? What is what is happening?” I thought no this 
cannot be happening. To me, I I really thought, all it was, I was passing away. I tried everything within me, 
to try and get out this limp feeling, and then I went [inhale and exhale of breath] a deep breath and woke 
up.  So I started to cry. Then I went to hospital, and erm they told me, basically that I’m just so exhausted. 
So my body won’t be willing to (..) sleeping, direct sleep but my mind was still active, so you’ve had that. 
Oh what’s it called, I can’t I can’t, oh I forgot the word they mentioned, but after that episode I, I, I, ended 
up going hospital quite a few times after that. And I’m realising “what the hell, why am I always in hospital 
on a drip?”” (Daniel, p.14-15, L86) 
  
“Oh the worst you can imagine. You you you think everything. You never gonna be cope in your life no 
more. Your life is done. You’ve damaged your family. All, all kind of things you know. It comes some in your 
mind.” (Alexander, p.19, L180) 
“I would come into the work high and he would instantly give me orange juice, cos it’s a common thing that 
orange juice cuts it down. Erm, and he would let me go off sometimes, get off early because I would just 
be so tired. It wasn’t until he took action erm because it got out of control, that he gave me a warning and 
it helped me, it pushed me in the right direction. I’m grateful for him.” (Josh, p.11, L76) 
 
“…what’s it doing to my family? And then until I went to rehab, I didn’t realise until they send back there 
questioning, how much I was actually hurting them, and I was hurting them a lot more then I was hurting 
me.” (Daniel, p.15, L86) 
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“Probably when you come down off these drugs you feel bad because, you waste how many days, you 
don’t go to work. You’re gonna upset your manager and you have too many appointments you miss them, 
too many parents call you never answer.” (Alexander, p.17, L110) 
 
“…(Laughs) You know, too many things happen. Like last time, some people I was using drugs with, they 
say I’m gonna stop, I’m not gonna use anymore. One of them came to my house, and they say you know 
last time when you brought your laptop I accessed your apple ID and stuff, and he’s studying technology, 
and then I said connect to apple ID and he did it. He got all my contacts, and they say remember when you 
come out at this chill-out or sex party you never know what they are doing. So you remember when we took 
a computer picture, they say if you do not come back to that sex party and buy us drugs, were gonna send 
this picture to, and we spent almost the last two months together. You think you are friends and stuff. And 
you may think that that person is good, but once they use drugs they will do everything. So at that point I 
recorded, as soon as I seen that guy it was the afternoon, so we sit outside and I record his voice and when 
he knew that I recorded what he was saying, he kind of backed off. So this is an example of it, I knew him 
for 2 months, spent all our time together and you can feel that person is good, but for him to get drugs he’ll 
do anything, so that makes you feel bad. It’s a waste.” (Alexander, p.14, L92) 
 
“I started missing two, three days of work together, two, three days, two, three days. You know it’s going to 
be a problem, if you spend a lot of money and you’re not going to work so there’s no income, I’m just 
spending, spending…” (Greg, p.17, L108) 
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3c) An internal debate between desires 
versus’ values and beliefs that motivates 
change 
“I felt guilty and good at the same time, it was a mix feeling like shouldn’t have done it, but I done it and I 
liked it…” (Greg, p.3, L30) 
 
“Like always I think, I always believe I can do better than this, and that I know this is wrong but you keep 
doing it, you keep doing it, so yeh I always have the thought that you’re controlling it, when you want to 
stop, you stop but the mephedrone is controlling you…” (Greg, p.11, L82) 
 
“I never brought it home into my home. I brought it home in ***, but I never brought it home in *** because 
that’s my own, my family lives. Spiritually that’s where I wouldn’t wanna bring something, the devil made 
into the Gods home. Erm, and that’s how I looked at it. I looked at it’s a bad, it’s the devils tool.” (Josh, p.22, 
L136) 
 
“I don’t know, I always knew I was having a problem. Drugs for me were something very scary. I grew up 
in the middle of people that were scared about drugs. You know drugs and alcohol all meant nothing to us, 
were scared about it. So sooner or later that thing, will come back, doesn’t matter how high you are .” 
(Robert, p.13, L126) 
 
  
 
